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Preface 
 
This dissertation is the product of the efforts to characterize radiation induced 
fibrosarcoma (RIF-1) tumors via diffusion and fluorine-19 (19F) nuclear magnetic 
resonance in vivo. 
 
The first stage of experiments concentrated on the spectroscopic characterization of water 
diffusion in RIF-1 tumors. New theories developed to understand the diffusion behavior 
of water molecules in porous media were applied to water diffusion in solid tumors. 
Studies conducted by my predecessors verified the theory in model systems such as rocks 
and glass beads.  Later, slight modifications were undertaken to account for differences 
between porous media and biological systems. The validity of the application in 
biological systems was then tested on red blood cells and murine tumors.  
 
The studies in this dissertation are a continuation of their efforts and the application of 
these tools to characterize RIF-1 tumors in vivo. Chapter 3 shows that the return-to-the-
origin (RTO) probability and the apparent diffusion coefficient (ADC), as measured by 
diffusion-weighted magnetic resonance spectroscopy, are sensitive to structural changes 
as induced by the development of tumor necrosis. Since spectroscopic measurements do 
not provide spatial information of these changes, diffusion-weighted magnetic resonance 
imaging was employed to measure the RTO probability and the ADC on a pixel-by-pixel 
basis (Chapter 4). Several technical problems needed to be overcome. For example, with 
imaging the signal-to-noise ratio was reduced due to fewer spins being interrogated in the 
 v
imaging slice and the lengthened echo time (TE) needed to accommodate the imaging 
acquisition time. Several adjustments to the imaging procedure were necessary and 
needed to be verified.  
 
The imaging experiment showed the ability of both the apparent diffusion coefficient 
(ADC) and RTO to detect necrotic tumor tissue. In spite of differences in slice thickness 
between magnetic resonance imaging (MRI) and histological analysis, regions of 
histologically-defined necrosis where spatially correlated with specific regions of the 
ADC and RTO maps. The study suggested that the ADC and RTO could be used to 
monitor tumor structural changes in response to chemo- or radiation therapy. 
 
Chapter 5 deals with the effects of changing the diffusion gradient duration in diffusion-
weighted magnetic resonance imaging on the measured ADC. Most of the clinical 
systems have limited diffusion gradient strength and compensate for it by lengthening the 
diffusion gradient duration and with it the MRI echo-time. This increase in gradient 
duration is a direct violation of the "δ-function pulse width criterion" in which the 
diffusion gradient pulse width is much smaller then the diffusion gradient separation and 
causes the resulting measurement to be similar to the constant-gradient variant of the 
diffusion experiment. With significant diffusion occurring during the long diffusion-
gradient pulse, we investigated the extent to which the measured diffusion coefficient is 
altered by working in the constant-gradient regime rather than the δ-function regime. 
 
 vi
Chapter 6 deals with the assessment of tumor oxygen status in RIF-1 tumors during 
treatment using the perfluorocarbon (PFC) perfluoro-15-crown-5-ether. Experiments 
conducted by my predecessors produced promising results, but required a large imaging 
slice thickness. Since changes in oxygen tension during therapy were expected to occur 
on cellular level, the imaging slice thickness had to be reduced as much as possible. The 
injection procedure was modified to increase the concentration of PFC within the tumor 
and modifications to the NMR pulse sequence allowed the imaging slice thickness to be 
reduced to a value that provided acceptable spatial resolution. The second problem was 
the clearance of the PFC from the tumor during therapeutic intervention. Multiple PFC 
injections allowed the tumor oxygen status to be monitored after chemotherapy 
administration. 
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Abstract 
 
Diffusion-weighted nuclear magnetic resonance has gained widespread use in the 
characterization of various diseases. Developments in the area of porous media theory 
have been successfully transferred and adapted for the use in biological tissue. 
Measurement of the displacement of diffusing water molecules can reveal structural 
information about the environment in which the molecules translate. The return-to-the-
origin (RTO) probability and the apparent diffusion coefficient (ADC) are based on the 
diffusion behavior of water molecules in a restricted environment. Water molecules in 
restricted space have smaller displacements, for a given diffusion time, than water 
molecules diffusing in bulk solution. 
 
The cell membranes and organelles in healthy biological tissue impart more restrictions 
on diffusing water molecules as compared to necrotic tumor tissue. In necrotic tissue the 
degradation of cellular structures by auto- and/or heterolysis allows water molecules to 
diffuse over larger distances without encountering restrictions. The spectroscopic 
measurement of the RTO probability and the RTO enhancement in RIF-1 tumors showed 
that the RTO probability is sensitive to these changes in structure. The study showed that 
smaller tumors, which are less necrotic, have a larger RTO probability and enhancement 
than larger RIF-1 tumors with a higher fraction of necrotic tumor tissue. 
 
Extension of the methodology to NMR imaging was used to answer the question if the 
RTO probability can provide spatial information about the necrotic area within RIF-1 
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tumors. The necrotic area measured by the ADC and histology were compared. While 
neither ADC or RTO could show its superiority over the other, both methods showed a 
good correlation between their mean values and the necrotic area fraction as measured by 
histology. The mean ADC and the mean RTO enhancement had a correlation with the 
necrotic tumor fraction, as determined by histology, of r = 0.86 and r = -0.82, 
respectively. Conventional T2-weighted images of the same tumor slice showed a poorer 
correlation (r = 0.62) with the necrotic fraction and no visual agreement with the 
histology. The general features of the ADC and RTO enhancement were in agreement 
with histology, however, more exact comparisons where not possible due to the large 
differences in slice thickness between the two techniques. 
 
Structural changes similar to those caused by tumor tissue necrosis can be induced by 
chemo- and radiation therapy and ADC and RTO enhancement were used to monitor 
these changes non-invasively.  RIF-1 tumors were grown on the hind leg of C3H mice 
and monitored daily by diffusion-weighted MRI. ADC and RTO-enhancement maps 
were created using data acquired from control animals and animals treated with 100 
mg/kg 5-Fluorouracil. Both ADC and RTO proved to be useful in the early detection of 
the efficacy of treatment as well as for monitoring the progress of therapy. 
 
Diffusion measurements by pulsed-field-gradient (PFG) MRI have become an important 
tool for detecting of pathophysiological changes caused by cancer and stroke. The 
increasing popularity of diffusion measurements has initiated their use on clinical MRI 
systems that have limited magnetic-field-gradient strength. These limitations make it 
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necessary to lengthen the diffusion-gradient duration to ensure sufficient signal 
attenuation for calculating the ADC. Unfortunately, increasing of the diffusion-gradient 
duration to a large extent violates the theoretical model used in the ADC calculation. The 
diffusion measurements are not performed in the finite pulse width regime, but rather in 
the constant gradient regime, requiring a different interpretation of the results. 
Examination of the differences in the measured diffusion coefficient showed that 
increasing both the diffusion-gradient duration and the echo time have a significant 
impact on the results of a diffusion measurement. 
 
A different way to assess changes in RIF-1 tumors as a function of treatment is the 
measurement of the tissue oxygen status. Cell hypoxia has long been linked with 
treatment resistivity and reoccurrence in cancers, where the oxygen status is a 
determining factor of treatment outcome. Perfluorocarbons (PFC's) have been used 
successfully to assess the tumor oxygen status in the past, but required a large MRI slice 
thickness due to compensate for the low PFC concentration. The tissue oxygen status of 
the tumor is assessed by intravenous injection of a PFC that is subsequently sequestered 
in the tumor. The measurement of the T1-relaxation time of the PFC allows the 
calculation of the oxygen content, which is linearly related to the relaxivity and the 
temperature. Fluorine-19, multiple-slice, inversion-recovery echo-planar imaging (EPI) 
allowed high spatial resolution assessment of the tissue oxygen status over the entire 
tumor. The results demonstrated that there is a large variation in tissue oxygenation 
between adjacent slices. Comparison of the oxygen distribution between various tumors 
 x
also showed that there is no common pattern in the spatial distribution of oxygen within 
the tumor. 
 
Monitoring of the oxygen status during chemotherapy showed an increase in hypoxic 
tissue and a reduction in tumor size in response to the toxicity of the chemotherapeutic 
agent. As the effects of the treatment subsided, rapid cell proliferation caused the tumor 
to regrow and a subsequent decrease in tissue oxygen tension was observed. The study 
clearly demonstrated the changes in oxygen tension in response to chemotherapy and the 
need for multi-slice MRI acquisition at high spatial resolution to detect these changes. 
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Chapter 1 
 
Nuclear Magnetic Resonance Theory 
 
 2
1.0  Nuclear Magnetic Resonance 
The phenomenon of nuclear magnetic resonance (NMR) has come a long way since its 
discovery by Bloch (Block, Hansen and Packard, 1946) and Purcell (Purcell, Torrey and 
Pound, 1946). NMR is a methodology to study the behavior of assemblies of large 
numbers of atomic nuclei in a magnetic field. The nuclear property that is of interest in 
NMR is its angular momentum or spin. The placement of atomic nuclei with spin in a 
constant magnetic field will result in the separation of a single energy level into multiple 
energy levels. The energy difference between states is proportional to the applied 
magnetic field strength. This splitting of energy levels is known as the Zeeman effect. At 
thermal equilibrium, the number of nuclei in lower energy states is slightly higher than 
the number of nuclei in higher energy states. Nuclei can move from a lower energy state 
to a higher by absorbing energy or relax from a higher to a lower energy state by 
transferring energy to the molecular lattice. 
 
In NMR we are interested in the angular momentum or spin of the nuclei. Since nuclei 
are positively charged, the spins can be modeled as a current loop with a resulting 
magnetic moment. At equilibrium, in the absence of an external magnetic field, the net 
magnetic moment of an ensemble of nuclei is zero. Exposing the nuclei to an external 
magnetic field leads to the splitting of a single energy level into multiple energy levels 
with different occupancy and hence a non-zero net magnetic moment. Following 
radiofrequency (RF) excitation the magnetic moment precesses around the direction of 
the applied magnetic field and induces a signal in a RF receiver coil that is proportional 
to the magnitude of the net magnetic moment of an ensemble of nuclei. As the spins 
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return to their equilibrium position, the net magnetic moment decreases toward zero. The 
rate of the return to equilibrium is dependent upon the environment of the nuclei and 
analysis of the decaying signal contains information about that environment. 
 
For many years NMR was used as a spectroscopic tool, before its use for imaging was 
proposed (Lauterbur, 1973). The number of different imaging techniques has increased 
since Lauterbur's proposal and advances in technology have significantly improved the 
quality of NMR images. Today, magnetic resonance imaging (MRI) is a widely accepted 
tool in the clinical environment for the detection and diagnosis of various diseases.  
 
To understand the formation of NMR spectra and images one needs to have an 
understanding of the underlying physics governing the formation of the signal. This 
chapter gives a brief introduction into the fundamentals, origin, generation, acquisition, 
and processing of the NMR signal and discusses only the relevant principles for the work 
in this dissertation. For a more detailed description of the physics and principles of NMR 
the reader may consult numerous references (Abragam, 1962; Morris, 1986; Smith and 
Lange, 1998; Salib and Brown, 1998). 
 
 
1.1  The Magnetic Field 
Between the two poles - north and south - of a magnet is a force field. The same force 
field produced by a permanent magnet can also be produced by an electrical current 
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flowing through a conductor. The magnetic field strength induced by a current, I, through 
an n-turn circular conductor of radius, r, is given by: 
 
( )
r
nlrH π2=                                                      [1.1.1] 
 
The magnetic field strength and the magnetic induction or flux density, B , have the same 
orientation in a vacuum and are related through the magnetic field constant, 0µ . 
 
HB 00 µ=                                                   [1.1.2] 
 
Introduction of material into the magnetic field changes the magnetic flux density in the 
material from 0B  to B  since the material can be polarized and contribute to the magnetic 
field strength, H , over the magnetic field constant, 0µ , and the dimensionless 
proportionality factor known as the susceptibility constant, χ . 
 
( )HB χµ += 10                                            [1.1.3] 
 
A examination of Eq. [1.1.3] shows that a sample in a magnetic field can alter the 
magnetic flux density to values larger or smaller than the values generated from the 
magnetic field strength, since χ  can be either negative or positive. This phenomenon is 
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of great importance in NMR since a change in the magnetic induction influences the 
NMR signal. 
 
 
1.2  Physical Principles 
The basic physical principles governing the NMR phenomenon are described by the 
behavior of nuclei exposed to an applied magnetic field. The following sections are a 
short description of these physical principles. 
 
 
1.2.1  Property of the Spin 
An important characteristic of the nucleus is the nuclear spin, which is the fundamental 
requirement for NMR. Spin is an inherent property of all protons and neutrons but only 
nuclei with a non-zero spin can be 
observed with NMR. The movement of 
protons, a small spherical positive 
charge distribution, and neutrons with 
their associated mass generates an 
orbital angular momentum, P . The 
rotation of the charge distribution 
around its center axis produces a small 
magnetic field. Even neutrons with 
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
µ
Fig. 1.2.1.1: A way to model the nuclear
magnetic moment of a proton is to
consider it as a spherical charge
distribution rotating around its axis.
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their unevenly distribution of positive and negative charges generate small magnetic 
fields. These small magnetic fields are called the nuclear magnetic dipole moment, µ . 
The relation between µ  and the nuclear angular momentum, P , is given by  
 
Pγµ =                                                  [1.2.1.1] 
 
where γ , the gyromagnetic ratio, is the proportionality constant for a given nucleus. The 
gyromagnetic ratio is a unique value for each nucleus and is proportional to the charge-
to-mass ratio of the nucleus. Table 1.2.1.1 shows the gyromagnetic ratios for nuclei 
commonly observed by in vivo NMR. 
 
 
1.2.2  The Nuclear Angular Momentum 
Classically the angular momentum, P , could be oriented in any direction and has an 
arbitrary magnitude. Quantum mechanically, however, the angular momentum can only 
have discrete (quantized) values given by: 
 
Nucleus 13C 23N 31P 19F 1H
γ /2π (MHz/T) 10.71 11.27 17.25 40.08 42.58
Table 1.2.1.1: Gyromagnetic ratios, γ, for nuclei commonly 
observed by in vivo NMR. 
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( )1+= IIP                                             [1.2.2.1] 
 
where  is Planck's constant, h, divided by 2π, and I is the spin quantum number (I = 0, 
1/2, 1, 3/2,...), which depends on the internal structure of the nucleus. Individual protons 
and neutrons have a spin quantum number of 
I = 1/2 and form pairs (one spin up and one 
spin down) causing a cancellation of their 
respective nuclear angular momenta. Nuclei 
with an odd number of protons and/or 
neutrons have unpaired spins resulting in a 
non-zero nuclear spin quantum number, I. In 
addition to the magnitude, the angular 
momentum has a direction, which can also be 
shown to be quantized. Allowed directions for the vector are limited to values 
corresponding to the values of zP  given by 
 
Iz mP =          with IIIImI ,1,...,1, −+−−=                                   [1.2.2.2] 
 
where Im  is referred to as the directional (or magnetic) spin quantum number. For a spin-
21  nucleus, Im  can only have the values of 21+  and 21−  yielding only two possible 
θ
θ
2
3
=P

2
3
=P
{
{
2
=zP
2
−=zP
Figure 1.2.2.1: The angular
momentum of a spin-1/2 system
and its possible orientations.
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orientations of P  (as represented in Fig. 1.2.2.1) with 4454cos 1 ′=





=
− oz
P
Pθ , 
2
±=zP  
and 
2
3
=P . 
 
 
1.2.3  The Nuclear Magnetic Dipole Moment 
The nuclear magnetic dipole moment, µ , is related to the angular momentum, P , by the 
gyromagnetic ratio, γ , as defined by Eq. [1.2.1.1]. Since P  is quantized (Eq. 1.2.2.1), 
then µ  must also possess discrete values by association through Eq. [1.2.1.1]. 
Combining Eq. [1.2.1.1] and Eq. [1.2.2.1] the nuclear magnetic dipole moment is given 
by 
 
( )1+= IIγµ                ... ,23 ,1 ,21 ,0=I            [1.2.3.1] 
 
The orientation of the nuclear magnetic dipole moment, µ , is always parallel or anti-
parallel to the angular momentum, P , and zero if the angular momentum, P , is zero. 
The energy levels associated with these states are therefore the same and are said to be 
degenerate. In the absence of a polarizing magnetic field the energy of a magnetic 
nucleus is independent of the orientation of µ . 
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1.2.4  The Nuclei in a Magnetic Field 
In the presence of an external magnetic field, 
0B , the degeneracy is removed. The 
potential energy, E, of the interaction 
between the magnetic field, 0B , and the 
magnetic dipole moment, µ , is: 
 
( ) ( )[ ]1cos 000 +=−=•= II
mBBBE Iµθµµ                                       [1.2.4.1] 
 
where θ  is the angle between the orientation of the magnetic field and the nuclear 
magnetic dipole moment. For a magnetic field, 0B , along the z-axis, the potential energy 
of the z-component of the magnetic dipole moment, zµ , is 
 
0BE zµ−=                                                              [1.2.4.2] 
 
where the z-component of the nuclear magnetic dipole moment given by 
 
mPzz γγµ ==              where IIIImI ,1,...,1, −+−−=             [1.2.4.3] 
 
as defined in Eq. [1.2.2.2]. 
 
θ{zµ µ
0B
Figure 1.2.4.1: Interaction
between the magnetic field and
the magnetic dipole moment
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For a spin- 21  nucleus with 21+=Im  and 21−=Im  there are only two possible 
orientations of the nuclear magnetic dipole moment, µ , and hence the z-component can 
only be parallel or anti-parallel with respect to the magnetic field 0B . The energy levels 
associated with each orientation are given by: 
 
2
0
001
BBBE zz
γµµ −=−=−=              for 21=Im               [1.2.4.4] 
and 
 
2
0
002
BBBE zz
γµµ +=−=−=              for 21−=Im              [1.2.4.5] 
 
Consequently, the difference in energy between the two different states is: 
 
0
00
12 22
BBBEEE γγγ =


−−=−=∆                      [1.2.4.6] 
 
In order for a proton to change from one energy state to the other one it needs to emit or 
absorb the energy difference, E∆ , in the from of a photon which can be found by Bohr's 
relation: 
 
υhE =∆                                                 [1.2.4.7] 
 
 11
Combination of Eq. [1.2.4.6] and [1.2.4.7] yields: 
 
υ
π
γ hhB =
2
0                                                [1.2.4.8] 
 
and can be simplified to 
 
0
0
2
1
2
Bγ
ππ
ω
υ ==                                           [1.2.4.9] 
 
Equation [1.2.4.9] indicates that resonance absorption, inducing the transition from one 
energy state to the other, occurs at the Larmor frequency which is directly proportional to 
the magnetic flux density by the gyromagnetic ratio. 
 
Classical physics provides a different way to visualize the behavior of the magnetic 
dipole moment in an external magnetic field. Viewing the magnetic dipole moment, µ , 
as a small magnet that is oriented at an angle, θ , with respect to the magnetic field, 0B , a 
torque is applied to the magnetic dipole moment, µ , causing it to precess around, 0B . 
The precession can be described by the Larmor frequency: 
 
0B×= µγω                                            [1.2.4.10] 
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1.2.5  Bulk Magnetization 
Up to this point we have only considered the behavior of a single isolated proton exposed 
to an applied magnetic field. The NMR signal arises, however from the vector sum of a 
large number of nuclear magnetic dipole moments, µ . In the absence of a magnetic field, 
the magnetic dipole moments are randomly oriented (Fig. 1.2.5.1) within the sample and 
the resulting net magnetic moment is zero. The application of a magnetic field, 0B , 
causes the nuclei to precess about z-axis at the Larmor frequency at an angle 0θ . 
Depending on their state, some nuclei precess about the -z-axis and the other nuclei about 
the +z-axis, forming two cones of precession (Fig. 1.2.5.2). In most materials at room 
temperature more protons precess in the upper cone than in the lower resulting in a net 
Figure 1.2.5.1: Random orientation of the
individual magnetic moments in a bulk
sample in the absence of a magnetic field.
The resulting magnetic moment of the
sample is zero.
Figure 1.2.5.2: The spin-½ nuclei of a
bulk sample in a magnetic field
precess about B0 in two cones
corresponding to the parallel and anti-
parallel state.
0B
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magnetization, 0M . The phase distribution of the nuclei in the upper and lower cone are 
randomly distributed and cancel, so there is no net transverse magnetization. 
 
The distribution of the magnetic dipole moments between the lower energy state 
(parallel), α, and the higher  energy state (anti-parallel), β, is shown in Fig. 1.2.5.3. For a 
spin-½ system, the spins will be distributed between the energy levels according to the 
Boltzmann distribution. The ratio of the populations is given by 
 
kT
E
kT
E
kT
E
e
e
e
N
N ∆−
−
−
==
α
α
β
β
                                                    [1.2.5.1] 
 
where αN  and βN  are the number of 
nuclei in the respective energy levels 
αE and βE , αβ EEE −=∆  is the energy 
difference between the two levels, 
K
Jxk 231028.1 −=  is the Boltzmann 
constant, T is the temperature in Kelvin 
and  
 
βα NNNT +=                                              [1.2.5.2] 
 
E2(β)
E1(α)
Nβ
Nα
E
Figure 1.2.5.3: The two energy states
α and β for a spin-½ system with spin
population according to the Boltzmann
distribution.
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is the total number of nuclei. NMR measures the population difference, n∆ , between the 
energy states, which is given by: 
 
kT
E
kT
E
e
eNNn ∆
−
∆
−
+
−
=−=∆
1
1
βα                                                   [1.2.5.2] 
 
Using the high "temperature approximation", where 1<<∆ kT
E , and approximating an 
exponential using a Taylor's series expansion leads to: 
 
kT
ENNNn T 2
∆
≅−=∆ βα                                  [1.2.5.3] 
 
Equation [1.2.5.3] represents an estimate of the population difference between the 
number of nuclei aligned with or against the externally applied magnetic field. The 
magnetization, 0M , is a result of the vector sum of the individual magnetic moments and 
can be represented by 
 
( ) ( )
kT
BnnM z 42
1 0
22
0
γγµ =∆=∆=                                  [1.2.5.4] 
 
or if we return to the classical approach, the net magnetization can be represented as the 
sum of the individual dipole moments (Fig. 1.2.5.4). Summation over the individual 
dipole moments (magnets) yields Eq. [1.2.5.5]. 
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( )×== 00 BdtdM


µγµ                                  [1.2.5.5] 
 
Examination of the Eqs. [1.2.5.4] and [1.2.5.5] reveals that the net magnetization 
increases in magnitude proportional to the applied magnetic field. 
 
 
1.3 Radio-Frequency Pulses and the Rotating Reference 
Frame 
Bloch (1946) developed a set of differential equations to describe the behavior of the 
macroscopic magnetization, 0M , in the presence of a magnetic field. The full Bloch 
equations in the laboratory frame reference are given by 
 
0B
0M
Figure 1.2.5.4: The individual nuclear magnetic dipole moments exposed
to a magnetic field sum up to the net magnetization, M0, since more
magnetic dipole moments are aligned parallel rather than anti-parallel to
the field.
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( )
2
10 sin T
M
MtBMB
dt
dM x
zy
x
−+= ωγγ                                    [1.3.1] 
( )
2
10 cos T
M
MtBMB
dt
dM y
zx
y
−+−= ωγγ                                 [1.3.2] 
( ) ( )[ ]
1
0
1 cossin T
MM
MtMtB
dt
dM z
yx
z −
−+−= ωωγ                 [1.3.3] 
 
where B0 is the static magnetic field, B1 is the magnetic field induced by the RF field, Mx, 
My, Mz, the x-, y- and z- components of the 
magnetization vector, respectively, T1 the  
longitudinal-relaxation time and T2 the transverse-
relaxation time. The Bloch equations can predict 
the behavior of the net magnetization during a 
NMR experiment, but the calculations are 
laborious. The Bloch equations are easier to solve 
in a coordinate system rotating around 0B  at the 
Larmor frequency, 0ω . In this frame the equation of the motion of the net magnetization 
can be rewritten as 
 
eff
rotating
BM
dt
Md
×= γ                                [1.3.4] 
 
z
x
yMx
My 
M
M
0B
1B
Figure 1.3.1: The net
magnetization vector, M,
and its components.
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with the effective magnetic field, effB , the vector sum of the static magnetic field, 0B , the 
magnetic field from the applied RF pulse, 1B , and the fictitious field, γ
ω , in the rotating 
frame of reference (Fig. 1.3.2). 
 
γ
ω
++= 10 BBBeff                                            [1.3.5] 
In the absence of the magnetic field, 1B , and by setting of the rotating frame frequency, 
ω , equal to the Larmor frequency (Eq. 1.2.4.9), 0ω , the effective field effB , becomes 
Figure 1.3.2: The effective magnetic field, effB , is the resulting vector 
sum of the static magnetic field, 0B , the magnetic field from the 
applied RF pulse, 1B , and the fictitious field, γ
ω , in the rotating frame 
of reference. 
x’
y’
z’
1B

0B

effB
γ
ω
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zero. 
 
000 =+= γ
ω
BBeff                                                       [1.3.6] 
 
Therefore, the motion equation of the net magnetization in the rotating frame (Eq. 
[1.3.4]) is also zero and the net magnetization, M , appears to be stationary. 
 
000 =




+×=×=
γ
ωγγ BMBM
dt
Md
eff
rotating
.                                 [1.3.5] 
 
In the presence of the magnetic field, 1B , from the applied RF pulse and with the rotating 
frame frequency, ω , equal to the Larmor frequency, 0ω , Eq. [1.3.4] simplifies to: 
 
1BMdt
Md
rotating
×= γ                                         [1.3.6] 
 
Thus an RF field oscillating at the Larmor frequency in a plane perpendicular to 0B  
generates a static 1B  field in the rotating frame of reference that is orthogonal to 0B  and 
the spins precess around 1B  at a frequency of 
 
11 Bγω −= .                                              [1.3.7] 
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Rewriting the Bloch equations in the rotating frame of reference (Figure 1.3.3) results in: 
 
( )
2
0 T
uv
dt
du
−−= ωω                                             [1.3.8] 
( ) zMBT
vu
dt
dv
1
2
0 γωω +−−−=                             [1.3.9] 
vB
T
MM
dt
dM zz
1
1
0 γ−

 −
−=                               [1.3.10] 
with  
 
( ) ( )tMtMu yx ωω sincos −=                                          [1.3.11] 
( ) ( )tMtMv yx ωω cossin +=                                        [1.3.12] 
ω
x
x’ y
z, z’
M

y’
vM y ='
uM x ='
Figure 1.3.3: Relation between the laboratory
frame of reference and the rotating frame of
reference.
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A closer look at Eq. [1.3.7] shows that control of the RF field duration allows the 
magnetization vector to precess or tip an angle tipθ  around the orthogonal axis. The tip 
angle, tipθ , can be calculated by 
 
RFtip tB1γθ =                                            [1.3.12] 
 
where RFt is the duration of the RF field pulse, 1B  the magnetic field generated by the 
applied RF field, and tipθ  the flip angle. Varying either the RF field duration or the 
magnitude of the 1B  field allows the flip angle to be controlled. 
 
 
1.4  Nuclear Relaxation 
Relaxation is the process by which the magnetization returns to its equilibrium 
configuration. Introduction of a sample into a magnetic field, 0B , causes the nuclei to 
precess about 0B  at an angle, 0θ , to the axis along the field. Excitation by an RF pulse 
forces the magnetic moments into phase unity, while simultaneously precessing about B1 
increasing the angle between the magnetization vector and the 0B  field. The recovery of 
the magnetization along the longitudinal axis of the 0B  field is termed T1 relaxation and 
the loss of phase coherence in the transverse plane is described by T2 relaxation. 
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1.4.1  T1-Relaxation (Longitudinal or Spin-Lattice 
Relaxation) 
Spin-lattice relaxation is the process by which the spins return to their equilibrium 
distribution following energy absorption imparted by an RF pulse. Absorption of energy 
by nuclei allows them to migrate from the lower energy state (E1) to the higher energy 
state (E2). The number of nuclei undergoing the transition from one energy state to the 
other energy state depends on the duration and magnitude of the imparted energy. Figure 
1.4.1.1 shows the population distribution after the excitation of the nuclei by a 90° and 
180° RF pulse.  
 
E2
E1
B0
E2
E2
E1
E1
900
1800
Figure 1.4.1.1: Distribution of the spin population at equilibrium (left side)
and after excitation by a 900 and 1800 RF pulse. Once excited the spins
return to their equilibrium distribution by the longitudinal relaxation
process. The resulting magnetization along the z axis is zero and -M0 for the
900 and 1800 RF pulse, respectively. The shaded arrows represent spins that
have absorbed energy and changed their orientation with respect to the main
magnetic field.
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The relaxation process by which the spins return to their thermal equilibrium deposits 
energy into the molecular lattice of which the spins are part. Fluctuating electromagnetic 
field components of other magnetic dipole moments in the lattice can interact with the 
spins in the same way that the fluctuating magnetic field from an applied RF pulse 
interacts with the spins. The components at the Larmor and twice the Larmor frequency 
can exchange energy with the spins and give rise to relaxation. The longitudinal 
relaxation can be described by 
 
1
0
T
MM
dt
dM zz −
−=                                            [1.4.1.1] 
 
where T1 is the time constant governing the relaxation process and M0 the equilibrium 
magnetization. Solving of the differential Eq. [1.4.1.1] leads to 
 
( ) 




−=
−
110
T
t
z eMtM                                               [1.4.1.2] 
 
for the case where a 90° RF pulse is used to excite the nuclei. 
 
 
1.4.2  T2 Relaxation (Transverse or Spin-Spin Relaxation) 
Transverse or spin-spin relaxation is a process by which the magnetization in the 
transverse plane losses its phase coherence. Excitation of the net magnetization by a 90° 
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RF pulse, flips the magnetization, M0, into the transverse plane. The spins are now 
oriented along the same axis and therefore their phase difference is zero. The observable 
NMR signal in the transverse plane is the vector sum of the magnetization of the 
individual spins, precessing at the Larmor frequency about the longitudinal axis. Motion 
of other particles in the lattice - especially other nuclei - causes variations in the local 
magnetic field. Nuclei interacting with these particles see either a stronger local magnetic 
field causing them to precess faster or a weaker magnetic field causing them to precess 
slower than the Larmor frequency. This fluctuation, which can be transient as well as 
random, causes the coherent signal to de-phase (i.e., lose its coherence), as the spins 
exchange energy, until there is no net transverse magnetization remaining and the spins 
have again assumed their random phase distribution. 
 
The difference in the precessional frequency of individual nuclei results in a loss of phase 
coherence which is quantified by the relaxation time constant, T2. Mathematically, the 
effect of the T2 relaxation can be expressed as 
 
( ) 20 T
t
xy eMtM
−
=                                              [1.4.2.1] 
 
where xyM  is the transverse magnetization at the time, t, and 0M  is the magnetization 
following a 90° RF pulse for a system that was initially at the Boltzmann equilibrium. 
 
Magnetic field inhomogeneity, molecular diffusion and magnetic susceptibility are other 
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external factors that can cause additional differences in the local magnetic field 
experienced by individual spins resulting in additional loss of the coherence. All these 
contributions are combined in the transverse relaxation time constant, *2T , given by: 
 
( ) ( ) ( )litysusceptibigeneityhomoinfielddiffusion TTTTT 2 222*2
11111
+++=         [1.4.2.2] 
 
 
1.5  The Free-Induction Decay 
The net magnetization can be flipped into the transverse plane by the applied 1B  field 
produced by an RF pulse. After removal of the 1B  field, the transverse magnetization, 
xyM , rotates in the xy-plane at the Larmor frequency. According to the law of Faraday, 
this time-varying magnetic field can induce a current in a receiver coil placed in the same 
plane. The sinusoidal signal induced by the transverse magnetization, xyM , is referred as 
the free-induction decay (FID) as shown in Fig. 1.5.1. Since we observe the signal from 
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Figure 1.5.1: The left side shows the free-induction decay (FID) generated by the
precessing magnetization in the transverse plane. The decay envelope is characterized
by the T2* relaxation constant. The right side shows the same FID seen from the
rotating-reference frame with the rotating-frame frequency equal to the Lamour
frequency.
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the rotating frame of reference, the frequency components contained in the FID are the 
differences between the rotating frame frequency and the precession frequency of the 
nuclei. The decaying envelope enclosing the FID in Fig. 1.5.1 is caused by the loss of 
phase coherence in the xy-plane due to *2T -relaxation effects and the FID can be 
described as 
 
( ) *20 T
t
xy eMtM
−
=                                             [1.5.1] 
 
where xyM  is the transverse magnetization at time, t, and 0M  the initial amplitude of the 
generated signal in the transverse plane following a 90° RF pulse applied to a system at 
the Boltzmann equilibrium. 
 
 
1.6  Fourier Transform 
The FID signal is detected in the time domain and characterized by its amplitude over 
time. The Fourier transform (FT) of the signal is a Lorentzian-shaped peak in the 
frequency domain described by its center frequency and its amplitude. Both the time-
domain and frequency-domain signals contain the same information, but the FT 
facilitates the extraction of multiple frequency components within a signal. The FT of a 
sine-shaped signal is a δ function (Fig. 1.6.1) at the frequency of the sine wave. In NMR, 
spins usually have different resonance frequencies due to differences in their 
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microenvironment. This results in a composite time-domain signal that is the summation 
of sine waves at different frequencies. Fig. 1.6.2 shows the time-domain signal for three 
different sine waves and their Fourier transform in the frequency domain. 
 
The mathematical relation between the time-domain signal, ( )tf , and the frequency-
domain signal, ( )ωF  is given by the FT 
 
( ) ( ) dtetfF iwt∞
∞−
−
=ω                                              [1.6.1] 
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Figure 1.6.1: Single frequency sine-wave in the time domain and its Fourier transform
in the frequency domain.
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Figure 1.6.2: Time domain signal of three sine waves with different frequencies, ω1 =
0.6ω2, ω2, ω3 = 1.4ω2 and their Fourier transform in the frequency domain. Note that all
three sine waves have the same amplitude, which is not apparent in the time domain.
ω3ω2ω1
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and the inverse Fourier transform (IFT) 
 
( ) ( ) ωω
π
ω deFtf ti
∞
∞−
=
2
1
.                                      [1.6.2] 
 
Since the FT and IFT are reciprocal representation of their domain, a simple 
multiplication in one domain is equivalent to a convolution in the other domain. This is 
expressed in the convolution theorem. 
 
( ) ( ) ( ) ( ) ( ) ( )tftftfFFF 2121 ⊗=⇔= ωωω                         [1.6.3] 
 
( ) ( ) ( ) ( ) ( ) ( )ωωω 2121 FFFtftftf ⊗=⇔=                        [1.6.4] 
 
where ⊗  denotes the convolution. Figure 1.6.3 summarizes the most commonly used 
Fourier pairs in NMR. 
 
One of the most important functions in NMR is the exponentially decaying sine wave of 
frequency, 0ω , with an envelope that is characterized by the transverse relaxation time 
constant, *2T . The FID can be written as 
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Figure 1.6.3: Commonly used Fourier pairs in NMR.
Top: The FT of a sine wave is a δ function at the frequency of the sine wave.
Center: The FT of an exponential decay is a Lorentzian function at zero frequency
Bottom: The FT of a rectangular wave from ±τ centered around zero is a sinc function
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( ) *20sin)( T
t
ettf
−
= ω                                           [1.6.5] 
 
The FT of the FID is a Lorentzian centered around 0ω  and has a full-width at half-
maximum (FWHM) of 
 
*
2
1
T
FWHM
π
=                                              [1.6.6] 
 
as shown in Figure 1.6.4. 
Another function of importance is the sine wave with an envelope of a sinc function 
( )
x
xsin . Convolution of the sinc function with a sine wave of frequency, 0ω , results in a 
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Figure 1.6.4: The FID and the Fourier transform of the FID. The frequency of the sine
wave within the envelope determines the center frequency of the Lorentzian and the
transverse relaxation constant, *2T , determines the full-width at half-maximum (FWHM)
of the Lorenzian given by *
2
1
Tπ
.
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rectangular wave centered around, 0ω , after the FT (Fig. 1.6.5). This will be discussed 
further in the section describing magnetic resonance imaging. 
 
 
 
t t t 2/ t
FT
0ω
Figure 1.6.5: A sine wave of frequency, 0ω , with an envelope of a sinc function and its
FT. The rectangular function is centered around the frequency 0ω  of the sine wave and
its width is determined by the sinc function, 
( )
x
xsin
.
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Chapter 2 
 
Spin Manipulation 
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2.0 Spin Manipulation
The previous chapter discussed the relevant underlying physical and mathematical
principles of NMR. This chapter deals with the manipulation of the net magnetization to
extract information from the sample. Most of the methods discussed in this chapter are
based on the evaluation of the amplitude, phase and frequency of the received signal after
excitation by RF energy.
2.1 T1 Measurement
The T1 or spin-lattice relaxation time, as discussed in the previous chapter, is the time
necessary to recover 63% of the equilibrium magnetization along the longitudinal axis
after excitation by RF. Following a 90° RF pulse, recovery of the longitudinal
magnetization is mathematically expressed by Eq. [1.4.1.2]. Figure 2.1.1 shows the
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Figure 2.1.1: T1 relaxation curve following excitation by a 90
o RF pulse. After a
time, t = T1, 63% of the longitudinal magnetization is recovered and after a time, t =
5T1, the longitudinal magnetization can be considered fully recovered for all practical
purposes.
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relaxation of the longitudinal magnetization following excitation by a 90° RF pulse. After
a time period of 5T1, the longitudinal magnetization is considered to have fully recovered
to the equilibrium state.
The T1 relaxation time can be determined by conventional NMR in a number of ways.
One of the most popular is the inversion-recovery (IR) pulse sequence (Fig. 2.1.2). The
IR sequence consists of a 180° RF pulse, which inverts the magnetization along the -z
direction, from where it recovers to its equilibrium state by T1 (spin-lattice) relaxation.
RF
Signal
180o
90o
TI
z
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z
x
y
z
x
y
z
x
y
M 180o 90
o
Figure 2.1.2: Inversion-recovery (IR) pulse sequence. The 180° RF pulse inverts the
net magnetization vector, M. In the following time interval (TI) the magnetization is
allowed to recover along the longitudinal axis towards equilibrium. After the
inversion time, TI, a 90° RF pulse flips the residual magnetization into the transverse
plane, where the signal can be measured.
TI
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Following inversion, the net magnetization vector has no transverse component and
hence is not influenced by the (usually much faster) transverse relaxation, *2T . Following
the 180° pulse, the magnetization recovers during an inversion time (TI) of variable
length. The extent of the recovery is assessed by applying a 90° RF pulse, which tips the
residual magnetization from the -z direction into the xy-plane, where the signal is
acquired. The magnitude of the residual signal (Fig. 2.1.3) depends on TI according to:








−=
−
1210
T
TI
xy eMM                                                   [2.1.1]
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Figure 2.1.3: Signal intensity versus TI for an inversion-recovery experiment.
The signal amplitude is dependent on the inversion time, TI, according to Eq.
[2.1.1]. The longitudinal magnetization recovers to its equilibrium state after
5T1.
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By varying TI over a suitable time range, the T1 relaxation time can be found by fitting
the acquired data to Eq. [2.1.1]. Alternatively the data can be fitted to the slope of
ln(Mxy/M0) versus TI in a logarithmic plot or to the exponential curve itself. In the case
where the inversion pulse is not exactly 180° , Eq. [2.1.1] can be modified to




−=
−
11 T
TI
xy BeAM                                          [2.1.2]
where A is some fraction of M0 and B is the inversion efficiency.
2.2 T2 Measurement
The loss of phase coherence in the transverse plane is not due to T2 relaxation effects
alone, but rather the cumulative results of many factors such as magnetic field
inhomogeneities, molecular diffusion, and magnetic susceptibility. For the purposes of
many NMR experiments it would be advantageous to eliminate the coherent effects of
susceptibility to assess only the spin-spin relaxation time, T2. One of the first methods to
measure the T2 relaxation value was the Hahn spin-echo method (Hahn, 1950), which is
based on the property that dephasing due to magnetic field inhomogeneities can be
inverted.
Fig. 2.2.1 shows the Hahn spin-echo pulse sequence. The initial magnetization along the
z axis is flipped into the transverse plane by a 90° RF pulse and the spins start to dephase.
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A 180° RF pulse applied along the x axis after the time, τ, reverses the order of the
precessing spins. The spins continue to move in their original direction and refocus after
another time period, τ. Phase gained due to incoherent processes, such as T2 relaxation,
cannot be refocused and manifests itself in the attenuation of the detected signal (Fig.
2.2.2). The refocused echo is know as the Hahn spin-echo and the attenuation of the
signal at TE = 2τ is only a function of the intrinsic properties of T2 relaxation. The
magnitude of the refocused signal depends on the time, ΤΕ, (Fig. 2.2.3) according to:
RF
Signal
τ τ
TE
T2
*
2T
90º
180º
Figure 2.2.1: Hahn spin-echo (SE) pulse sequence. After excitation by a 90º RF
pulse, spins dephase during the time interval,
 τ. A 180º RF pulse reverses the
order of the precessing spins allowing them to refocus at the time TE = 2τ. Only
spins dephased by coherent processes (such as magnetic filed inhomogeneities)
will refocus at TE, while incoherent processes, such as T2 relaxation, have a
residual phase shift causing signal attenuation.
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where TE = 2τ is the echo time and M0 is the initial amplitude of the transverse
magnetization following a 90° RF pulse applied to magnetization at the Boltzmann
equilibrium. By varying ΤΕ over a suitable time range, the T2 relaxation time can be
found by fitting the acquired data to Eq. [2.2.1].
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Figure 2.2.2: Spin behavior during the Hahn spin-echo sequence. The 90º RF pulse
flips the magnetization into the transverse plane where it dephases during the time
period, τ. The subsequent 180º RF pulse inverts the phase and dephased spins
refocus after the second time interval τ to form the Hahn spin-echo.
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2.3 Diffusion
This section is intended to provide the reader with an introduction to the theory of
diffusion. It briefly discusses the underlying mechanism and theories important for
understanding the following chapters. For a more detailed description and deeper insights
into the theory of diffusion, the reader is referred to publications by Berg (1993) and
Crank (1975).
2.3.1 Diffusion Theory
The self-diffusion coefficient, D, is a measurement of the net displacement of molecules
caused by thermal energy (Brownian motion). A molecule in a system at temperature, T,
has an average thermal energy of
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Figure 2.2.3: Transverse magnetization (signal) versus echo time (TE) for a Hahn
spin-echo pulse sequence. The signal amplitude is dependent on the echo time, TE,
according to Eq. [2.2.1].
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nkT
ET =                                                  [2.3.1.1
where k is the Boltzmann constant and n is the number of degrees of freedom. The
thermal energy of the particle is independent of its size, but the average velocity due to
thermal energy associated with this particle is dependent upon its mass by
m
nkT
vT =                                                     [2.3.1.2]
In an isotropic solution, the diffusion coefficient, D, of a molecule is not only dependent
on its mass, but also on the viscosity and temperature of the medium. This relationship
can be quantitatively expressed by the Stokes-Einstein equation
hR
kT
f
kT
D
πη6
==                                             [2.3.1.3]
where k is the Boltzmann constant, T is the temperature in Kelvin and f is the frictional
coefficient of the particle undergoing motion. The second equality assumes a spherical
particle with a hydrodynamic radius, Rh, moving in a medium with a temperature-
dependent viscosity, η .
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The probability of finding a molecule originally at point 0r
!
 to be at position r
!
 some time
later can be measured by the root-mean-squared (RMS) displacement, 2x
( ) ( ) ( ) ( ) rdrdtrrPrrrrrx !!!!!!!!! 000202
1
2
0
2 ,|∫
∞
∞−
−=−= ρ                 [2.3.1.4]
where ( )0r!ρ  is the spin density at location 0r! , and ( )trrP ,|0 !!  the conditional probability
for a particle to move from 0r
!
 to r
!
 in the time, t. For an isotropic system, the solution to
Fick’s second law,
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                         [2.3.1.5]
yields the Gaussian displacement profile,
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Substituting Eq. [2.3.1.6] into Eq. [2.3.1.4] yields
( ) Dtrrx 2202 =−= !!                                [2.3.1.7]
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which is known as Einstein’s relation (in one dimension). For diffusion in more than one
dimension, Einstein's relation is given by
nDtx 22 =                                               [2.3.1.8]
where 2x  is the root-mean-squared displacement, and n is the number of degrees of
freedom (number of dimensions) in which the spin can move. For isotropic, non-
restricted diffusion, a plot of the root-mean-squared displacement 2x  versus t  is
linear, while for anisotropoic or restricted diffusion, the plot would deviate from its linear
behavior.
2.3.2 Stejskal-Tanner Diffusion Measurement
The classical method of measuring diffusion with NMR is the pulsed-field gradient spin-
echo (PFGSE) of Stejskal-Tanner (Stejskal and Tanner, 1965). Figure 2.3.2.1 shows the
PFGSE pulse sequence, where magnetic field gradients are used to encode the molecular
displacement by phase labeling the spins undergoing diffusion following a 90° RF pulse.
The first gradient pulse imparts a phase shift of
∫=Φ
δ
γ
0
11 )( dtptGz                                        [2.3.2.1]
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on the transverse magnetization, where γ  is the gyromagnetic ratio, δ  is the gradient
pulse duration, Gz is the applied gradient strength of the diffusion-sensitizing gradient
along the z-direction, and 1p  is the position of the spin along the z-axis during the first
diffusion-gradient pulse. It should be noted that any gradient direction could have been
chosen. A 180° RF pulse inverts the phase of the spins to 1Φ−  in the transverse plane,
before the second diffusion gradient imparts another phase of
( )∫=Φ
δ
γ
0
22 dtptGz                                     [2.3.2.2]
Figure 2.3.2.1: Stejskal-Tanner pulsed-field gradient spin-echo (PFGSE)
sequence. The first gradient imparts a phase to the spins while the second
gradient removes the phase. Spins undergoing diffusion between the two pulses
will not refocus completely and have a residual phase which results in signal
attenuation.
δδ
∆
GZ GZ
TE
90o
180o
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on the spins where 2p  is the position of the spin along the z-axis during the second
diffusion-gradient pulse. The resulting phase shift after the two gradient pulses is
therefore
( )∫ −=Φ−Φ
δ
γ
0
1212 )( dtpptGz                        [2.3.2.3]
For stationary spins, p1 = p2, and there is no residual phase accumulation, while for
moving spins ( p1 ≠ p2) there is a net residual phase shift. For an assembly of incoherently
moving spins, the sum of the residual phase shifts will attenuate the spin-echo amplitude
with respect to that of non-moving spins. The accumulated phase and magnitude of the
attenuated signal is dependent on the phase difference the spins acquire during the
observation period and can be written as
( )( ) ( ) 2112
0
,|12 dpdpppPe
S
S Gi τδδγ ×= ∫
∞
∞−
Φ−Φ                  [2.3.2.4]
where ( ) 212 ,| dpppP τ  is the conditional probability that a spin starting at position 1p
will be found after a time, τ , between position 2p  and 22 dpp + , S0 is the spin-echo
amplitude without diffusion gradients, and S is the echo amplitude of the attenuated
signal.
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The signal attenuation for a Stejskal-Tanner spin-echo diffusion experiment with finite
pulse width is given by (Stejskal and Tanner, 1964)



−∆−
=
3
0
222 δδγ DG
e
S
S
                                      [2.3.2.5]
where S is the measured signal, 0S  is the signal amplitude with no diffusion gradient
applied, δ  is the diffusion gradient duration, γ  is the gyromagnetic ratio, D is the
diffusion coefficient, and ∆  the time separation between the applied diffusion gradients.
The above equation can be re-written as (LeBihan et. al., 1991)
bDe
S
S
−
=
0
                                              [2.3.2.6]
where



−∆=
3
222 δδγ Gb                                             [2.3.2.7]
represents the gradient terms. For non-rectangular gradient pulses b must be modified to
reflect the shape of the gradient pulses (Price and Kuchel, 1990). For half-sine-shaped
diffusion gradient pulses, b is:
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2.3.3 Diffusion-Weighted Stimulated-Echo
In order to measure the NMR signal at long diffusion times one has not only to deal with
the signal attenuation due to diffusion (Eq. 2.3.2.5) but also with the simultaneously
occurring signal attenuation due to T1 and T2 relaxation. This becomes a particular
problem when the T2 of the sample is much shorter than the diffusion time, since the
signal attenuates due to T2 relaxation by
2T
TE
eS
−
∝ .                                                  [2.3.3.1]
Since T1 in biological systems is usually much longer than T2, it is possible to store the
net magnetization for some part of the experiment along the longitudinal axis where it is
only influenced by the slower T1 relaxation.
The stimulated-echo (STE) pulse sequence (Hahn, 1950) is an example of how this can
be accomplished. Fig. 2.3.3.1 shows a diffusion-weighted STE pulse sequence with
added diffusion gradients (Tanner, 1970). The first 90° RF pulse puts the magnetization
into the transverse plane and the second 90° RF pulse stores half of the transverse
magnetization along the longitudinal axis. During the time, TM, the stored magnetization
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is only affected by T1 relaxation and the crusher gradient completely dephases any
magnetization that remained in the transverse plane after the second 90° RF pulse. This
deliberate dephasing of the residual transverse magnetization during the TM period
results in a signal reduction by a factor of two. The third 90° RF pulse returns the
longitudinal magnetization into the transverse plane for measurement. It is important to
note that an echo is formed by any combination of two or more RF pulses. Depending on
the timing within the pulse sequence, these spurious echoes can interfere with the desired
Crusher
Signal
RF
90o 90o 90o
TE/2 TE/2TM
δ
GZ
δ
GZGradient
∆
Figure 2.3.3.1: Diffusion-weighted stimulated-echo pulse sequence. The first 90o
RF pulse flips the net magnetization in the transverse plane and the diffusion
gradient is applied. The second 90° RF pulse stores half of the transverse
magnetization along the longitudinal axis The third 90°  RF pulse returns the
magnetization to the transverse plane after the time, TM. The second diffusion
gradient pulse removes the phase imparted by the first diffusion gradient pulse.
The crusher gradient during the TM period destroys any residual magnetization in
the transverse plane and any spurious echoes.
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stimulated echo. One way to eliminate these spurious echoes without disturbing the
stimulated echo is to insert a crusher gradient in the TM period. The crusher will dephase
all residual transverse magnetization not stored along the longitudinal axis following the
second 90° RF pulse.
2.4. Magnetic Resonance Imaging
2.4.1. Frequency Encoding
The basis of magnetic resonance imaging is the dependence of the precessional frequency
on the magnetic field strength as expressed by the Larmor equation
00 Bγω = .                                                    [2.4.1.1]
In a uniform magnetic field, 0B , all spins in a sample will precess at the same frequency,
0ω . Inspection of the Larmor equation (Eq. [2.4.1.1]) shows that the precessional
frequency can be altered by changing the magnetic field strength the spins are
experiencing. If we add a magnetic field of magnitude, G, to the static magnetic field,
0B , the precessional frequency is then
( )GB += 0γω .                                        [2.4.1.2]
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Adding of a linear magnetic field gradient onto the static magnetic field will  result in a
change in the precessional
frequency that is directly
proportional to the magnetic field
gradient. Since the field strength for
a linear gradient is directly
proportional to the spatial location,
the resulting frequency can be
related to a spatial location (Fig.
2.4.1.1). Hence spins at different
locations along the direction of the
gradient will precess at different
frequencies. Data acquisition during
the application of the gradient results in a FID containing a range of frequencies which
are related to the spatial location along the gradient orientation by
SlopeGradient
Frequency
Location
  
2
 
×
=
π
γ .                         [2.4.1.3]
A Fourier transform of the FID reveals the different frequency components and allows
the calculation of their spatial origin by Eq. [2.4.1.3] while the magnitude of the
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Figure 2.4.1.1: Spatial position as a function
of the relative magnetic field strength.
Application of a linear magnetic field
gradient causes spins at different locations to
precess at a frequency proportional to the
field strength at their location.
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frequency represents the relative contribution of the spins at this frequency to the signal
(Fig. 2.4.1.2).
2.4.2. Phase Encoding
The NMR signal consists of an amplitude, frequency and phase. Since the magnitude
contains information about the spin density and the frequency the spatial information in
one dimension (Section 2.4.1) there is only the phase left to encode the second dimension
with spatial information necessary for image reconstruction.
Direction
Gradient 
Strength
ωB0
+∆B
-∆B
+∆ω-∆ω
Frequency 
Amplitude
FT of signal
Gradient
Figure 2.4.1.2: Placing a half spherical object in a magnetic field with a gradient
causes spins in the center of the sphere to resonate at ω0 and spins at the outer limits
of the object to resonate at ω0-∆ω and ω0+∆ω. The Fourier transform of the measured
FID yields a frequency which corresponds to their spatial location and the magnitude
of the frequency corresponds to the number of spins at that location which are
contributing to the signal.
ω0
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The application of a linear magnetic field gradient will cause the spins to precess at a
frequency proportional to the field strength at their location. This behavior can be used to
impart a phase to the spins which is proportional to their location in space. Application of
a magnetic field gradient for a time, phaset , will cause spins to precess at a higher or lower
frequency than the Larmor frequency, 0ω . During this time period, the spins accumulate
a phase, rΦ , with respect to 0ω , which is dependent on the gradient strength, phaseG  at
their spatial location r
!
, and the time, phaset , the gradient is applied, by
( )[ ]∫=Φ
phaset
phasephasephaser dtrtG
0
 
!! γ                                      [2.4.2.1]
where γ  is the gyromagnetic ratio and the maximum phase accumulation, maxΦ , is then
determined by the duration of the gradient.
The gradient used to impart the phase on the spins is known as the phase-encoding
gradient and provides the spatial information in the second dimension necessary to
reconstruct the image.
2.4.3 Slice Selection
In the above sections it was shown how a signal can be generated that contains all the
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spatial information needed to create an image. Since we are seldom interested in an
image of the entire sample, but rather a part of it, it becomes necessary to excite only the
portion of the sample under investigation. The basic method in MRI used to select a
certain part of the sample is based on the Fourier relationship between the time domain
and frequency domain. By amplitude modulating the RF pulse in the time domain, it is
possible to selectively excite specific locations in the frequency domain. In MRI we are
commonly interested in a section with a rectangular slice profile. To excite such a section
in the frequency domain the RF pulse in the time domain must be a sinc function (Fig.
1.6.5). A sine wave with a sinc envelope allows us to give the rectangular function in the
frequency domain an offset equal to the frequency of the sine wave (see Section 1.6).
Hence, in order to excite a rectangular profile of bandwidth ω∆  in the frequency domain,
a RF pulse with a sinc envelope of 
ω∆2
1
 needs to be applied (Fig. 2.4.3.1).
t t t 2/ t = ∆ω
FT
Sine Wave of Frequency ω0
 with a Sinc Envelope in the
time domain
Rectangular Wave
centered around ω0 in
frequency domain
ω0
Figure 2.4.3.1: Fourier relationship between sinc function and rectangular function.
The frequency of the sine wave contained in the sinc function (time domain)
determines the offset of the rectangular function in the frequency domain.  The
bandwidth of the rectangular function is given by  the sinc envelope.
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For a sinc wave modulated with an RF frequency of 0ω  the excited bandwidth is
20
ω
ω
∆± .
To achieve a perfect rectangular excitation profile, a sinc pulse with an infinite number of
side lobes is necessary. Practical limitations prohibit such a sinc pulse and an
approximation with three to five lobes is commonly used. The Fourier transform of such
a truncated sinc pulse is a rectangular profile with ripples at the edges. These ringing
artifacts are a direct result of the truncation of the high frequency components and can be
neglected in most imaging experiments.
To achieve slice selection, a linear magnetic field gradient is applied at the same time as
the sine wave with the sinc envelope. From Eq. [2.4.1.2], the superposition of a magnetic
field gradient, G, onto the static magnetic field, 0B , influences the Larmor frequency by
( )GBG +=+= 00 γωωω                                            [2.4.3.1]
or we can express the change in frequency around 0ω in terms of the change in field
strength
G∆=∆ γω                                                       [2.4.3.2]
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Since the slice thickness is directly related to the frequency profile and the frequency is
directly related to the gradient field strength, the slice thickness can be adjusted by
simply varying the strength of the superimposed gradient, G, according to
SlopeGradient
Frequency
ThicknessSlice
  
2
 
  
×
=
π
γ                  [2.4.3.3]
Figure 2.4.3.2. illustrates the dependence of the slice thickness on the frequency profile
(left side) and on the gradient strength (right side).
Figure 2.4.3.2: Effects of gradient strength and frequency bandwidth on the slice
thickness. The left side shows the effects of the frequency bandwidth on the slice
thickness. At a constant gradient strength, an increase in bandwidth results in a thicker
slice. The right side illustrates the influence of the gradient strength on the slice
thickness at a constant frequency bandwidth. As the gradient strength decreases the
slice thickness increases.
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A slice offset can be achieved by convolution of the RF sinc function with a sine wave of
frequency, ω , while simultaneously applying a magnetic field gradient. Only spins along
the magnetic field gradient precessing at a frequency that corresponds to the frequency of
the sine wave contained in the RF sinc function will be excited. A change in slice offset is
accomplished by changing the frequency of sine wave contained in the sinc function. The
needed change of the RF center frequency can be calculated by
x∆=∆ Gγω                                             [2.4.3.4]
where ω∆  is the change of the sine wave frequency contained in the RF pulse, γ  is the
gyromagnetic ratio, G is the linear magnetic field gradient and x∆  is the slice offset with
respect to the isocenter of the magnet. This can be done by changing the transmitter
frequency, 0ω , to ωωω ∆+= 0 , or by a modulation of a sinc function containing a
sine wave at the Larmor frequency, 0ω , with a linear phase ramp in the time domain,
where the maximum phase determines the slice offset.
2.4.4 k-Space and Imaging
Consider that the spins occupying a small volume element, dV , at position r
!
, and
possess a spin density, ( )r!ρ , then the NMR signal arising from this volume element,
dV , can be written as
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( ) ( ) ( )trGBidVertGdS  0, !!!! •+= γρ                              [2.4.4.1]
with G
!
 is the applied magnetic field gradient for frequency encoding. Setting our
receiver at the Larmor frequency, the so-called "on resonance" condition, we extract only
the resulting the frequency difference imparted by the frequency-encoding gradient
rG
!!
•= γω                                               [2.4.4.2]
Integration over the volume element leads to the NMR signal in time domain
( ) ( ) rdertS
dV
trGi !!
!!∫∫∫ •= γρ                                       [2.4.4.3]
which has the form of a Fourier transform. To make the Fourier relation more obvious the
concept of a reciprocal space by a vector, k
!
, was introduced (Mansfield, 1975) where the
space vector, k
!
, is defined as
tGk
!!
γ
π2
1
=                                             [2.4.4.4]
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and has units of inverse space. The k space can be transversed by changing either the time
or the gradient magnitude. Using Eqs. [2.4.4.3] and [2.4.4.4], the Fourier transform and
the inverse Fourier transform of the imaging signal can be written, respectively, as
( )∫∫∫ •= rderkS rki !!! !
!
πρ 2)(                                    [2.4.4.5]
and
( ) ( )∫∫∫ •−= kdekSr rki !!! !
!
πρ 2                                   [2.4.4.6]
Data acquisition in imaging mode is equivalent to a Fourier transform of the spin density,
( )r!ρ , and results in the measured signal, ( )kS ! . An inverse Fourier transform (Eq.
[2.4.4.6]) of the detected signal, ( )kS ! , returns the spin density, ( )r!ρ , and allows the
reconstruction of the image.
2.4.4.1 Spin-Echo Imaging
The conventional method to sample k space makes use of the phase- and frequency-
encoding capabilities of the applied magnetic field gradients. The proportionality of the
k-space vector, k
!
, with the gradient vector, G
!
, allows to move along one direction of the
Cartesian k space, by simply incrementing the phase-encoding gradient. Application of
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the frequency-encoding gradient orthogonal to the phase-encoding gradient allows
encoding of a single line in k space. Repeating this process while simultaneously
increasing the strength of the phase-encoding gradient, the two-dimensional k space can
be traversed line by line (Figs. 2.4.41.1 and 2.4.4.1.2).
The k-space signal acquired by such a MRI sequence is
( ) ( ) ( )∫ ∫
∞
∞−
∞
∞−
+
= dxdyeyxkkS
ykxki
yx
yxπρ 2,,                   [2.4.4.1.1]
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Figure 2.4.4.1.1: Conventional imaging of the k
space. The phase-encoding gradient moves the k-
space vector in one direction (vertical) and the
frequency-encoding gradient sweeps across the
horizontal line at the position of the phase-encoding
gradient. By incrementing the phase-encoding
gradient and repeating the frequency sweep along the
horizontal line, the entire k space can sampled.
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where x is the location along the frequency-encoding direction, xk , y is the location along
the phase-encode direction, yk , and ( )yx,ρ  the spin density of the excited slice at the
spatial location ( )yx, . Image reconstruction is done by a two-dimensional Fourier
transform of the data collected in k space.
Figure 2.4.4.1.2: Spin-echo (SE) imaging pulse sequence.The RF sinc pulses
are used to excite a rectangular slice profile and the slice select gradient
determines the thickness of the imaging slice. The phase-encoding gradient
imparts a phase to the excited spins and encodes spatial information into the
signal in one dimension. The entire k space is sampled by incrementing the
phase-encoding gradient for each line in k space and acquiring of the signal in
the presence of the frequency-encoding gradient. Reconstruction of the image
is done by a two-dimensional Fourier transform of the collected data.
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2.4.4.2 Echo-Planar Imaging
A more time efficient technique than the line-by-line sampling of k space is known as
echo-planar imaging (EPI). The simultaneous application of a broadening gradient, with
an alternating gradient orthogonal to the broadening gradient, allows the sampling of the
two-dimensional k space in a single acquisition (Mansfield, 1977). The broadening
gradient acts similar to the phase-encoding gradient in one dimension and the alternating
gradient samples k space using a zig-zag pattern (Fig. 2.4.4.2.1).
Figure 2.4.4.2.2 shows a typical spin-echo EPI sequence and illustrates the simultaneous
application of the gradients. The zig-zag sampling of the k space is a result of the
concurrent application of the broadening gradient and the alternating gradient. Since the
sweeping of the k space alters in direction, it becomes necessary to reverse the data in
each alternating sweep before conventional, two-dimensional Fourier transform
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Figure 2.4.4.2.1: K-space trajectory for echo-
planar imaging. The broadening gradient moves
the wave vector linearly in the vertical dimension
while the alternating gradient moves the wave
vector horizontally in the second dimension.
60
processing is performed. It should be noted, that only the data in the center of the
acquisition window are T2 weighted, while the remaining data have some 
*
2T  weighting.
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Figure 2.4.4.2.2: Spin-echo echo-planar imaging (SE-EPI) pulse sequence.
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3.0 The Return-to-the-Origin Probability and the ADC of
Water as Indicators of RIF-1 Tumor Necrosis.
The objective of these experiments was to study structural changes in murine RIF-1
tumors in response to changes in necrotic volume, using two different NMR measures of
water molecule displacement. One of the problems in this study was the immobilization
of animals to avoid motion during the acquisition of the diffusion-weighted images. A
new stereotaxic device, with an integrated headpiece for the administration of an
inhalation anesthetic, was designed and built to ensure adequate immobilization of the
animal during the NMR procedure. My contributions to the experiments were the design
of the study, inoculation of the animal with tumor cells, data acquisition, and data
analysis.
3.1 Introduction
The objective of this study was to compare the return-to-the-origin (RTO) probability and
the apparent diffusion coefficient (ADC) of endogenous water molecules for their ability
to detect tumor hypoxia and necrosis. Diffusion of water in vivo is highly influenced by
the presence of local restrictions, such as cell membranes and organelles, and is therefore
sensitive to changes in tissue structure and membrane permeability. This sensitivity has
made diffusion-weighted MRI an early and reliable predictor of cerebral ischemia
(Moseley, 1990). Recent studies of the diffusion coefficient in tumors (Zhao et al., 1995,
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1996a) suggest that the diffusion coefficient is also sensitive to pathophysiological and
structural changes in tumors.
Tumor vasculature consists of blood vessels recruited from the host vasculature and from
angiogenesis in response to tumor cell growth (Jain, 1988). The distribution of nutrients
and oxygen through the vasculature is governed by the flow rate (Less et al., 1991) and
the vascular morphology (geometric arrangement, diameter, length, and number). Despite
the similarities in the underlying mechanism of angiogenesis between the host vessel and
the tumor (Patan et al., 1996), they are completely different with respect to organization.
The vascular architecture of tumors differs significantly from the host organ and the flow
rate of red blood cells is no longer dependent on the vessel diameter but is also orders of
magnitudes lower (Jain, 1996). In normal healthy tissue, cell proliferation is coupled to
angiogenic processes to ensure an adequate supply of oxygen and nutrients to the cells as
well as the removal of cellular waste. The rapid cell proliferation in tumors causes the
outgrowth of the vasculature and is often accompanied by defective angiogenesis. Cells
in poorly vascularized and/or inadequately supplied regions of the tumor become oxygen
deprived and subsequently necrotic.
Usually two types of hypoxia, which can be characterized by the underlying
physiological processes, can be found in tumors and their occurrence in solid tumors has
been confirmed by other researchers (Guichard et al., 1980; Moulder and Rockwell,
1984; Chapman, 1984). Chronic or "diffusion limited" hypoxia results from the limited
distance that oxygen diffuses through tissue before it is metabolized. Thomlinson and
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Gray (1955) have determined that the average distance oxygen diffuses in tissue before it
is metabolized is approximately 150 µm and cells beyond this distance are generally
poorly oxygenated. Since rapid cell proliferation in tumors can exceed the output of
angiogenic processes, some population of cells within the tumor will become hypoxic as
their distance from the vascular supply increases.
Acute or "perfusion limited" hypoxia is a result of impaired vasculature. Tumor cells
suffering acute hypoxia are in close proximity to blood vessels which have transiently
impaired blood flow due to stasis, flow reversal or collapsed vessels (Jain, 1988). The
lack of oxygen results in decreased aerobic ATP synthesis due to reduced oxidative
phosphorylation. For a short duration of time, anaerobic glycolysis can substitute for
aerobic ATP synthesis with lactic acid as a byproduct. Anaerobic glycolytic ATP
production can only be sustained over short periods of time before ATP synthesis ceases.
Reduced ATP availability leads to decreased Na+/K+-pump activity accompanied by the
slow influx of Na+ and Ca++ as well as efflux of K+. In response to the breakdown of the
ion homeostasis, the cell tries to reduce the intracellular Na+ concentration by allowing
the influx of extracellular water. Loss of osmoregulation, therefore, results in cell
swelling, dilation of endoplasmatic reticulum, mild swelling of the mitochondria, loss of
mircovilli, blebs, disaggregation of polysomes and aggregation of condensed chromatin
around the nuclear periphery (Wyllie et al., 1980).  Most of these changes are reversible
if the cell is supplied with sufficient oxygen.  Dying cells cross this "point of no return"
and enter the second stage defined by severe swelling of mitochondria, nuclear pyknosis,
cytoplasmic swelling, dissolution of cytoplasmic organelles and ruptured plasma
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membranes (Wyllie, 1981). The necrotic cells are degraded by autolysis or immigrating
leukocytes through lysosomal activity (heterolysis). This reduced oxygenation of tumor
regions is of major importance in the treatment of cancer and has long been recognized as
a determining factor in cancer therapy outcome (Thomlinson and Gray, 1955) as well as
associated with therapeutic failure and reoccurrence (Horseman et al., 1986).
Diffusion-weighted NMR measures the net displacement of diffusing molecules caused
by thermal energy (Brownian motion). The net displacement of molecules diffusing from
location, r , to location, r′ , (Figure 3.1.1) is related to the self-diffusion coefficient, 0D ,
by the Einstein relation:
( ) tnDrr 022 =′−                                         [3.1.1]
r r’
lminlmin
Fig. 3.1.1: Illustration of unrestricted diffusion due to thermal energy
(Brownian motion). A molecule diffuses during the diffusion time, tdiff, from
location r to location r’. The net displacement of the molecule during the
diffusion time can be related to the self-diffusion coefficient by the Einstein
relation. The dotted circles with radius lmin around the start- and endpoint are
the uncertainty of the measured locations. The uncertainty is determined by the
time needed to encode the initial and final positions.
66
where 2)( rr ′−  is the ensemble averaged mean-squared displacement, n is the number
of dimensions for which the displacement is measured and t  is the time allowed for
diffusion. The mean-squared displacement of an ensemble of diffusing molecules can be
measured with the Stejskal-Tanner (1965) pulsed-field-gradient (PFG) pulse sequence
(Fig. 3.1.2). Diffusing molecules are tagged at their initial position with a diffusion-
gradient pulse and untagged at their endpoint by a second, equal diffusion-gradient pulse.
Stationary molecules refocus after the echo time and do not attenuate the detected signal,
since they do not gain any phase during the diffusion measurement. Molecules displaced
by diffusion from their initial position will not refocus after the echo time, due to the
random nature of the diffusion process, and thus have a residual phase. The acquired
Figure 3.1.2: Stejskal-Tanner pulsed-field gradient spin-echo (PFGSE) pulse
sequence where G is the applied gradient strength, δ  is the gradient pulse duration,
∆  is the diffusion-gradient separation time, and TE/2 is half of the echo time.
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phase manifests itself in an attenuation of the spin echo For unrestricted diffusion the
signal magnitude can then be written in accordance with Eq. [2.3.2.5] to be
tDkeMtkM 0
2
0),(
!!
−
=                                  [3.1.2]
where
δγGk
!!
= ,                                                    [3.1.3]
0M  is the signal measured without the presence of the diffusion gradient, D0 is the self-
diffusion coefficient, γ  is the gyromagnetic ratio, δ  is the diffusion-gradient pulse
duration, G
!
 is the applied diffusion-gradient strength, ( )3δ−∆=t  is the diffusion time
for rectangular diffusion gradients, and ∆  is the diffusion-gradient separation. As Eq.
[3.1.2] shows, measurement of the signal attenuation, at various values of the gradient
strength allows the extraction of the self-diffusion coefficient from the linear slope of the
ln(M/M0) versus tk
2 plot.
Because molecules can diffuse during the finite time used for tagging and untagging,
their displacement has to be larger than the distance lmin (Fig. 3.1.1) to be detectable. The
length of the distance, lmin, the uncertainty in the initial and final position, is inversely
proportional to the gradient duration, δ, the gradient strength, G
!
, and therefore, k
!
.
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δγ Gk
l !!
 
11
min ==                                           [3.1.4]
Early in the evolution of NMR diffusion measurements it was realized that in systems
with barriers to diffusion or internal structures the measured diffusion coefficient deviates
from that of bulk water (Woessner, 1963; Stejskal and Tanner, 1968). An example of this
is shown in Fig. 3.1.3. The deviation from the diffusion coefficient, 0D , of bulk water
depends on the amount of restrictions diffusing water molecules encountered during the
diffusion time, t. As the diffusion time increases, more molecules will experience some
kind of restriction thereby reducing the ensemble average of the mean-squared
displacement (Fig. 3.1.4) with respect to freely diffusing water. Equation [3.1.2] no
Figure 3.1.3: Plot of the attenuation curves ln(M/M0) versus k
2 for freely diffusing
water () and water diffusing in the interstitial space of a polystyrene bead pack ( )
(from by Helmer et al., 1995). The data were acquired using a Stejskal-Tanner pulse
sequence with ∆ = 50 ms, δ = 1.5 ms and a maximum applied diffusion-gradient
strength, G, of 72.8 G/cm.
-7
-6
-5
-4
-3
-2
-1
0
0.0 0.5 1.0 1.5
k
2
 x 10
7
 [1/cm
2
]
ln
(M
/M
0
)
69
longer strictly applies (Tanner and Stejskal, 1978) in the restricted case since the
measured diffusion coefficient depends upon the number of barriers encountered and
hence upon the diffusion time. To indicate this deviation from the bulk diffusion
coefficient the measured diffusion coefficient is now written with an explicit dependence
upon the diffusion time and is also referred to as the apparent diffusion coefficient
(ADC). For very short diffusion times, only molecules within a distance shorter than the
diffusion length
tDld 0~                                             [3.1.5]
will experience diffusion barriers and hence are sensitive to restrictions (Latour et al.,
r
lmin
r’
lmin
Fig. 3.1.4: Illustration of diffusion in the presence of diffusion barriers. The
diffusion barriers encountered during the movement from location r to location r’
reduce the net displacement of the diffusing molecule. The dotted circles with
radius lmin around the start and endpoint are the uncertainties in r and r’ which are
determined by the time needed to encode the initial and final positions.
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1993). These will be few in number and other molecules will not experience any
restrictions. The measured diffusion coefficient, D(t), will therefore be close to the bulk
diffusion coefficient, D0. In this case, for small k values, Eq. [3.1.2] can still be used by
assuming that the diffusion coefficient, D, is now a function of the diffusion time, t
(Woessner, 1963). Modification of Eq. [3.1.2] to account for the time-dependent
diffusion coefficient yields
( ) ( )ttDkeMtkM  20, −= .                                      [3.1.6]
In this regime, the time-dependent diffusion coefficient, ( )tD , reflects the local properties
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Figure 3.1.5: Plot of the measured diffusion coefficient versus the square-root of the
diffusion time for a RIF-1 tumor with a volume of 1.5 cm3 (Helmer, 1999). The
surface-area to volume ratio, S/V, can be calculated from the initial slope of the
curve and the tortuosity, T, can be extracted from the plateau region of the curve.
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of the sample, such as the average surface-area to volume ratio (Mitra et al., 1992; Mitra
et al., 1993; Latour et al., 1993). The initial slope of the time-dependent diffusion
coefficient, ( )tD , versus the square-root of the diffusion time curve (Fig. 3.1.5), is related
to the average surface-area to volume ratio, VS , by (Mitra et al., 1992)
( ) ( )ttD
V
S
D
tD ϑ
π
+−= 0
0 9
4
1 .                             [3.1.7]
As the diffusion time increases, more diffusing molecules will encounter restrictions,
reducing the average displacement. One way to explain the behavior of the time-
dependent diffusion coefficient, ( )tD , in the long time regime is the use of a common
morphology (Calaghan, 1991). By dividing the diffusion space into subregions, each of
the individual regions would display a diffusion coefficient at short diffusion times
according to
( ) ( )ttDke
M
tkM 2
0
,
−
=                                  [3.1.8]
and the measured magnetization is the superposition of the individual subregions, n, with
their diffusion coefficient, ( )tDn  and weighting np .
( ) ( ) ( )∑ ∑ −==
n n
ttnDk
n
n e
M
tkM
M
tkM 2
00
,,
                    [3.1.9]
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Increasing the diffusion time will allow more molecules to diffuse into restricting
boundaries thereby reducing their diffusion coefficient with respect to the bulk value. If
the diffusion time is sufficiently long to allow all the molecules to probe the entire
diffusion space, they would all encounter the same number of diffusion barriers and
hence their mean-squared displacement will be equal. The equal mean-squared
displacement of the subregions yields a similar diffusion coefficient, ( ) effn DtD = , for all
regions and Eq. [3.1.9] can be rewritten to be
( ) ( ) teffDk
t
tnDk
t
ee
M
tkM t 22
0
, −
∞→
−
∞→
==                     [3.1.10]
where effD  is the effective diffusion coefficient of the sample characterizing the average
or "effective" properties of the medium in which the molecules are diffusing.
The application of some ideas from porous media theory to biological samples can
provide a model to extract structural information from the time-dependent diffusion
coefficient (Latour et al., 1994). At long diffusion times the bulk diffusion coefficient,
D0, of water molecules diffusing in the pore space of a porous medium is reduced by the
tortuosity, T, of the medium (Johnson et al., 1982; Haus and Kehr, 1987; Nicholson and
Rice, 1991) to Deff as described by the relation
T
D
Deff
0
= .                                              [3.1.11]
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In biological tissue, with intra- and extracellular compartments, the diffusing molecules
can diffuse across the cell membrane separating the intra- and extracellular space. To
account for this additional pathway the definition of the tortuosity has to be modified to
include the membrane permeability. The validity of these ideas has been successfully
shown in packed erythrocytes (Latour et al., 1994) and applied to biological systems such
as rodent tumors (Helmer et al., 1994, 1995).
Crick (1970) derived the membrane permeability of cells from the effective diffusion
coefficient using a simplified model, with a large concentration gradient over many cells
with equal diameter, and found the following relationship:
aDDeff κ
111
0
+= ,                                        [3.1.12]
where 0D  is the diffusion coefficient of freely diffusing water, effD  is the effective
diffusion coefficient at long diffusion times, κ  is the permeability, and a the length of
each cell in the direction of diffusion. Equation [3.1.12] demonstrates how structural
properties such as cell membrane permeability and geometrical properties like cell
dimensions, can alter the effective diffusion coefficient. However, this model is
incomplete since it does not account for the compartments with different diffusion
coefficients, parallel diffusion pathways around diffusion barriers, and differences in the
water concentration between different compartments. A more complete model has been
put forth by Latour et al. (1994) that accounts for these parameters.
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In samples with well-defined periodic geometries and connections between different
sample regions, diffusing molecules can move to adjacent regions. For a certain value of
k, molecules moving to an adjacent region will have acquired the same phase as those
molecules that started in the initial region. This phase coherence will manifest itself as a
peak in the measured signal (Fig. 3.1.6), which is often termed a "diffraction peak" in
analogy to light scattering. The location of the diffraction peak is determined by the
magnitude of k
!
 (Eq. 3.1.3), and the structural length, a, (Callaghan et al., 1991, 1992) as
given by:
π2=ka                                                 [3.1.13]
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Figure 3.1.6: Plot of the signal attenuation ln(M/M0) versus k for a monosized
sphere pack acquired at a ∆ = 100 ms and a bead diameter of 15.8 µm (Helmer
1999). The displayed diffraction peak marked by the arrow.
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In systems consisting of many different structures of varying length scales, no diffraction
peaks can be observed, since there is no repeating geometrical structure (Mitra et al.,
1995) and the information contained in the diffraction peaks are no longer obtainable.
However, structural information can still be extracted from this type of data by
calculation of the return-to-the-origin probability.
The return-to-the-origin (RTO) probability measures the probability that a diffusing water
molecule starting within a sphere of radius rd
!
 around r
!
 will be found in the same sphere
of radius rd ′
!
 around r ′
!
 (Fig. 3.1.7) after diffusing for a time, t. The radius dr  is equal to
minl  as defined in Eq. [3.1.14] and is the minimum resolution of the RTO measurement.
r
r’
rd
!
rd ′
!
Figure 3.1.7: Illustration of diffusion in the presence of barriers. The barriers
encountered during movement from location r
!
, to r ′
!
 decrease the mean-squared
displacement but increase the probability that the molecule will be found within the
sphere of radius rd ′
!
, after diffusing for a time, t.
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To calculate the RTO probability in a pulsed-field-gradient NMR experiment, we start
with the measured signal, which can be expressed in terms of the diffusion propagator:
( ) ( ) ( ) ( )∫ ′′′′−•=
V
rdrdrtrrGrrkietkM
!!!!!!! ρ,,,                       [3.1.14]
where ( )r ′!ρ  is the proton density at r ′! , ( )trrG ,, ′!!  is the diffusion propagator, ( )tkM ,!  is
the measured signal which depends on the diffusion time and k
!
. The diffusion
propagator (Mitra et al., 1992) has to satisfy the diffusion equation
( ) ( )trrGD
t
trrG
,,
,, 2
0 ′∇=∂
′∂ !!!!
           for t > 0         [3.1.15]
where 0D  is the bulk diffusion coefficient and
( ) ( )rrtrrG ′−==′ + !!!! δ0,,                              [3.1.16]
starts at position r
!
, moves to position r ′
!
 during the time, t, larger than zero.
The probability that a diffusing molecule starting  within a sphere of radius rd
!
 around r
!
,
will be found in a sphere of radius rd ′
!
 centered around r ′
!
, after diffusing for a time, t,
can be mathematically expressed by the conditional probability, ( )trrP ,| ′!! . The
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conditional probability, ( )trrP ,| ′!! , can be expressed in terms of the diffusion propagator,
( )trrG ,, ′!! , and the spin density, ( )r!ρ , as
( ) ( ) ( ) rdrdrtrrGtrrP ′′′= !!!!!!! ρ,,,| .                         [3.1.17]
and it can be seen that the measured signal, Eq. [3.1.14], is therefore a function of the
conditional probability. Substituting Eq. [3.1.17] into Eq. [3.1.14] and integrating over all
initial and final positions yields the RTO probability
( ) ( ) ( )∫= kdtkMtP
"!
,
2
1
3π
                                  [3.1.18]
with
( ) ( ) ( ) ( ) rdrtrrGrdtrrPtP ′′′=′′= ∫∫ !!!!!!! ρ,,),|                   [3.1.19]
for the RTO probability averaged over all positions. For molecules diffusing in
homogeneous media, Eq. [3.1.18] can be rewritten to be
( ) ( ) ( )∫
∞
=
0
2
2
,
2
1
dkktkMtP
π
.                             [3.1.20]
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Since it is not possible to have an infinitely large k, the data are integrated up to the
largest possible value of k, kmax, and the RTO probability becomes a function of time and
kmax.
( ) ( ) ( )∫=
max
0
2
2max
,
2
1
,
k
dkktkMktP
π
                     [3.1.21]
The RTO probability is proportional to the area under the attenuation curve (Fig. 3.1.8)
ln(M/M0) versus k. Figure 3.1.8 shows examples of the measured signal for the
calculation of the RTO probability obtained from a Cutbank 26 mudstone rock core at
varying diffusion times (Helmer, 1999). For small values of k, the signal is comprised
from restricted and unrestricted water molecules, while at large values of k the signal
arises from only from highly restricted water molecules. At large k values, the measured
Figure 3.1.8: Plots of the magnetization ln(M/M0) versus k for a Cutbank
26 mudstone rock core at varying diffusion times of 25 (), 75 (), 175
(!), 275 (✕ ) and 275 (+) ms (Helmer, 1999).
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signal arises from restricted spins, whose diffusion coefficient is low. Inspection of Eq.
[3.1.21] shows that the measured signal is weighted by k2 and therefore the RTO
probability is most sensitive to the signal arising from restricted water molecules.
For the case of unrestricted diffusion, analytical solution of  Eq. [3.1.20] yields
( ) ( ) 2300 4
1
tD
tP
π
= .                                      [3.1.22]
Normalizing the RTO probability to the volume of the sphere results in the dimensionless
probability,
( ) ( )∫= max
0
2
3
max
max ,
3
,
k
kdktkM
k
ktF
!!!!
,                        [3.1.23]
which is independent of the length scale. The normalized RTO probability, F(t), is
denoted as the absolute RTO probability to distinguish it from the RTO probability, P(t),
which is expressed in units of the inverse length scale. Figure 3.1.9 shows a plot of the
absolute probability, F, versus 1/k calculated for the data in Fig. 3.1.8. It is apparent from
Fig. 3.1.9, that for a sphere of large radius in which the diffusing spins never leave the
sphere around their initial position the probability, F, is 1. As the radius of the sphere
decreases, the probability that diffusing molecules will be found within the sphere or
have never left their sphere of origin also decreases. Therefore, the set of curves all
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decrease as lmin (=1/k) decreases in Fig. 3.1.9. As the diffusion time increases, molecules
are allowed to move larger distances thereby decreasing their probability to be found near
the initial position. This latter behavior can be seen in Fig. 3.1.9 as F decreases with
increasing diffusion times. The curves of freely diffusing water (dashed line in Fig. 3.19)
shows a lower absolute RTO probability than the curves of the Cutbank 26, at the same
diffusion time. This enhancement of restricted diffusion over bulk diffusion is expressed
by the RTO enhancement.
The RTO enhancement is the normalization of the RTO probability by that of free
diffusion and, like the absolute RTO probability, is dimensionless and not dependent on
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Figure 3.1.9: Plot of the absolute RTO probability, F, versus 1/k for water
diffusing in the pore space of a  Cutbank 26 mudstone rock core (     ) calculated
from the data shown in  Fig. 3.1.8 and free water (      ) for varying diffusion
times of 25, 75, 175, 275 and 475 ms (Helmer, 1999).
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the length scale of the measurement
( ) ( )( ) ( ) ( )tPtDtP
tP
tR 2
3
0
0
4π== .                           [3.1.24]
Using the maximum value of maxkk
!!
= , the RTO enhancement can also be written as
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                [3.1.25]
which describes how much more probable it is that a diffusing molecule encountering
restricting barriers returns to its sphere of origin as compared to a molecule diffusing in a
bulk, unrestricted solution. Figure 3.1.10 shows the RTO enhancement over freely
diffusing water for the data shown in Figs 3.1.8 (signal magnitude) and 3.1.9 (absolute
RTO probability, F). The plot demonstrates that there is no enhancement for a sphere
with a very large radius, since water molecules cannot leave the sphere origin. For a
sphere of small radius, molecules diffusing in a restricted environment are more likely to
be found with the sphere after diffusing for a time, t, than water molecules diffusing in a
bulk solution. Therefore, the RTO enhancement increases with decreasing sphere radius.
For long diffusion times, there is an increase in the RTO probability since the RTO
probability of free diffusing water molecules decreases faster than the RTO probability of
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highly restricted spins, with their limited displacement.
3.2 Experimental Methods
3.2.1 Animal Preparation
All experiments and procedures were approved by the Animal Research Committee
(ARC) of the University of Massachusetts Medical School. Animals were housed under
diurnal lighting conditions and allowed free access to food and water before and after
Figure 3.1.10: Plot of the RTO probability enhancement, R, versus 1/k of water
diffusing in the pore space of a Cutbank 26 mudstone rock  core (raw data shown in
Fig. 3.1.8) at diffusion times of 25, 75, 175, 275 and 475 ms (Helmer, 1999). The
enhancement is the quotient of the RTO probabilities of the rock sample and free
water.
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imaging. Eight-week old, female C3H mice (Taconic Farms, Germantown, NJ) were
anesthetized by intraperitoneal injection of 60 mg/kg sodium pentobarbital (Abbott
Laboratories, Chicago, IL). For the spectroscopy and imaging NMR experiments, the
lower back and right hind leg were shaved and the remaining hair removed with a
commercial hair remover (NAIR, Carter Wallace Inc., New York, NY).
Radiation-induced-fibrosarcoma, RIF-1 (Twentyman et al., 1980), cells from a second
passage, suspended in Waymouth's medium supplemented with 15 % v/v fetal bovine
serum (FBS) and 10 % v/v glycerol, were stored in liquid nitrogen. Prior to inoculation,
the frozen cells were defrosted at room temperature and 0.15 ml of the suspension
containing ~1 x 105 cells were subcutaneously injected in the lower back or right hind leg
with a 30-gauge hypodermic needle. RIF-1 tumors were allowed to grow to a range of
volumes (0.4 to 2.1 cm3) in order to obtain varying necrotic volumes. The tumor volume
was determined by measuring the three major orthogonal axes with slide calipers. The
volume was calculated to be
HeightWidthLengthVolume       
6
  ×××=
π
                 [3.2.1.1]
assuming an ellipsoidal volume (Euhus et al., 1986; Tomayko and Reynolds, 1989)
For data acquisition, anesthesia was induced with 2% isofluorane delivered in air at 1.5
l/min and maintained at 1.5% isofluorane at the same flow rate. The body temperature
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was maintained at 37° C by circulating 34° C warm air through the stereotaxic holder,
controlled with a T-type temperature probe (Omega, Stanford, CT) and a two-point
feedback system.
3.2.2 NMR Measurements
Data were acquired using a horizontal bore GE CSI-II 2.0 T 45-cm imaging spectrometer
operated at 85.56 MHz, equipped with ± 20 G/cm self-shielded gradients and a four-turn
solenoidal RF coil with an inner diameter of 15 mm for spectroscopy and 18 mm for
imaging.
NMR Spectroscopy:
A total of ten animals was used for the spectroscopic measurement of the RTO
probability and enhancement. To avoid the influence of susceptibility gradients from
large blood pools (sometimes present in tumors) on the measurement of the diffusion
coefficient and to achieve large k values with short diffusion gradient duration, the RTO
probability was measured spectroscopically with a modified pulsed-field-gradient
stimulated-echo pulse sequence (Latour et al., 1993a) designed to cancel any effects of
internal gradients (Fig. 3.2.2.1). The cancellation was achieved by separating pairs of
gradient pulses with opposite polarity by 180° RF pulses in each of the TE/2 time
periods. Five pairs of diffusion gradients were used with a diffusion-gradient duration of
1.5 ms. The diffusion gradients were successively incremented in 0.3 G/cm steps from
0.3 to 15 G/cm. Data were acquired over a range of five different diffusion times (42, 92,
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192, 292, and 492 ms) with a spectral width, SW = ± 2000 Hz, signal averages, NEX = 4,
and 2048 data points.
NMR Imaging:
A total of fourteen animals were used for the NMR imaging study and two animals, with
a large disagreement between the geometric shape of the imaging slice and the histology
slice, were excluded from the analysis. The coronal plane for image acquisition was
located at a constant offset of 3.0 mm with respect to the isocenter of the instrument to
avoid image acquisition in the area of the underlying muscle tissue. The animals were
immobilized in the stereotax, which ensured a relatively reproducible position in the bore
of the magnet.
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Figure 3.2.2.1: Modified pulsed-field-gradient stimulated-echo pulse sequence. Pairs of
gradient pulses are applied separated by 180° RF pulses to cancel the effects of internal
gradients on the diffusion measurement. The diffusion gradients have a duration of δ
and an amplitude of G. Crusher gradients, used to destroy any unwanted magnetization
and spurious echoes, are displayed in shaded gray. The sequence is based on a
stimulated-echo pulse sequence and supplemented with π pulses to reduce the exposure
of spins to the internal gradient fields.
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Coronal, diffusion-weighted, stimulated-echo echo-planar images were acquired with a
field of view, FOV = 30.0 mm, a 64 × 64 in plane resolution, a slice thickness of 3.0 mm,
a repetition time, TR = 6 s, number of averages, NEX = 4, an echo time of 56.0 ms, and a
spectral width, SW = ± 70KHz. Diffusion gradients were incremented in 32, 0.6 G/cm
steps, from 0.0 to 18.6 G/cm. The diffusion time was 201.5 ms with half-sine-shaped
diffusion-gradient pulses of duration, δ =7.0 ms. T2-weighted images of the same slice
were acquired at nine different echo times (10, 20, 40, 60, 80, 100, 150, 200, and 300 ms)
with the same imaging parameters as the diffusion-weighted images.
3.2.3 Histology
Immediately following the NMR experiment, the animal was sacrificed by cervical
dislocation. The tumor was excised and stored in formalin for fixation. Hematoxylin and
eosin (H&E) staining, for the detection of viable and necrotic tumor tissue, was
performed on the fixated neoplasms. For the spectroscopy experiment, a slice through the
center of the RIF-1 tumor was chosen for histology. In the case of the imaging study,
three slices (located at the top, center and bottom of the corresponding MRI slice) were
selected for histology. The stained histology slices had a thickness of 5 µm for both
experiments.
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3.2.4 Data Analysis
NMR Spectroscopy:
The RTO probability was calculated from the measured signal, ),( tkM
!
, using Eq.
[3.1.20]
( ) ( ) ( )∫=
max
0
2
2max ,2
1
,
k
kdktkMktP
!!!
π
                        [3.2.4.1]
with



=
π
δγ 2Gnk
!
,                                              [3.2.4.2]
where G is the applied diffusion-gradient strength, γ  is the gyromagnetic ratio, δ  is the
diffusion-gradient duration, n the number of diffusion-gradients applied, and ( )π2  the
geometric correction factor for half-sine-shaped diffusion gradients. The absolute RTO
probability, ),( tkF
!
, and the RTO enhancement, ),( tkR
!
, were then calculated from
),( tkP
!
 using Eqs. [3.1.23] and [3.1.25], respectively.
NMR Imaging:
As discussed earlier, for small k values, the slope of the signal attenuation curves is linear
and deviates little from the Gaussian diffusion behavior. A previous study (Helmer et al.,
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1995) found that the diffusion attenuation curves of RIF-1 tumors start to deviate from
linearity at a normalized signal attenuation ln( ),( tkM
!
/M0) greater than approximately
20%. Hence the apparent diffusion coefficient (ADC) maps were calculated on a pixel-
by-pixel basis from the initial slope of the ln( ),( tkM
!
/M0) versus k
2t signal attenuation
curve, where the signal attenuation is less than 20%.
The RTO enhancement, ),( tkR
!
, was calculated from the complete data set. The RTO
probability was generated from Eq. [3.1.2] by numerical integration of the ),( tkM
!
/M0
versus k signal attenuation curve on a pixel-by-pixel basis using the IDL (Interactive Data
Language, Boulder, CO) programming language. The result was then inserted into Eq.
[3.1.25], using a bulk water diffusion coefficient of 3.0 x 10-5 cm2/s at 37° C, to
determine the RTO enhancement for the creation of the RTO enhancement maps.
T2 maps were generated by fitting the images, acquired at different echo times (TE's), on
a pixel-by-pixel basis with a least-squared algorithm to the T2-relaxation equation
2
0
T
TE
xy eMM
−
= ,                                           [3.2.4.3]
where Mxy is the transverse magnetization at the echo time, TE, and M0 is initial
magnitude of magnetization following a 90° RF pulse applied to a system at the
Boltzmann equilibrium. Histograms of the diffusion, RTO-enhancement and T2 maps
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were generated for all tumors and normalized by the total non-zero pixel count of the
corresponding map.
Histological slices were digitized using a computer-based imaging system (Alpha Imager
2000, Alpha Innotech Inc., CA) and stored for further processing. Necrotic areas were
measured by manual tracing using the OPTIMAS (BIOSCAN, Edmonds, WA) image
processing software package. The necrotic areas detected on the histology stains were
then compared to the ADC, R, and T2 maps to identify necrotic and viable tissue area.
Normalization of the necrotic area, as detected by manual tracing, by the entire tumor
area of the histological slice yields the necrotic tumor fraction.
3.3 Results
NMR spectroscopy:
Figure 3.3.1 shows the natural logarithm of the measured signal intensity (ln(M/M0))
versus k2 for water diffusing in a 1.4 cm3 RIF-1 tumor at five different diffusion times of
42 (), 92(), 192 (ρ), 292 () and 492 () ms. The signal attenuation of the plot
ln(M/M0) versus k
2 is linear for small values of k2 and approaches a constant for large
values of k2. It can be seen that an increase in diffusion time increases the signal
attenuation. The signal attenuation curve of the ln(M/M0) versus k
2 plot for the shortest
diffusion time of 42 ms levels off at a value of approximately -1.4 while the attenuation
curve for the longest diffusion time of 492 ms levels off at approximately -3.0.
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Figure 3.3.2 shows a plot of the absolute RTO probability, F, versus 1/k for the data
shown in Fig. 3.3.1. The solid lines are calculated from the RIF-1 tumor data of Fig. 3.3.1
and the dashed lines are calculated for freely-diffusing water. The plot demonstrates that
the existence of restrictions in RIF-1 tumors leads to higher RTO probability as compared
to water molecules diffusing in a bulk solution. Larger diffusion gradients translate to a
fine resolution.
Molecules diffusing freely for 42 ms have approximately a 3.8% chance to be found
within a radius of lmin = 3 µm near their origin, while water molecules diffusing in a
tumor have a 41% chance to be found within the distance of lmin = 3 µm of their starting
Figure 3.3.1: Plot of the natural logarithm of the measured signal intensity (ln(M/M0))
versus k2 for water diffusing in a RIF-1 tumor of 1.4 cm3 at five different diffusion times
ranging from 42 (↓ ), 92(′ ), 192 (ρ ), 292 (↵ ) to 492 ( ) ms.
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Figure 3.3.1: Plot of the natural logarithm of the measured signal intensity (ln( / 0))
versus k2 f r t r iff si g in a IF-1 tumor of 1.4 cm3 at five diff rent diffusion times
ranging fro  42 (◊), 92 (), 192 (Δ), 292 () to 492 (Ο) ms.
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position. This difference in the absolute RTO probability becomes even larger at longer
diffusion times, as molecules have more time to probe the surrounding space and make
contact with the restricting boundaries.
Another way to view the effect of restrictions on diffusing water molecules is to plot of
the RTO enhancement, R, versus 1/k. Figure 3.3.3 shows a plot of the RTO enhancement,
R, versus 1/k calculated from the RTO tumor data displayed in Fig. 3.3.1. The graph
displays the enhancement between water molecules diffusing in RIF-1 tumors and bulk
solution. Water molecules diffusing for 42 ms in RIF-1 tumors are 10.8 (41 versus 3.8)
times more likely to be found within a sphere of radius 3 µm than water molecules
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Figure 3.3.2: Plot of the absolute RTO probability, F, versus 1/k for a single RIF-1 tumor
at five different diffusion times of 42, 92, 192, 292 and 492 ms and the corresponding,
calculated curves for water. The solid lines are calculated from the RIF-1 tumor data of
Fig. 3.3.1 and the dashed lines are calculated for freely diffusing water.
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diffusing in bulk solution, which is the same result as seen in Fig. 3.3.2 presented in a
different way.
Figure 3.3.4 shows a plot of the RTO enhancement, R, for four different RIF-1 tumor
volumes ranging from 0.7 (), 0.8 (), 1.1 () to 1.4 cm3  (), plotted versus five
different diffusion times (42, 92, 192, 292, and 492 ms) at 1/k = 2.7 µm.. The graph
demonstrates that the differences in RTO enhancement, due to different amounts of
restricting diffusion barriers, are largest at long diffusion times. The larger tumors, which
are generally more necrotic, display smaller RTO enhancement than the smaller tumors.
The smallest tumor (0.7 cm3) in Fig. 3.3.4, with the smallest necrotic tumor fraction, has
the largest enhancement (R = 208), while the largest tumor has the smallest enhancement
(R = 130) at a diffusion time of 492 ms.
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Figure 3.3.3: Plot of the RTO enhancement, R, calculated from the absolute RTO
probability as displayed in Fig. 3.3.2, versus 1/k for water diffusing in a RIF-1 tumor at
five different diffusion times ranging from 42, 92, 192, 292 to 492 ms.
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are generally more necrotic, display smaller RTO enhancement than the smaller tumors.
The smallest tumor (0.7 cm3) in Fig. 3.3.4, with the smallest necrotic tumor fraction, has
the largest enhancement (R = 208), while the largest tumor has the smallest enhancement
(R = 130) at a diffusion time of 492 ms.
Even though the results gained by NMR spectroscopy are promising, they are strongly
influenced by volume averaging effects due to contributions from many different tissue
types. NMR imaging, with its higher spatial resolution compared to spectroscopy, can
reduce the amount of volume averaging and allow comparison with histology for further
validation of the findings.
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Figure 3.3.4: RTO enhancement, R, for four different RIF-1 tumor volumes,
ranging from 0.7 (↵ ), 0.8 (′ ), 1.1 () to 1.4 cm3  ( ), plotted versus five different
diffusion times (42, 92, 192, 292, and 492 ms) and a sphere radius of 2.7 µm.
Large tumors are generally more necrotic resulting in a lower RTO enhancement.
The graph demonstrates that the best separation in RTO enhancement between
tumors of different necrotic fractions is achieved at long diffusion times.
Figure 3.3.4: RTO enhancement, R, for four different RIF-1 tumor volumes,
ranging from 0.7 (), 0.8 (), 1.1 () to 1.4 cm3 (), plotted versus five different
diffusion times (42, 92, 192, 292, and 492 ms) and a sphere radios of 2.7 µm.
Large tumors are generally more necrotic resulting in a lower RTO enhancement.
This graph demonstrates that the best separation in RTO enhancement between
tumors of different necrotic fractions is achieved at long diffusion times.
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NMR Imaging
Figure 3.3.5 shows a plot of the natural logarithm of the measured signal intensity
ln(M/M0) of 32 images versus k
2 from two pixels of a RIF-1 tumor and the calculated
curve for freely diffusing water at a temperature of 37° C. The curves show a difference
in signal attenuation for a pixel in viable () and necrotic () tumor tissue. Tissue types
were identified by examination of the corresponding histological slice. Both tumor tissue
curves show evidence of restricted diffusion as compared to the freely diffusing water
(). The viable tissue displays a smaller ADC (less steep initial slope) than the necrotic
tissue. The difference in ADC values is the difference in the initial slope of the two
curves. ADC values extracted from the tumor data in Fig. 3.3.5 give 77 and 133 × 10-7
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Figure 3.3.5: Plot of the natural logarithm of the signal intensity ln(M/M0) versus
k2=(γ Gδ )2 for a pixel in viable (↵ ) and necrotic ( ) RIF-1 tumor tissue as well
as the calculated curve for freely diffusing water () at 37° C. Data were
acquired using a diffusion-weighted stimulated-echo pulse sequence with a
diffusion-gradient pulse duration of 7.0 ms, a diffusion time of 201.5 ms and 32
diffusion-gradient increments form 0 to 18.6 G/cm in 0.6 G/cm steps.
Figure 3.3.5: Plot of the natural logarithm of the signal intensity ln(M/M0) versus
k2=(γGδ)2 for a pixel in viable () and necrotic () RIF-1 tumor tissue as well as the
calculated curve for freely diffusing water () at 37°C.  Data were acquired using a
diffusion-weighted stimulated-echo pulse sequence with a diffusion-gradient pulse
duration of 7.0 ms, a diffusion time of 201.5 ms and 32 diffusion-gradient
increments from 18.6 G/cm in 0.6 G/cm steps.
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cm2/sec, for viable and necrotic tissue, respectively. The plot further shows that viable
and necrotic tissue possesses a different RTO probability, which is proportional to the
area between the curve and the k2 axis. Data points with the larger k values are given the
largest weighting in the calculation of the RTO enhancement. The RTO enhancement
was calculated to be 16.4 and 7.1 for viable and necrotic tissue, respectively.
Figure 3.3.6 shows the generated T2, ADC and R maps of three representative RIF-1
tumors in comparison to the corresponding H&E stained histology slice obtained from
the same spatial location as the NMR imaging slice. Maps and histological section have a
slice thickness of 3.0 mm and 5 µm, respectively. The volumes of the three RIF-1 tumors
displayed in A, B and C are 0.7, 1.3 and 2.1 cm3, respectively. The viable tissue in the
histological section is depicted by the dark color and the necrotic tissue by the brighter
gray tones, with the largest tumors showing the largest necrotic area. Visual comparison
of the histological sections and the ADC and RTO enhancement maps in Fig. 3.3.6 show
that there is only general spatial agreement between the MRI parameters and the necrotic
regions. ADC and RTO enhancement maps, with their coarser resolution compared as to
the histology, display only the more prominent features found in the histological section.
T2 maps displayed on the left side of Fig. 3.3.6 show only small changes for the varying
degrees of necrosis and no spatial correlation with either the ADC and RTO enhancement
maps or the histological section.
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Figure 3.3.6: T2, ADC and RTO enhancement maps of three representative RIF-1 tumors with a slice thickness of 3.0 mm in 
comparison to the corresponding hematoxylin and eosin (H&E) histology slice of 5µm thickness obtained at the same spatial 
location.  ADC and RTO maps were created from diffusion-weighted NMR images acquired with a diffusion time of 201.5 
ms, an echo time of 56 ms, and 32 increments of the diffusion-gradient from 0.0 to 18.6 G/cm in 0.6 G/cm steps.  T2 maps are 
generated from nine images with varying echo times. 
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Figure 3.3.7: Histograms generated form the ADC and RTO enhancement maps in Fig.
3.3.6 and normalized by the total non-zero pixel count of the respective maps. The tumor
volumes for the three tumors A, B, and C are 0.7, 1.3 and 2.1 cm3, respectively.
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Figure 3.3.7 shows the histograms generated from the ADC and RTO enhancement maps
in Fig. 3.3.6 normalized by the total non-zero pixel count of the respective maps. The
ADC histogram (Fig. 3.3.7, A) shows a sharp peak for the smallest tumor with almost no
necrosis. As the tumor volume increases, so does the amount of necrosis present in the
tumors (Fig. 3.3.6). The mean ADC for the three representative tumors of volume 0.7,
1.3, and 1.4 cm3 is 68, 77, and 97 x 10-7 cm2/sec, respectively, with the tumor displaying
the largest amount of necrosis having the highest mean ADC. The increase in mean ADC
is accompanied by an increase in the width of the distribution, which is caused by a shift
of pixels towards higher ADC values and a decrease in the distribution magnitude. The
RTO enhancement histograms (Fig. 3.3.7, right side) show a behavior similar to that of
the ADC.  For the smaller two tumors with little necrosis, a relatively narrow distribution
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Figure 3.3.8: Plot of the T2 map mean versus the necrotic tumor fraction as
determined by hematoxylin and eosin (H&E) staining, for 12 RIF-1 tumors of varying
sizes and degrees of necrosis.
99
can be observed. The mean RTO enhancement for the three representative tumors of
volume 0.7, 1.3, and 1.4 cm3 is 14, 13.7, and 9.8, respectively, with the tumor displaying
the largest amount of necrosis having the smallest RTO enhancement. The decrease in the
RTO enhancement with increasing necrosis is accompanied by a dispersion of the
histogram and a shift of pixels towards lower RTO enhancement, while the magnitude of
the distribution decreases.
Figure 3.3.8 is a plot of the mean T2, calculated from the NMR T2 maps, versus the
necrotic tumor fraction (as determined by H&E staining) for 12 RIF-1 tumors of varying
sizes and degrees of necrosis. The mean T2 correlates poorly (r = 0.62) with the necrotic
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Figure 3.3.9: Plot of the ADC map mean versus the necrotic tumor fraction, as
determined by hematoxylin and eosin (H&E) staining, for 12 RIF-1 tumors of
varying sizes and degrees of necrosis.
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tumor fraction and exhibits only small change over the entire range of necrotic tumor
fractions.
Figure 3.3.9 is a plot of the mean ADC, calculated form the ADC histograms, versus the
necrotic tumor fraction, as determined by H&E staining, for 12 RIF-1 tumors of varying
sizes and degrees of necrosis. The plot illustrates how well the mean ADC tracks necrosis
in RIF-1 tumors over a wide range of necrotic tumor fractions. The correlation coefficient
for this data is r = 0.86.
The graph in Fig. 3.3.10 plots the mean of the RTO enhancement histograms versus the
necrotic tumor fraction, as determined by H&E staining, for 12 RIF-1 tumors of varying
sizes and necrotic volumes. The correlation coefficient for this data is r = 0.82.
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Figure 3.3.10: Plot of the RTO enhancement map mean versus the necrotic tumor
fraction, as determined by hematoxylin and eosin (H&E) staining, for 12 RIF-1
tumors of varying sizes and degrees of necrosis.
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3.4 Discussion and Conclusion
Fig. 3.3.1 clearly shows the differences of the water signal attenuation from RIF-1 tumors
for a varying range of diffusion times. The differences in the initial slope of the
attenuation curves at small values of k2 show the time-dependence of the diffusion
coefficient, D(t). With increasing diffusion times, t, the diffusing molecules sample larger
spaces and therefore have an increased chance to find obstacles in their diffusion path,
reducing their mean squared displacement. This behavior is well reflected by the initial
slopes of Fig. 3.3.1, where shallowest slope is observed for the shortest diffusion time
and the steepest for long diffusion times. In this regime of small k2 values, the
measurement includes most of the spin population. In the plateau region (large k2
regime), the signal arises predominately from a spin population with low diffusion
coefficients. These spins have not been completely dephased by the large applied
diffusion gradient.
Since diffusing molecules at long diffusion times encounter more restrictions than at
short diffusion times, their absolute RTO probability, F(t), is increased. This increase in
F(t) for longer diffusion times is illustrated in Fig. 3.3.2, where F(t) is plotted versus 1/k
for five different diffusion times. The plot demonstrates that for a large radius (~1/k) of
the sphere of origin the absolute RTO probability approaches unity, since the diffusing
molecules cannot diffuse far enough to leave the sphere around their point of origin. For
very small values of 1/k (small radius), the absolute RTO probability decreases since it is
less likely that the molecules will return to their sphere of origin or have never left it.
Comparing of the absolute RTO probability of water molecules diffusing in a RIF-1
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tumor with that of water diffusing in an unrestricted bulk solution, demonstrates a
significantly increased F(t) in the restricted tissue environment. Further inspection of Fig.
3.3.2 reveals that for water molecules diffusing for 492 ms in RIF-1 tumor tissue, there is
approximately a 25% chance that the molecules will be found within a sphere of 7-µm
radius. By comparison, water molecules diffusing in bulk solution have only a 1% chance
of being found within a sphere of equal dimensions. For shorter diffusion times, like 42
ms, the absolute RTO probability for diffusing molecules to return to a sphere with radius
7 µm is 75% in RIF-1 tumors and 32% in the bulk phase. This can be interpreted that at
492 ms, water molecules in a RIF-1 tumor are about 25 times more likely to be found
within a sphere of the above dimensions than bulk water molecules, but only twice as
likely for a diffusion time of 42 ms. The plot in Fig. 3.3.2 also shows that the largest
enhancements are achieved at long diffusion times.
This enhancement over freely diffusing water for different diffusion times and sphere
radii is described by the RTO enhancement in Fig. 3.3.3. The RTO enhancement is a
different way to present the enhancement of restricted diffusion over that of free diffusion
as seen in Fig. 3.3.2. The extracted enhancement from Fig. 3.3.2 maps to the plot of the
RTO enhancement, R.  At a sphere radius of 7 µm, the absolute RTO probability for 42
ms was 0.75 and 0.32 for diffusion in RIF-1 tumor and bulk water, respectively. This
results in an enhancement of 2.3, which is in perfect agreement with the plot in Fig. 3.3.3.
The plot also shows that R increases with diffusion time. For the example with the sphere
radius of 7 µm and a diffusion time of 492 ms the calculated RTO enhancement ( R = 25)
and the extracted enhancement (R = 0.25/0.01) of the RIF-1 tumor (F = 0.25) over freely
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diffusing water (F = 0.01) from Fig. 3.3.2 are in agreement. A further increase in the
RTO enhancement can be achieved by decreasing the radius of the sphere (~1/k). For the
example at a diffusion time of 42 ms, the reduction to 3 µm yields an R of 10.8. This can
be verified by inspection of Fig. 3.3.2, were the F at these parameters is 0.41 for the RIF-
1 tumor and 0.038 for the freely diffusing water, respectively. From the examples above,
it can be seen that the largest enhancement is achieved at long diffusion times and a small
sphere radius (lmin).
A plot of the maximum RTO enhancement (1/kmax) of water as a function of diffusion
time in RIF-1 tumors (Fig. 3.3.4) illustrates the increase in RTO enhancement with
increasing diffusion time. The plot clearly reveals that the RTO enhancement decreases
with tumor size and that the smaller tumors have a larger enhancement than the larger
tumors. This is presumably due to the presence of more viable (i.e., less necrotic) tumor
tissue. Smaller solid tumors presumably have less necrotic tissue and the
spectroscopically-measured diffusion coefficient is expected to be higher since viable
tissue presents more restrictions to diffusing molecules than necrotic tissue. Necrotic
tissue debris is removed by auto- and/or heterolysis, leaving behind spaces with fewer
membranes and organelles. Therefore, water molecules can diffuse longer distances
without encountering any obstacles. As tumors grow larger, the amount of necrosis
generally increases and the contribution of signals from water molecules with larger
diffusion coefficients gives rise to an overall increase in the tumor water diffusion
coefficient. This is consistent with the results found by Helmer et al. (1995), where
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higher diffusion coefficients in RIF-1 tumors generally correlated with increased tumor
necrosis.
Since spectroscopic data has contribution from a many different tissue types, the resulting
measurement is strongly influenced by volume-averaging effects. NMR imaging can
reduce this problem, since smaller imaging volumes are thought to contain fewer tissue
types. The increased spatial resolution achieved by NMR imaging allows a comparison of
the NMR data with tumor histology and should make it a more sensitive metric.
Plots of the signal attenuation, ln(M/M0), versus k
2 for pixels originating in clearly viable
and necrotic tumor tissue (Fig. 3.3.5), as verified by comparison to the histology, show
that the ADC and RTO enhancement are sensitive to the structural differences between
viable and necrotic tissue. The presence of restrictions causes a deviation from the linear
diffusion behavior of water and thus both the ADC and the RTO probability can be used
to distinguish between the two types of tumor tissue. The apparent diffusion coefficient,
extracted from the initial slope of the signal attenuation, and the RTO enhancement,
calculated from the complete data set, allow separation between viable and necrotic tissue
due to the differences in pathophysiological structure.
Figure 3.3.5 shows a 73% difference in the initial slope of the attenuation curves for a
pixel in necrotic (solid circle) and a pixel in viable tissue (solid diamond). The steeper
initial slope of the attenuation curve from the necrotic tissue results in a higher apparent
diffusion coefficient, ADC (133 × 10-7 cm2/sec), than the shallower slope of the
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attenuation curve from the viable tissue (77 × 10-7 cm2/sec). Viable tissue confines
diffusing water molecules to a smaller area (i.e. reduces their average net displacement)
and consequently reduces their apparent diffusion coefficient. In necrotic tissue, the
diffusing water molecules have a larger free diffusion path, yielding a larger average net
displacement and hence a higher apparent diffusion coefficient. This is consistent with
our hypothesis that necrotic tissue has fewer restricted water molecules.
The differences in the attenuation curves for viable and necrotic tissue in Fig. 3.3.5 also
illustrate the differences in the RTO probability, which is proportional to the area
between the attenuation curve and the k2 axis with data from large k values given the
largest weighting. The attenuation curve of necrotic tumor tissue encloses a larger area as
compared to the attenuation curve of viable tissue. The RTO enhancement for the viable
and necrotic tissue was calculated to be 16.4 and 7.1, respectively, resulting in a 131%
difference between the two tissue types. In comparison to the ADC (73%), the RTO has
twice the dynamic range for the same two pixels.
The calculated ADC and RTO enhancement maps in Fig. 3.3.6 show only general spatial
agreement with the histology. Larger areas in the histology slice, which are clearly
classifiable as either necrotic (bright gray tones) or viable (dark gray tones) tumor tissue
are well represented by the ADC and RTO enhancement maps. Both ADC and RTO
enhancement maps display the same general features. The T2 maps, which are a function
of the tissue water content, show little agreement with either the histology or the ADC
and RTO enhancement maps. Given the difference in ADC and RTO enhancement for
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viable and necrotic tissue, an attempt was made to determine thresholds for the two
quantities that identify necrotic and viable tissue on both maps. The detected necrotic
area for varying thresholds was correlated with the necrotic tumor fraction of the
histological slide. The best correlations between the necrotic area on the histology slices
and the necrotic area (n=12) detected by thresholding of the ADC and RTO enhancement
maps was 0.69 and 0.72, respectively, for an ADC threshold of 84 x 10-7 cm2/sec and
RTO enhancement threshold of 6. Despite the reasonably good correlation coefficients,
the necrotic areas detected by the thresholds had relatively poor visual correspondence
with the necrotic areas in the histological section.
Since major features in the MRI maps showed a general agreement with the histology,
histograms (Fig. 3.3.7) of the maps were created. The increase in necrotic fraction with
increasing tumor size (0.7, 1.3 and 2.1 cm3) is reflected by a shift in the histogram mean
ADC and RTO enhancement. Mean ADC values shift with increasing tumor volume
from 68 to 77 to 97 × 10-7 cm2/sec, respectively. This behavior is expected, since an
increase in necrotic fraction would be reflected as an increase in the mean ADC value of
the histogram. The use of the mean rather than the median was desirable in this case to be
sensitive to extreme values. Similar behavior was observed for the RTO enhancement
histograms, where the mean values shifted from 14.2 to 13.2 to 9.8, respectively, due to
the decreased RTO probability in necrotic tissue.
The change in histogram means from the smallest tumor volume to the largest is 42% for
the ADC and 44% for the RTO enhancement. These numbers show that when parameter
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values from different tissue types are averaged, the large difference between the RTO
enhancement and the ADC are eliminated. The means of the histograms resemble more
the spectroscopic approach, where different tissue types are averaged together and it can
be implied that, due to this volume averaging, spectroscopic studies will not gain the
advantage of the greater sensitivity achieved by the RTO enhancement.
The mean T2 values, with their small dynamic range, exhibit only small changes over the
entire range of necrotic tumor fractions and poor correlation (r = 0.62). This result is not
unexpected considering that T2 maps showed neither visual agreement with histology or
any significant changes in T2 values between T2 maps of varying necrotic area. T2
measurements are a function of the tumor tissue water content and thus not sensitive to
the structural differences between viable and necrotic tumor tissue.
In comparison, the mean ADC values show a high correlation (r = 0.86) with the necrotic
tumor fraction and a good tracking of the increasing necrosis by the mean ADC (Fig.
3.3.9). The ADC pixel distribution in tumors with relatively little necrosis consists of
pixels that reside primarily in viable tissue. These pixels have low ADC values and hence
their distribution is centered around a relatively small mean ADC. Increased necrosis
within the tumor slice causes an increased contribution from pixels with high ADC
values, associated with necrotic tissue, and thereby a shift of the mean ADC towards
higher values. As the contribution of pixels from necrotic tumor tissue increases, so does
the mean ADC.
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Similar behavior, but in the opposite direction, can be seen in the plot of the mean RTO
enhancement versus the necrotic tumor fraction (Fig. 3.3.10). The net displacement of
molecules diffusing in viable tissue results in a low RTO enhancement. In tumors with
small necrotic tumor fractions, most of the pixels have high RTO enhancement and hence
the RTO enhancement pixel distribution is centered around a low mean RTO
enhancement value. Increasing amounts of necrosis permit a larger net displacement of
diffusing water molecules and the contribution of pixel with low RTO enhancement,
associated with necrotic tumor tissue, increases. The increase in the number of pixels
displaying a low RTO enhancement causes the mean RTO enhancement to shift towards
a lower value. The decrease of the mean RTO enhancement with increasing necrotic
tumor fraction can be observed in Fig. 3.3.10 and illustrates that the RTO enhancement
can be used to differentiate different amounts of necrosis. Correlation of the mean RTO
enhancement with the necrotic tumor fraction results in a correlation coefficient of r =
0.82.
The poor visual agreement of the ADC and RTO enhancement maps with the histology
can be attributed to the volume-averaging effects due to the 3-mm slice thickness used
during imaging. The sharper outline of the stained tumor slice is due to the higher spatial
resolution of the histology compared to the in-plane resolution of 0.47 mm per pixel for
the calculated ADC and RTO enhancement maps. The volume-averaging is enhanced by
the MRI slice thickness of 3 mm compared to the slice thickness of ~5 µm for histology.
This large difference in slice thickness leads to a reduction in the details and averaging of
different tissue types within a single pixel of the MRI maps.
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The averaging of different tissues in each pixel is further enhanced by the regions of
necrotic and viable tissue. This can be seen in the histological section in Fig. 3.3.6, A. As
necrosis progresses, more and more cells per unit area become necrotic, causing the stain
to appear brighter and making it more difficult to clearly separate necrotic from viable
tissue. Separation of the tissue in three categories - viable, mixed and necrotic - may
seem more appropriate, but is even more difficult to achieve due to the varying amount of
mixed tissue and this issue will need to be addressed in future studies.
Another problem for comparisons between imaging and histology arises from the
distortion inherent to the echo-planar imaging process. During the sweeping of k space,
the EPI gradient switching alters the phase of the acquired signal which leads to
distortions in the image during the Fourier transform. Although these distortions are
small in our case, the mismatch in geometry hampers a comparison with histology. To
enhance the problem, the histology has its own geometrical distortions due to dehydration
of the tumor section during staining. Fixation and staining are dehydrating processes and
impart a significant amount of shrinkage on the histology slice, making a direct one-to-
one comparison impossible. While the imparted shrinkage still allows a comparison of
the general features, the necrotic area cannot be determined accurately, since the amount
of reduction in geometry is unknown. The assessment of the necrotic area with respect to
the slice area allows determining tumor necrosis on a relative basis.
Despite these differences, it has been demonstrated that both the ADC and RTO
enhancement can be used as indicators of necrosis in tumor tissue and are more sensitive
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than conventional T2-weighted MRI. The RTO enhancement is, however, more sensitive
than the ADC, implying that the number of restricted spins (the signal at the largest
diffusion gradient) is a better measure of the tissue viability than is a parameter that
reflects both unrestricted and restricted water molecules. The advantage of the  ADC data
set, which is a subset of the RTO data set, is a shorter acquisition time and smaller values
of the space vector for data collection. For the collection of the RTO data set, large k
values are necessary, which require large diffusion gradient magnitudes that are not
commonly available on most  clinical MRI scanner.
Both the ADC and RTO enhancement provide a large improvement for detecting necrosis
as compared to T2-weighted MRI, which is not sensitive to the structural differences of
the two tissue types under investigation. The ability of the ADC and RTO enhancement
to differentiate between viable and necrotic tissue could be especially useful in defining
dynamic changes in tumors in response to therapeutic intervention at early time points,
where a non-invasive method is needed to verify the efficacy of chemo- or radiation
therapy.
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4.0 Return-to-the-Origin Probability and ADC
Mapping of Water as Early Indicators of the Efficacy of
Chemotherapy in RIF-1 Tumors
The purpose of this study is to compare the ability of the return-to-the-origin (RTO)
probability and the apparent diffusion coefficient (ADC) to detect and characterize
changes in water diffusion in response to chemotherapeutic treatment of RIF-1 tumors
using 5-Fluorouracil (5-FU). Information pertaining to tissue structure can be gathered by
measuring the displacement of endogenous water molecules. The degree to which
diffusing water molecules are restricted is reflected by both the return-to-the-origin
(RTO) probability and the apparent diffusion coefficient (ADC). Molecules in viable
tissue have a low ADC and high RTO probability due to the presence of restricting
boundaries, like cell membranes and organelles, that confine the molecules. Water
molecules in necrotic tissue experience fewer restrictions and hence have a higher ADC,
while their RTO probability is decreased. Chemo- and radiotherapy induced
pathophysiological and structural changes associated with tissue necrosis can be detected
by ADC and RTO probability. Mice bearing RIF-1 tumors treated with 50 and 100 mg/kg
5-Fluorouracil (5-FU) were monitored on a daily basis until the tumor volume exceeded
2.0 cm3. Diffusion-weighted, stimulated-echo echo-planar images were taken daily and
ADC maps and RTO enhancement maps were constructed from the images. This study
shows that changes in the dynamic state of tumor physiology after therapeutic
intervention can be visualized by both the ADC and RTO enhancement. The largest
changes in mean ADC (87%) and mean RTO enhancement (106%) were observed at the
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time point of maximum tumor regression, four days after the administration of the
chemotherapeutic agent. This characterization of tumor response to chemotherapy
permits the evaluation of optimal biological responses to therapy management and could
potentially optimize the timing of therapy scheduling and thus improve patient care.
4.1 Introduction
Therapy schedules for most chemotherapy treatments are based on the limited
understanding of pharmacokinetics and dosage is dependent upon the normal tissue
response of the patient. A better understanding and monitoring of the dynamic state of
tumor physiology in response to treatment would allow an improvement in the design of
therapy scheduling strategies to optimize vulnerable periods of tumor biology for an
increase in the efficiency of current treatment strategies. The purpose of this study is to
compare the ability of the return-to-the-origin probability (RTO) and the apparent
diffusion coefficient (ADC) to detect and characterize dynamic changes in water
diffusion in response to chemotherapeutic treatment by 5-Fluorouracil (5-FU) of RIF-1
tumors. Recent studies of tumors have shown that the ADC is sensitive to pathological
and structural changes in tumors associated with ischemia and necrosis (Helmer et al.,
1995; Zhao et al., 1995a).
These structural changes can be assessed by the ADC and the application of the RTO
probability as described in Chapter 3. The RTO probability (Mitra et al., 1995b) measures
the probability that diffusing water molecules will be found near their initial position
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after diffusing for a time, t. In the presence of diffusion-restricting barriers, the RTO
probability will increase with respect to that of freely-diffusing water. This enhancement,
R, over free diffusion is a useful metric to assess structural changes as they relate to
necrosis and to differentiate between viable and necrotic tumor tissue (Helmer et al.,
1997; Meiler et al., 1998).
Rapid cell proliferation causes a neoplasm to outgrow its vasculature. Cells in the
affected areas lack an adequate supply of oxygen and become hypoxic. If the oxygen
supply to these regions is not restored, the hypoxic cells become necrotic and the process
of cellular degradation begins. This process causes structural changes as viable cells
become hypoxic and subsequently turn necrotic. Hypoxia and necrosis cause cell
swelling, rupture of membranes and subsequent auto- and/or heterolysis (Wyllie, 1981) to
remove the resulting debris. Similar changes in structure can be induced by chemo- and
radiation therapy (Aiken et al., 1994; Zhao et al., 1996). Magnetic resonance
spectroscopy (MRS) in vivo can monitor metabolic changes in response to rapid tumor
growth or therapeutic intervention. While MRS can detect changes in tumor metabolism
(Steen, 1989; Kamm et al., 1996), it suffers from a relatively coarse spatial resolution due
to the low abundance of these nuclei. In order to evaluate and verify the progression and
efficacy of therapy, it would be advantageous to visualize changes in tissue viability at
the spatial resolution achievable by water-proton MRI. As reported in Chapter 3, return-
to-the-origin probability and ADC imaging can overcome these shortcomings in spatial
resolution and allows visualization of necrosis in tumor tissue in response to therapeutic
intervention.
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4.2 Experimental Methods
4.2.1 Animal Preparation
All experiments and procedures were approved by the Animal Research Committee
(ARC) of the University of Massachusetts Medical School. Animals were housed under
diurnal lighting conditions and allowed free access to food and water before and after the
imaging experiments. Eight-week-old, female C3H mice (Taconic Farms, Germantown,
NJ) were anesthetized by intraperitoneal injection of 60 mg/kg sodium pentobarbital
(Abbott Laboratories, Chicago, IL). The right hind leg was shaved and remaining hair
removed with a commercial hair remover (NAIR, Carter Wallace Inc., New York, NY).
Radiation induced fibrosarcoma, RIF-1 (Twentyman et al., 1980), cells from a second
passage were suspended in Waymouth's medium supplemented with 15% v/v FBS and
10% v/v glycerol and stored in liquid nitrogen. Prior to inoculation, the frozen cells were
defrosted and 0.15 ml of the suspension containing 1 x 105 cells was subcutaneously
injected into the right hind leg with a 30-gauge hypodermic needle.
4.2.2 Chemotherapy
5-Fluorouracil (5-FU) powder (Sigma Chemicals, St. Louis, MO) was dissolved in sterile
0.9 % saline (Baxter, Deerfield, IL) and agitated with a vortex mixer. Animals were
separated into three groups of 10 animals each; control group, drug group I and drug
group II. As soon as the tumor volume reached 0.7 cm3, the animals received an
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intraperitoneal injection of either drug or placebo. The control group received a placebo
of saline, while the drug group I and II were injected with 50 and 100 mg/kg 5-FU,
respectively. Both doses are well below the LD50 dose of 260 mg/kg  (Sijens et al., 1991).
Tumor growth was assessed daily for all animals. The endpoint of the study was reached
when the tumor volume exceeded 2.0 cm3. Tumor volume was determined by measuring
the three major orthogonal axes with sliding calipers and the volume was calculated to
be: V = π/6 × length × width × height (Shackney et al., 1978; Spang-Thomson et al.,
1980; Euhus et al., 1986; Fiennes, 1988; Tomayko and Reynolds, 1989).
4.2.3 Dose Response Studies
Dose-response studies were performed prior to the MRI experiments in order to
determine the tumor doubling time and the point of maximum tumor regression. The
tumor volume was measured daily. None of the animals showed a significant reduction in
body weight or activity. Tumor growth data were collected for all animals to determine
tumor doubling time (TDT) and time-to-maximum regression (TMR).
4.2.4 NMR Measurements
Diffusion-weighted, stimulated-echo echo-planar images were acquired using a
horizontal bore GE CSI-II 2.0 T / 45 cm imaging spectrometer operated at 85.56 MHz for
protons and equipped with ± 20 G/cm self-shielded gradients. Experiments were
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performed using a 4-turn solenoidal RF coil with 18-mm inner diameter placed around
the tumor. Anesthesia was induced with 2% Isofluorane delivered in air at 1.5 l/min and
maintained at 1.5% Isofluorane at the same flow rate. During the MRI experiments, the
body temperature was maintained at 37οC by circulating 34οC warm air through the
animal holder. The temperature was controlled using a T-type temperature probe
(Omega, Stanford, CT) and a two-point feedback system.
The coronal plane for image acquisition was located at a constant offset of 3.0 mm with
respect to the isocenter of the instrument to avoid image acquisition in the area of the
underlying muscle tissue. The animals were immobilized on a stereotaxic holder, which
ensured reproducible positioning in the bore of the instrument with respect to the
isocenter, the underlying muscle, and the RF coil. The imaging plane was kept at a fixed
location to monitor changes at this location. This approach was chosen since the
positioning has better reproducibility than positioning with respect to the changing tumor
core. During the time course of the study, the tumor was allowed to grow through the
imaging plane.
Coronal images were acquired through the tumor with FOV = 30.0 mm, 64 × 64 data
matrix, slice thickness of 3.0 mm, TR = 6 s, NEX = 8, TE = 56.0 ms, and SW = ±70KHz.
Diffusion-gradients were incremented in 32, 0.6 G/cm steps from 0.0 to 18.6 G/cm. The
diffusion time was 201.5 ms with a half-sine-shaped gradient pulse with a width of δ =
7.0 ms. T2-weighted, spin-echo echo-planar images were acquired for nine different echo
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times (10, 20, 40, 60, 80, 100, 150, 200, and 300 ms) with the same imaging parameters
used for the diffusion-weighted images.
4.2.5 Data Analysis
Dose response Study
Animals with tumors showing injury were excluded from the study. The tumor doubling
time (TDT) was determined for each group using the formula (Houchens and Ovejera,
1991)
12 ttTDT −=                                                  [4.2.3.1]
where t2 is the time point for the larger volume and t1 is the time point of the smaller
tumor volume. TDT was measured as the tumor volume doubled from initially 0.7 cm3 to
1.4 cm3. A single factor ANOVA test was applied to establish the statistical significance
between the treatment groups and the control group.
The time of maximum regression was calculated as the time difference between the time
point of the smallest tumor volume after injection of the drug and the time point at which
the tumor had a volume of 0.7 cm3 by
1min ttTMR −=                                                     [4.2.3.2]
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where tmin is the time point of the smallest tumor volume and t1 is the initial time point.
Means and standard deviations were calculated for the treatment groups and the statistical
significance was evaluated by a single factor ANOVA test.
NMR Measurements
MRI data were analyzed on an Apollo 735 (Hewlett Packard, Palo Alto, CA) computer
workstation using in-house software written in C and IDL (Interactive Data Language,
Boulder, CO) programming language.
The slope of the signal attenuation curves is linear and deviates little from the Gaussian
behavior at small k values. In a previous study, Helmer et al. (1995) found that the
diffusion attenuation curves of RIF-1 tumors start to deviate from linearity at a signal
attenuation )/),(ln( 0MtkM  greater than 20%. Hence the ADC maps were calculated on
a pixel-by-pixel basis from the initial slope of the )/),(ln( 0MtkM  versus tk
2  signal
attenuation curve, where the signal attenuation is smaller than 20%.
The RTO enhancement, ),( tkR , was calculated from the complete data set acquired. The
RTO probability was generated from Eq. [3.1.2] by numerical integration of the
)/),(ln( 0MtkM  versus k signal attenuation curve on a pixel-by-pixel basis. The result
was then inserted into Eq. [3.1.25], using a bulk water diffusion coefficient of 3.0 x 10-5
cm2/sec at 37° C, to determine the RTO enhancement for the creation of the RTO
enhancement maps. The tumor temperature was assumed to be equal the body
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temperature of the animal ( 37° C) even if some areas within the tumor may be up to 1.5°
C lower.
T2 maps were generated by fitting the images, acquired at different echo times (TE's), on
a pixel-by-pixel basis with a least-squared algorithm to the T2-relaxation equation
2
0
T
TE
xy eMM
−
=                                                        [4.2.5.1]
with Mxy is the transverse magnetization at the echo time, TE, and M0 the initial
magnitude of the magnetization following a 90° RF pulse applied to a system at the
Boltzmann equilibrium.
Histograms of the ADC, RTO-enhancement and T2 maps, excluding the background,
were generated for all tumor maps and normalized by the total non-zero pixel count of
the corresponding map. The mean and standard deviation of the mean of the histograms
was calculated for each group at each day.
Hematoxylin and eosin (H&E) staining was performed on histological slices from the
tumors. Histological slices of ~5-µm thickness were obtained from positions at the top,
center and bottom of the corresponding MRI slice. The stained histological sections were
then digitized on a computer-based imaging system (Alpha Imager 2000, Alpha Innotech
Inc., CA.) and stored for further processing. Necrotic areas were measured by manual
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tracing using a personal computer and OPTIMAS (BIOSCAN, Edmonds, WA) image-
processing software. The histological sections were then compared to the ADC, RTO-
enhancement and T2 maps to correlate necrotic and viable tissue areas.
4.3 Results
Dose Response Study
Figure 4.3.1 shows the tumor growth curves for three representative RIF-1 tumors, since
a plot of all tumors would obscure the displayed features. The control animal (?) shows
a steady increase in tumor volume over time, while animals treated with a single dose of
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Figure 4.3.1: Plot of tumor volume as a function of time for a representative
animal of the control group ( ), the with 50 mg/kg 5-Fluorouracil (5-FU) treated
group (), and the with 100 mg/kg 5-FU treated group (′ ). Tumor volumes were
assessed from their first appearance until they exceeded 2.0 cm3. At a volume of
0.7 cm3 (Day 0)  control and treatment animals were injected with a placebo and 5-
FU, respectively.
5-FU
injection
i re 4.3.1: Plot of tumor volume as a function of time for a representative
ani al of the control group (?), the ith 50 mg/kg 5-Flourouracil (5-FU) treated
group ( ), and the with 100 g/kg 5-FU treated group ().  Tumor volumes
were assessed from their first appearance until they exceeded 2.0 cm3.  At a
volume of 0.7 cm3 (Day 0) control and treatment animals were injected with a
placebo and 5-FU, respectively.
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50 mg/kg () and 100 mg/kg () 5-FU (Day 0) exhibit a transient regression in tumor
volume before tumor growth resumes. The calculated TDT for the tumors is displayed in
Table 4.3.1 and the mean ± standard deviation for each group was determined to be 3.1 ±
0.6 days for the control group (n = 9), 5.8 ± 0.6 days (n = 8) and 7.8 ± 0.7 days (n = 6) for
the group treated with 50 mg/kg and 100 mg/kg 5-FU, respectively. The statistical
significance between the control and drug groups was established by a single factor
ANOVA test (p < 0.0001) for both treatment groups, taking into account the different
number of animals in each group.
The time to maximum regression (TMR) was determined to be 3.1 ± 1.1 days and 3.8 ±
0.4 days (mean ± SD) for the 50 mg/kg (n = 9) and 100 mg/kg (n = 6) 5-FU treatment
groups, respectively. The statistical significance between the TMR for the two treatment
Tumor Doubling Time (TDT) [Days]
Treatment GroupAnimal No. Control Group
50 mg/kg 5-FU 100 mg/kg 5-FU
1 1.91 5.27 7.80
2 3.87 5.73 7.52
3 2.90 5.37 8.72
4 3.54 6.50 6.76
5 3.31 7.05 8.10
6 2.68 4.77 8.19
7 3.45 5.38
8 2.55 6.36
9 3.64
Mean 3.09 5.80 7.84
± SD 0.63 0.76 0.66
Table 4.3.1: Tumor doubling time (TDT) of RIF-1 tumors grown on the right hind leg
of C3H mice determined at tumor volumes between 0.7 and 1.4 cm3. The column
displays the individual TDT for each tumor from the control group and the treatment
group of 50 mg/kg and 100 mg/kg 5-FU as well as the mean and standard deviation for
the respective groups.
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groups was established by a single ANOVA test (p < 0.015) taking into account the
different number of animals in each group.
NMR Measurement
Figure 4.3.2 displays the generated ADC, RTO enhancement, and T2 maps of a
representative RIF-1 tumor for an animal from the control group as a function of time
(days) and volume, as well as the corresponding H&E stained histological section. The
section used for histology was obtained at the last day from the same spatial location as
the NMR imaging slice. The ADC and RTO enhancement maps show an increase in
ADC values and a decrease in the RTO enhancement over the period of five days when
the RIF-1 tumor grew from 0.7 to 2.1 cm3. At Day 5 a regression in the ADC values and
a slight increase in the RTO enhancement can be observed. The T2 maps exhibit only
small changes over the 5-day observation period. Areas in the ADC and RTO
enhancement maps associated with necrotic tissue are represented by high ADC and low
RTO enhancement  values,  while areas of  low  ADC  and high  RTO enhancement
values are associated with viable tumor tissue. The histological section obtained at the
last imaging day displays viable tissue in dark and necrotic tissue in bright gray tones.
Visual comparison of the histological section and the generated ADC and RTO
enhancement maps at the last day (Day 5) show only general spatial agreement between
the MRI parameters and the necrotic regions. No agreement can be found between the
necrotic areas and the T2 maps.
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Figure 4.3.2: ADC, RTO enhancement, and T2 maps as a function of time (days) and volume for a RIF tumor from the control
group.  The ADC and RTO enhancement maps were acquired with a diffusion-weighted, stimulated-echo echoplanar pulse 
sequence at a diffusion time of 201.5 ms, a diffusion-gradient duration of 7 ms, and a slice thickness of 3 mm.  The T2 maps 
were created from nine different images with echo times of 10, 20, 40, 60, 80, 100, 150, 200, and 300 ms. The histological 
slice from the corresponding location of the MRI slices was obtained at the last day (Day 5) and has a thickness of 5 µm.  Low
ADC and high RTO enhancement values are associated with viable tumor tissue while high ADC and low RTO enhancement 
values are associated with necrotic tumor tissue. 
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Figure 4.3.3: ADC, RTO enhancement, and T2 maps as a function of time (days) and volume for RIF-1 tumor from the 
treatment group.  Following the imaging procedure on Day 2, 100 mg/kg of the chemotherapeutic agent 5-Fluorouracil (5-FU) 
was administered via intraperitoneal injection.  The ADC and RTO enhancement maps were acquired with a diffusion-weighted,
stimulated-echo echo-planar pulse sequence at a diffusion time of 201.5 ms, a diffusion-gradient duration of 7 ms, and a slice 
thickness of 3 mm.  The T2 maps were created from nine different images with echo times of 10, 20, 40, 60, 80, 100, 150, 200, 
and 300 ms. The histological slice from the corresponding location of the MRI slices was obtained at the last day (Day 11) and 
has a thickness of 5 µm.  Low ADC and high RTO enhancement values are associated with viable tumor tissue while high ADC 
and low RTO enhancement values are associated with necrotic tumor tissue.  The figure continues on the next page. 
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ADC, RTO enhancement and T2 maps shown in Fig. 4.3.3 as a function of time (days)
and volume for a RIF-1 tumor from an animal treated with 100 mg/kg 5-FU, together
with the corresponding H&E stained histological section obtained at the last day from the
same spatial location as the NMR imaging slice. The maps span an 11-day period and
treatment was administered at Day 2 when the tumor volume was 0.7 cm3. The maps
show an initial overall increase in ADC and decrease in RTO enhancement throughout
the tumor and achieve extreme values between Day 5 and Day 6. Thereafter, the overall
ADC values decrease and the RTO enhancement increases over the remainder of the
observation period. T2 maps in comparison show only minor changes over the entire
observation period.
Figure 4.3.4 shows the histograms of the ADC, RTO enhancement, and T2 maps for a
RIF-1 tumor as a function of time for the control animal data in Fig. 4.3.2. As indicated
by the maps, the histograms show a shift towards higher ADC values (Fig. 4.3.4, A) and
lower RTO enhancement values (Fig. 4.3.4,  B). The relatively narrow distribution from
Day 1 disperses over a larger range of values over an observation period of five days. The
histograms of the T2 maps (Fig. 4.3.4, C) show a relatively narrow peak and no shift of
the T2 value distribution over time. At the last day there is a large increase in magnitude
but the distribution is still centered around the same values  as on the previous days.
Figure 4.3.5 shows the histograms of the ADC, RTO enhancement, and T2 maps for a
RIF-1 tumor as a function of time for data from a animal treated with 100mg/kg 5-FU
from Fig. 4.3.3. Histograms of the ADC  (Fig. 4.3.5, A) at Day 1 show a distribution
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centered around low ADC values, which are associated with viable tissue. After the
chemotherapy was administered at Day 2, the distribution shifts towards higher ADC
values and is largest between Day 5 and Day 6. Thereafter, the distribution shifts back
towards lower ADC values, while the distribution disperses over a wider range of values.
Histograms of the RTO enhancement (Fig. 4.3.5, B) display a behavior similar to that of
the ADC histograms.  At the first two days, the distribution is  centered around high RTO
enhancement values associated with viable tissue. After the single dose of 5-FU was
administered at Day 2, the distribution shifts towards lower RTO enhancement values,
indicative of necrotic RIF-1 tumor tissue, with the largest shift around Day 5. Thereafter,
the distribution shifts back towards higher RTO enhancement values over the following
day and assumes a wider distribution of values.
The T2 histograms (Fig. 4.3.5, C) show no shift of the distribution. At the first two days
before the chemotherapy was administered, the T2-value distribution has a relatively
narrow and  well-defined peak. Thereafter, the distribution disperses over a wider range
of values and the magnitude decreases, with the larger dispersion and smallest magnitude
occurring between Day 5 and Day 6. Over the remainder of the days, the width of the
distribution and the magnitude return towards their  pre-treatment values.
Figure 4.3.6 shows the mean of the histograms from Figs. 4.3.4 and 4.3.5 over time
(days) for the control animal and the animal treated with 100 mg/kg 5-FU. The mean
ADC of  the control  animal  increases at  the first  three days and  then return  towards its
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Figure 4.3.4: Histograms of the ADC (A), RTO enhancement (B), and T2 (C) maps
from a RIF-1 tumor as a function of time (days) for data from a control animal (Fig.
4.3.2). The histograms were generated from the 3.0-mm-thick ADC, RTO enhancement
and T2 maps, excluding the background, and normalized by the total non-zero pixel
count of the respective map. The spatial location of the imaging slice was kept at a
constant location with respect to the isocenter of the instrument, and the tumor was
allowed to grow through the imaging plane during the 5-day observation period.
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Figure 4.3.5: Histograms of the ADC, RTO enhancement, and T2 maps from a
RIF-1 tumor as a function of time (days) for data from a animal treated with
100mg/kg 5-FU in Fig. 4.3.3. The histograms were generated from the 3.0-mm-
thick ADC, RTO enhancement, and T2 maps, excluding the background, and
normalized by the total non-zero pixel count of the respective map. The spatial
location of the imaging slice was kept at a constant location with respect to the
isocenter of the instrument and the tumor was allowed to grow through the
imaging plane during the 11-day observation period.
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value of Day 1. The animal treated with 100 mg/kg 5-FU shows a large increase in the
mean ADC after the drug was administered at Day 2. Mean ADC values follow the same
behavior as observed in the ADC maps and histograms. The largest reduction is seen
between Day 4 and Day 6, when the mean is reduced to less than half of the value it had
before therapeutic intervention.
Figure 4.3.6, B displays the mean RTO enhancement as calculated from the histograms.
For the control animal, the mean RTO enhancement values decrease over the first three
days before they recover over the remainder of the 5-day observation period. The mean
RTO enhancement of the treatment animal shows a behavior similar to that of the mean
ADC. Mean RTO enhancement values decrease after the 5-FU was administered and
peaks at Day 6, at twice the value before treatment. Thereafter, the mean RTO
enhancement increases towards the higher initial values for the remainder of the 11-day
period.
Figure 4.3.7 shows the mean ± standard deviation of the mean ADC (A), RTO
enhancement (B), and T2 (C) for a RIF-1 tumor plotted over time (days) for the control
group (n = 5) and the group treated with 100 mg/kg 5-FU (n = 5). The plot of the mean
ADC (Fig. 4.3.7, A) for five animals shows the difference between the control and
treatment group. Mean ADC values of the two groups deviate after drug administration,
with the largest separation on Day 6. The mean ADC for the treatment group increases
towards a higher mean ADC and is 87% higher at Day 6 compared to the pre-treatment
mean  ADC. At  this  time  point,  the treated  tumor volume is approximately equal to the
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Figure 4.3.6: Mean of the ADC (A), RTO enhancement (B), and T2 (C) histograms in
Figs. 4.3.4 and 4.3.5 plotted over time (days) for the control animal ( ) and the animal
treated with 100 mg/kg 5-FU (′ ). Chemotherapy was administered following data
acquisition at Day 2. The histograms were generated from the ADC, RTO enhancement,
and T2 maps shown in Figs. 4.3.2. and 4.3.3.
Figure 4.3.6: Mean of the  ( ),  enhance ent (B) and T2 (C) histograms in
Figs. 4.3.4 and 4.3.5 plotted over ti e (days) for the control ani al (?) and the ani al
treated with 100 mg/kg 5-FU ().  Chemotherapy was administered following data
acquisition at Day 2.  The histograms were generated from the ADC, RTO enhance ent,
and T2 maps shown in Figs. 4.3.2 and 4.3.3.
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Figure 4.3.7: Mean ± standard deviation of the mean ADC (A), RTO
enhancement (B) and T2 (C) for a RIF-1 tumor plotted over time (days) for the
control group (n = 5) and the group treated with 100 mg/kg 5-FU (n = 5). The
means were calculated from the ADC, RTO enhancement, and T2 maps using
at a slice thickness of 3.0 mm. Chemotherapy was administered to the animals
in the treatment group after the tumor volume was 0.7 cm3. The maps were
acquired at a constant spatial location with respect to the isocenter of the
instrument and the tumors were allowed to grow through the imaging plane
during the observation period of five and 11 days for the control and treatment
groups, respectively.
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pretreatment volume. Thereafter, the mean ADC decreases over the remainder of the
observation period. The mean ADC of the control group shows an increase followed by a
slow decrease over time. At the last observation day, when the tumor volumes are similar
(~2.0 cm3), the mean ADC values for both the control (Day 5) and treatment group (Day
11) are in the same range.
The mean RTO enhancement (Fig. 4.3.7, B) over time exhibits the same behavior as the
mean  ADC, but in the opposite direction. Mean RTO enhancement values of the control
and treatment group deviate after drug administration, with the largest separation between
the groups on Day 6. The mean RTO enhancement for the treatment group decreases
towards lower values and is smallest on Day 6. At this time, where the tumor volumes are
approximately equal, the mean RTO enhancement before treatment is 106% higher than
the mean RTO enhancement at Day 6. For the remainder of the 11 days, the RTO
enhancement increases towards the initial value. The RTO enhancement of the control
animal shows a decline of the mean RTO enhancement, with a slight increase at the last
day. At Day 5 and Day 11, the last observation day for the control and treatment group,
respectively, when the tumors are similar in volume, the mean RTO enhancement of both
groups is same range.
The plot of the mean T2 over time shows no significant changes for either the control or
the treatment group. Both groups stay within a relatively narrow range over the 5- and
11-day periods for the control and treatment group, respectively. The largest change in
mean T2 was observed at Day 6, showing a 17% increase.
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4.4 Discussion and Conclusion
Dose Response Study
The plot in Fig. 4.3.1 illustrates the differences in tumor growth for the three groups.
Animals treated with 50 and 100 mg/kg 5-FU show a clear reduction in tumor volume
after the drug was administered. After the drug level of 5-FU, with a half live of 50 min
in RIF-1 tumors (Sijens et al., 1991), decreased to a low enough level, the rapid cell
proliferation regains its dominant effect and the tumor volume again increases. Animals
treated with 100 mg/kg 5-FU exhibited a longer regression period compared to the
animals treated with the lower dose. This prolonged effect in the higher-dose group can
be attributed to the increased level of metabolized 5-FU.  The TMR for the 100 mg/kg is
in agreement with the data shown by Li et al. (1991). The tumor doubling time and time
to maximum regression were longest for the animals treated with 100 mg/kg.
Consequently, the 100 mg/kg 5-FU dose, which provides a longer time span for
observation, was chosen for the NMR experiments.
The reference point for  the determination of the tumor doubling time and time to
maximum regression was selected to be 0.7 cm3. This volume was chosen to characterize
the tumor since it is large enough for imaging but usually has only small regions of
necrosis despite the usual assessment of the tumor doubling time between 0.1 and 0.2 cm3
(Houchens and Ovejera, 1991), where the neoplasm has little, if any, necrosis.
NMR Measurement
The imaging maps from a control animal (Fig. 4.3.2) give a good illustration of the
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changes in RIF-1 tumor detected by diffusion-weighted MRI. In these maps, the imaging
plane was placed at the center of the tumor on Day 1 and kept constant over the
observation period. This approach was thought to more reproducible than keeping the
imaging plane in the center of a tumor with changing volume and shape. Therefore, only
maps with similar tumor volumes are directly comparable. At Day 1 the relatively small
tumor (0.7 cm3) is comprised of mostly viable tissue, which exhibits low ADC and high
RTO enhancement values. As the tumor grows, the development of necrosis results in
increasing ADC values with a corresponding decrease in the RTO enhancement. ADC
values measured are in agreement with data published Helmer et al. (1995), who found
that areas of high ADC correlated with necrotic tissue in the corresponding histological
section.  The slight reduction of ADC and small increase in RTO enhancement at Day 5
can be attributed to the growth of the tumor through the imaging plane. Viable tissue
from the tumor periphery is growing into the imaging plane, replacing the necrotic tissue
imaged at earlier time points. The T2 maps, which are a function of the tissue water
content, exhibit only small changes over the 5-day observation period, showing that the
range of T2 values is small in necrotic and viable tissue. H&E-stained histological
sections obtained at the last imaging day, from the same spatial location as the imaging
slice, show only general spatial agreement of the necrotic regions with the ADC and
RTO enhancement maps, while the generated T2 maps showed little or no agreement.
The ADC and RTO enhancement maps of the treatment group (Fig. 4.3.3) display a
different temporal evolution as compared to the control group. On the first day, prior to
treatment, the tumor maps have relatively low ADC and high RTO enhancement values
137
indicative of viable tumor tissue. After the injection of the 5-FU on Day 2 , there is a
significant increase in the size of regions in the maps with high ADC and low RTO
enhancement values. Extreme values are achieved at the time point (Day 5 and Day 6)
where the tumor reaches its smallest volume. The increase in ADC and decrease in RTO
enhancement 24 hours after the drug administration is thought to be due to edema, since
the tumor volume continued to increase over that time period. Thereafter, as the tumor
volume regresses, the changes seen in ADC and RTO enhancement are most likely due to
an increase in necrotic tissue and the subsequent removal of the tissue debris. This
interpretation is supported by the decrease in tumor volume following the drug
administration and the consistently high ADC and low RTO enhancement until the tumor
reaches its smallest volume. Sijens et al. (1991) has shown that injection of 5-FU alters
the tumor energy metabolism. The decrease energy availability results in hypoxia and
subsequent cell death within 48 h after therapeutic intervention.
After the TMR, the overall ADC values decrease and the RTO enhancement increases
over the remainder of the observation period. The increase in tumor volume causes the
tumor to grow through the fixed imaging plane and hence the sample slice changes with
time. T2 maps of the treated animals show no significant changes over the 11-day
observation period.
The structural changes measured by the ADC and the RTO enhancement can also be
visualized by inspection of the histograms generated from the maps. The histograms of
the control animals (Fig. 4.3.4) show a narrow distribution of low ADC values at Day 1,
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representing pixels from viable tissue. The narrow distribution of ADC values decreases
over time with a shift in the distribution towards higher ADC values representative of
necrotic tumor tissue. The growth of viable tissue into the imaging plane at Day 5, which
can be seen in the ADC maps, is recognizable as a shift in the distribution towards lower
ADC values. The histograms of  the RTO enhancement (Fig. 4.3.4, B) show a behavior
similar to that of the ADC.  At Day 1, the histogram shows high RTO enhancement
values representative of viable tissue. Over the ensuing days, progressively more tissue
becomes necrotic, causing the distribution  to shift towards lower RTO enhancement
values. At Day 5, the pixels associated with tumor necrosis are still visible in the
histogram, and pixels from the viable tissue growing into the constant imaging plane
show up at high RTO enhancement values. This simultaneous appearance of viable and
necrotic tissue causes a wider distribution of the pixels. Histograms of the T2 maps show
little or no shift of the distribution in either direction.
The histograms for the treatment group show the same general tendency as for the control
group, since the pathophysiological changes (i.e., necrosis)  caused by the  effects of 5-
FU are similar to the necrotic changes that accompany rapid cell proliferation.  In the
ADC histogram, the narrow distribution at low ADC values, representing viable tumor
tissue, increases at Day 2. On Day 3, 24 hours after the injection of 5-FU, the distribution
broadens and shifts towards higher ADC values with the largest shift at Day 6. After Day
6, a reduction of the drug effect allows the growth of new tumor tissue. This growth of
viable tissue, together with an upward shift of the tumor core with respect to the imaging
plane, results in an increased amount of viable tissue in the (fixed) imaging plane. As
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progressively more viable tissue occupies the imaging plane, the ADC shifts to lower
values. The RTO enhancement histograms display a complementary behavior. At Day 1,
there is a small contribution to the distribution at low RTO enhancement values. The bulk
of the distribution is comprised of high RTO enhancement values, which represent viable
tumor tissue. Over the time course of the subsequent days, most of the viable tissue
becomes necrotic, with a shift in the RTO-enhancement distribution towards lower
values. As the therapeutic effects of the 5-FU subside, the growth of viable tissue into the
imaging plane results in the shift of the RTO-enhancement distribution to higher values.
A comparison of the distributions before treatment and at Day 6, where the tumor
volumes equal, shows the large changes in ADC and RTO enhancement induced by
chemotherapy. A direct comparison of the histograms with the control group is only
possible at days of equal tumor volume as before treatment (0.7 cm3) and at the endpoint
of the study (2.1cm3). Comparison at these time points show that the distributions ADC
and RTO enhancement for the control and treated animals are similar. This can be
expected for the small tumor volume, since at this time point the treatment and control
tumor are the same and no therapeutic intervention had taken place. The comparable
distributions at the endpoint of the study for the control animal (Day 5, 2.1 cm3) and the
treated animal (Day 11, 2.1 cm3) suggest that a single bolus injection of 5-FU has no
prolonged effects on the tumor. The histograms of the T2 maps display no visible shift of
the distribution over the 11-day observation period. After drug administration, the
distribution disperses over a wider range accompanied by a decrease in the magnitude,
with the largest dispersion and smallest magnitude at Day 6. Thereafter, the distribution
returns to its pre-treatment distribution over the remainder of the time.
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Plots of mean ADC, RTO enhancement and T2 (Fig. 4.3.6) show the same trend observed
in the maps and histograms of the control and treated animals. The mean and not the
median was used in order to be sensitive to shifts to extreme values exhibited by the three
MRI modalities. For both the mean ADC and mean RTO enhancement, mean values
calculated from the maps of the control animal show a strong increase in ADC and
decrease in RTO enhancement, which is a consequence of increased necrosis due to rapid
cell proliferation. As more viable tissue grows into the imaging plane and replaces the
necrotic tissue at this location, a regression in the mean ADC and mean RTO
enhancement can be observed. The observed increase and subsequent decrease of the
mean T2 is a result of the dispersion of the distribution rather than changing degrees of
necrosis.
The plots of the mean ADC, RTO enhancement and T2 for the animal treated with 5-FU
is relatively stable over the first two days (before injection of 5-FU). Within twenty-four
hours after the injection of 5-FU (Day 3), the mean ADC showed its high sensitivity to
structural changes and increased  by 59% with respect to the mean ADC before
treatment. The largest change in the mean ADC was observed at Day 6, with an increase
of 122% compared to the pre-treatment value. Over the remainder of the observation
period of the experiment, the mean ADC shifted slowly back towards ADC values seen
in the initial days. This drop in ADC is caused by the progressive growth of viable tissue
into the imaging plane in combination with reoccurring rapid cell proliferation. Similar
but larger changes can be observed for the mean RTO enhancement. The mean pre-
treatment RTO enhancement value is 101% greater than the mean RTO enhancement
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measured 24 hours after therapeutic intervention and 171% greater than the minimum
value detected at Day 6, when the tumor had its smallest volume. This indicates that the
mean RTO enhancement has a higher sensitivity to structural and pathophysiological
changes induced by chemotherapy than the mean ADC. It is believed that this increased
sensitivity results from highly restricted spins, which have a higher weighting in the
calculation of the RTO enhancement compared to the ADC, which is calculated form a
composition of highly- and less-restricted spins. The mean T2 displays only small
changes over the 11-day period. At the first day after treatment, the mean T2 value
changes by 10% with respect to the pre-treatment value. The largest change of 18% was
observed at Day 6, where the T2 histogram shows the largest dispersion of the
distribution. The observed changes in the dispersion of the distribution are most likely
due to the chemotherapeutic intervention.
A plot of the mean ± standard deviation of the mean ADC, RTO enhancement and T2
over time (Fig. 4.3.7) for the  control group (n=5) and the group treated with 100 mg/kg
5-FU (n=5) show the same behavior observed in the representative animals. The means of
the control group show an initial increase in the mean ADC and decrease in the mean
RTO enhancement as tumor necrosis increases with tumor volume. The regression of the
mean at the last days in the control animals is an artifact of the experiment. As the tumor
volume increases over time, viable tumor tissue displaces the necrotic tissue in imaging
plane, which was kept at a constant location with respect to the magnet isocenter. This
penetration of viable tissue into the imaging plane results in the decrease of ADC and
increase of RTO enhancement at the last days. Again, the mean T2 shows only small
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changes and does not differ significantly from that of the treatment group.
The changes in mean ADC and RTO enhancement observed at the first day after drug
administration are not as large as those observed in the representative animal. The
maximum difference in the averaged mean is still at Day 6, the TMR. It should be noted
that the tumor volumes at the point of maximum regression are similar to the initial
volume and thus comparable. The mean ADC shows an increase of 87% over the pre-
treatment value, while the mean RTO enhancement at pre-treatment is 106% higher than
the  mean RTO enhancement at Day 6. The variability between tumors of the same group
results in a large standard deviation. Over the remainder of the observation period, the
mean ADC and RTO enhancement of the treatment group progressively returns to its
initial value. The plot of  the mean T2 for the treatment group shows only small changes
over the 11-day period and illustrates clearly the insensitivity of the T2 maps to
chemotherapeutic intervention.
This study demonstrates that diffusion-weighted MRI is sensitive to structural changes
that accompany tumor growth and treatment and that these changes can be visualized
using ADC and RTO enhancement maps. The high sensitivity of both diffusion-weighted
metrics compared to conventional T2-weighted MRI enables the early detection of
therapeutically-induced changes at an early time point in therapy. The RTO enhancement
is, however, more sensitive than the ADC implying that a measure of water diffusion that
is weighted towards highly restricted spins is a better measure of tissue viability than is a
parameter that reflects both unrestricted and restricted water molecules. In spite of that,
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the ADC data set (which is a subset of the RTO data set) has the advantage of shorter
acquisition times and the smaller diffusion gradient values necessary for data collection.
The ability of the ADC and the RTO enhancement to differentiate between viable and
necrotic tissue could be especially useful in defining dynamic changes in tumors in
response to therapeutic intervention at early time points in the course of treatment.
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5.0 The Diffusion Coefficient Measurement as a
Function of the Diffusion Gradient Duration
The measurement of the tissue water diffusion coefficient by pulsed-field-gradient (PFG)
NMR is an important tool for the detection of pathophysiological changes in cancer and
stroke. Measurements of the diffusion coefficient on clinical MRI systems have been
limited by the maximum gradient strength available on these systems. The limited
gradient strength requires the lengthening of the diffusion gradient duration, δ, to ensure
sufficient signal attenuation for the calculation of the diffusion coefficient. Diffusion
coefficient measurements that are not in the narrow-pulse regime (δ <<∆, where ∆ is the
diffusion gradient separation time), but rather in the constant-gradient regime (δ ~ ∆),
violate the experimental conditions of the diffusion experiment as described by Stejskal
and Tanner (1965) and thus need to be interpreted differently.
The goal of these experiments was to show the dependence of the measured diffusion
coefficient, ( )tD , on the gradient-pulse duration, δ . I was responsible for the animal
preparation, data acquisition and modification of some of the experiments as well as a
minor part of the data analysis.
Parts of the experiments were presented at the Experimental NMR Conference (ENC)
Meeting 1997 (Helmer et al., 1997) as a poster entitled "Experimental Determination of
Finite Pulse Width Effects in Diffusion Coefficient Measurements."
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5.1 Introduction
Most of the early diffusion measurements using NMR were performed in the presence of
a constant magnetic field gradient (Hahn, 1950; Carr and Purcell, 1954; Torry, 1956).
This means that the diffusion-gradient duration is on the order of the diffusion-gradient
separation (δ ~ ∆). Although most of the early diffusion experiments were done in
homogeneous, bulk liquid, the influence of spatial restrictions on the measured diffusion
coefficient has been recognized and considered in the early history of these
measurements (Woessner, 1963; Robertson, 1966; Wayne and Cotts, 1966; Murday and
Cotts, 1966). The breakthrough for NMR diffusion measurements came with the
δ
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Figure 5.1.1: Two different NMR pulse sequences used to measure the diffusion
coefficient. Sequence A is an example of a constant-gradient pulse sequence
characterized by the long diffusion gradient duration. The diffusion-gradient
duration, δ , for such a sequence is on the order of the diffusion gradient separation,
∆. Sequence B is a typical pulsed-field-gradient diffusion sequence (Stejskal and
Tanner, 1965), characterized by the short diffusion gradient duration, δ ,  with respect
to the diffusion-gradient separation time, ∆.
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introduction of the pulsed-field-gradient (PFG) diffusion measurement (Stejskal and
Tanner, 1965, Stejskal, 1965; Tanner and Stejskal, 1968), which is still widely used
today. An example of a constant-gradient diffusion sequence and a pulsed-field-gradient
sequence is shown in Fig. 5.1.1. Sequence A is a constant-gradient diffusion sequence
characterized by the long diffusion-gradient duration, δ, which is in the order of the
diffusion-gradient separation time, ∆. The pulsed-field-gradient sequence (Fig. 5.5.1, B),
is characterized by very short diffusion-gradient durations, δ. Diffusion-gradient pulses
are switched on only for very short periods of time to establish the initial and final
position of diffusing molecules. The diffusion-gradient separation in such pulse
sequences is much longer than the diffusion gradient duration (∆ >> δ).
With the advent of NMR imaging for medical applications, diffusion has gained
importance since the detection of many diseases is based on changes in tissue
microstructure. These changes in microstructure have been exploited in the detection of
structural tissue changes in cancer and stroke research. The biological tissue contains cell
membranes and organelles, which present barriers to water diffusion, reducing the
displacement of water molecules. Since NMR diffusion experiments measure the mean-
squared displacement of an ensemble of water molecules due to thermal motion, a
reduction in the displacement alters the measured diffusion coefficient.
In the PFG diffusion measurement, a gradient pulse of short duration is applied to impart
a phase that depends on the position on the spins and after at time, t, a second gradient
pulse of short duration removes the same amount of phase. Signal from spins that have
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not diffused away from their initial position will be unaffected by this operation, while
the signal from spins that have moved will be attenuated. The resulting signal attenuation
of the detected signal is a function of the area under the curve of the gradient pulse and
the temporal separation between the short gradient pulses. The attenuation of the detected
signal due to diffusion is given by
( ) DtkeMtkM 20, ?? −=                                         [5.1.1]
where
δγGk
??
= ,                                                  [5.1.2]
( )tkM ,?  is the measured NMR signal, 0M  is the initial signal without attenuation, D is
the diffusion coefficient, t is the diffusion time, γ  is the gyromagnetic ratio, G
?
is the
applied diffusion gradient strength, and δ  is the diffusion-gradient pulse duration.
Inspection of Eq. [5.1.1] shows, that the signal attenuation for a given diffusion time
depends on k
?
 and the diffusion coefficient, which is proportional to the mean-squared
displacement, as described by the Einstein relation. The diffusion coefficient can be
extracted from the slope of the signal attenuation curve )0/ln( MM  versus tk
2 .
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In order to achieve sufficient signal attenuation to accurately measure the diffusion
coefficient, k
?
 has to be increased. According to Eq. [5.1.2] there are only two ways to
adjust the signal attenuation - the diffusion gradient strength and the diffusion gradient
duration. With γ , the gyromagnetic ratio, constant and the applied diffusion gradient, G,
limited by technical considerations, only the diffusion pulse duration, δ , can be
increased to gain sufficient signal attenuation for an accurate calculation of the diffusion
coefficient, D(t). In clinical MRI systems with low diffusion gradient strength, the signal
attenuation has to be achieved by increasing the diffusion gradient duration, a violation of
the narrow-pulse width criteria ( )∆<<δ . The experiment is now no longer in the finite-
pulse width regime but rather in the constant gradient regime ( )∆~δ . The influence of
the narrow-diffusion-gradient pulse-width criterion and its importance for the
interpretation of many experiments has been studied by several groups (Bless, 1993;
Mitra and Halperin, 1994; Wang et al., 1995) in order to provide an analytical expression
for measurements in the restricted-diffusion regime.
Diffusion measurements in the presence of a constant gradient were first discussed by
Hahn (1950) who found that the signal attenuation is
( ) 32203
2
0
, τγτ GDe
M
GM −
= .                             [5.1.3]
where τ is half of the echo-time.
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The signal attenuation equation for restricted diffusion in a constant-gradient field was
described theoretically (Robertson, 1966) and experimentally (Wayne and Cotts, 1966)
much later. These investigators concentrated on cases involving weak diffusion gradients
and small restricting volumes, where diffusing spins are restricted before they exhibit
significant dephasing.
Diffusion in the presence of restricting barriers can be characterized based on three
different parameters (Hürlimann et al., 1995). 1) The diffusion length
tDlD 0≡                                                  [5.1.4]
which is the average distance a molecule diffuses during the time, t. 0D  is the bulk
diffusion coefficient and t is the diffusion time. 2) The dephasing length
3 0
G
D
lG γ
≡                                                      [5.1.5]
which is the distance a molecule has to diffuse in the applied gradient field to gain a
phase of 2π. Molecules gaining a phase larger than 2π can no longer be differentiated
from molecules gaining only a small phase. In this case, G is the applied diffusion
gradient strength, γ the gyromagnetic ratio, and 0D  is the bulk diffusion coefficient.
151
3) The structural length, Sl , which is the characteristic length scale of the pore space or
structure in the confining geometry.
In the first or free-diffusion regime ( SGD lll ,< ), where the diffusion length, Dl , is shorter
than the dephasing length, Gl , and shorter than the structural length, Sl , the signal decays
according to the Hahn expression (Hahn, 1950) for free diffusion in a constant gradient
field by
( )
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In the second or motion-averaging regime, diffusing molecules have crossed the pore/
structure space many times and therefore have fully experienced the restrictions. In this
regime the attenuation has been described by Robertson (1966)
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The equation holds for various geometries; however, the numerical prefactor in the
exponent must be modified depending upon the specific geometry (Neuman, 1974). The
third regime is where the dephasing length, SDG lll ,< , is smaller than the diffusion
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length, Dl , as well as the structural length, Sl . In this regime the signal arises
predominantly from spins in proximity to restricting walls, where boundaries have
reduced their displacement and hence their dephasing during the experiment. Spins not
confined by boundaries exhibit larger displacements and therefore are completely
dephased during the diffusion measurement, and thus do not contribute to the resulting
signal. The decaying magnetization in this regime, at long diffusion times, is given by
(Swiet et al., 1994).
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with 8018.11 −=− a  and c is a constant depending on the geometry of the restriction.
Considering the above regimes, it has often been argued that the Hahn formula (Eq.
[5.1.6]) for unrestricted diffusion at short diffusion times is applicable to a sample where
diffusion is restricted since diffusing spins have not traversed the structural space. Recent
studies have shown (Stoller et al., 1991; Swiet and Sen, 1994; Hürliman et al., 1995) that
the application of the Hahn formula to restricted diffusion is only valid at small diffusion
gradient values with small dephasing.
When comparing the attenuation decay for the constant-diffusion-gradient experiment
with that of the PFG-diffusion experiment, it becomes apparent that there are significant
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differences. With increased gradient duration, there is significant diffusion during the
diffusion-sensitizing gradient. Diffusion measurements in a finite-diffusion-pulse
experiment will display a smaller diffusion coefficient (Mitra et al., 1995) due to the
increased contribution of restricted molecules to the signal. Diffusion measurements
performed under constant-gradient conditions will show a higher diffusion coefficient
since restricted spins make a smaller contribution to the signal.
In addition to the different weighting of spin populations, arising from restricted and less
restricted areas of the sample, the longer TE periods needed to accommodate longer
diffusion gradient duration result in an additional loss of spins displaying a short T2
relaxation. This in turn leads to a further increase in the measured diffusion coefficient
since spins with short T2 relaxation are usually associated with molecules in more
restricted environments, which have smaller ADC's.
The different weighing of spins in the finite- and constant-diffusion gradient experiment
leads to differences in the diffusion coefficient. The goal of this study was to compare
experimental results obtained in the finite- and constant-gradient regime for biological
systems, which contain restricting structures.
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5.2 Experimental Methods
5.2.1 Animal preparation
All experiments and procedures were approved by the Animal Research Committee
(ARC) of the University of Massachusetts Medical School. Animals were housed under
diurnal lighting conditions and allowed free access to food and water before and after the
NMR experiment. Eight-week-old, female C3H mice (Taconic Farms, Germantown, NJ)
were anesthetized by intraperitoneal injection of 320 mg/kg chloral hydrate. The lower
back was shaved and the remaining hair removed with a commercial hair remover
(NAIR, Carter Wallace Inc., New York, NY).
Radiation induced fibrosarcoma cells, RIF-1 (Twentyman et. al., 1986), of the second
passage, suspended in Waymouth's medium supplemented with 15% v/v glycerol, were
stored in liquid nitrogen. Prior to inoculation the frozen cells were defrosted at room
temperature and 0.15 ml of the solution containing ~ 1 x 105 cells were subcutaneously
injected into the lower back of the animal with a 30-gauge hypodermic needle. RIF-1
tumors were allowed to grow to a range of 0.4 to 3.0 cm3. The tumor volume was
determined by measuring the three major orthogonal axes with slide calipers and the
volume was calculated to be
HeightWidthLengthVolume       
6
  ×××=
π
                       [5.2.1.1]
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assuming an ellipsoidal volume (Euhus et al., 1986; Tomayko and Reynolds, 1989).
For data acquisition, anesthesia was induced with 2% isofluorane delivered in air at 1
l/min and maintained at 1.5% isofluorane at the same flow rate. The body temperature
was maintained at 37° C by circulating 34° C warm air through the stereotax, controlled
with a T-type temperature probe (Omega, Stanford, CT) and a two-point feedback
system.
5.2.2 NMR Measurements
Spectroscopic data were acquired using a horizontal bore GE CSI-II 2.0 T 45-cm imaging
spectrometer operated at 85.56 MHz for protons, equipped with ± 20 G/cm self-shielded
gradients and a four-turn solenoidal RF coil with 15-mm inner diameter.
Four distinct pulse sequences, as depicted in Fig. 5.2.2.1, were used for data acquisition.
NMR data from the spin-echo sequences were acquired with a repetition time, TR = 10 s,
six different half echo times, TE/2 = 6.5, 11.5, 21.5, 46.5, 81.5 and 126.5 ms, a spectral
width, SW = ±2000 Hz, four signal averages (NEX = 4) and 2048 data points.
The first sequence in Fig. 5.2.21 was used to simulate a constant-gradient experiment.
The trapezoidal diffusion gradient fills the entire TE/2 period except for a 1.5 ms delay
after  the first diffusion  gradient  to allow  the eddy  currents  generated  by the  diffusion
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Figure 5.2.2.1: The four different pulse sequences used to obtain experimental
data for comparison of the narrow pulse width and constant gradient regime. 1.
Spin-echo sequence for the constant gradient experiment. 2. Spin-echo sequence
with a gradient length of TE/4. 3. Spin-echo sequence with short, constant
diffusion gradient. 4. Modified stimulated-echo sequence to cancel the effects of
background gradients and narrow diffusion gradient. The filled, gray-shaded
gradients are crusher gradients.
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gradient to decay. The second spin-echo sequence in Fig. 5.2.2.1 was similar to the first
sequence but with the diffusion gradient filling only half the TE/2 period. The third spin-
echo sequence in Fig. 5.2.2.1 was a short diffusion-gradient pulse sequence. The
diffusion-gradient duration for this sequence was kept constant at δ = 5 ms and the TE/2
period was chosen to be equal to the previous two sequences, while including the T2-
relaxation effects present in the constant gradient (Sequence 1) and half-constant-gradient
(Sequence 2) experiments. Data for the constant-gradient, half-constant gradient and
narrow-gradient experiments were acquired using a spectral width, SW = ±2000 Hz, a
repetition time, TR = 10 s, four signal averages (NEX =4), 2048 data points and six TE
periods of 6.5, 11.5, 21.5, 46.5, 81.5 and 126.5 ms. The fourth sequence in Fig. 5.2.2.1 is
a modified stimulated-echo sequence (Latour et al., 1993) used to cancel the effects of
internal background gradients present during the experiment. The cancellation was
achieved by separating pairs of gradient pulses of opposite polarity by 180° RF pulses in
each of the two TE/2 periods. Two pairs of diffusion gradients were used with a diffusion
pulse duration, δ , of 1.5 ms. Data were acquired using the fourth sequence over a range
of 12 diffusion times between 13.1 and 613.1 ms with a repetition time, TR = 10 s, an
echo time of, TE = 20 ms, a spectral width, SW = ±2000 Hz, four signal averages (NEX
= 4) and 2048 data points. This sequence minimized both the finite-pulse-width effects
and the T2 decay present in the spin-echo experiments.
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5.2.3 Data Analysis
The signal attenuation for the four sequences employed in these experiments are given by
the following equations. These equations are corrected for the shape of the diffusion
gradient pulses (Price and Kuchel, 1991). For the spin-echo sequences with a rectangular
gradient pulses with pulse edges, the signal attenuation is given by

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

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with the correction factor
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where M is the measured signal, M0 is the signal without diffusion attenuation, D is the
diffusion coefficient, G is the diffusion gradient strength, γ  is the gyromagnetic ratio, δ
is the diffusion gradient duration inclusive of one rise time, ε  is the diffusion-gradient
ramp time and ∆  is the diffusion-gradient separation. For the modified stimulated-echo
sequence with half-sine-shaped diffusion gradients, the signal attenuation is given by
Dtke
M
M 2
0
−
=                                  [5.2.3.3]
with
159
( )nGk 24 δγ=                                      [5.2.4.4]
and
64
TE
t −−∆= δ                                [5.2.3.5]
where M is the measured signal, M0 is the signal without attenuation, D is the diffusion
coefficient, G is the diffusion gradient strength, γ  is the gyromagnetic ratio, δ  is the
diffusion-gradient duration, n is the number of gradient pairs, ∆ is the diffusion-gradient
separation, TM is the evolution time, and TE is the echo time.
The diffusion coefficient, D(t), for all sequences was extracted from the slope of a plot of
ln(M/M0) versus the exponent of Eq. [5.2.3.1] for the trapezoidal diffusion gradients and
Eq. [5.2.3.3] for the half-sine-shaped diffusion gradient.
5.3 Results
Figures 5.3.1 through 5.3.3 show data for RIF-1 tumors with three different volumes. The
volumes of the tumors were 1.6, 2.6 and 3.0 cm3, respectively. The upper graph of each
figure shows the measured diffusion coefficient, D(t), of the spin-echo sequences with a
constant (), half-constant () and the narrow diffusion gradient () for diffusion times
varying from 4 to 133 ms. In each of the plots, the diffusion coefficients measured with
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the constant-gradient sequence and the half-constant-gradient sequence diverge from
those measured with a narrow diffusion gradient. Examination of the graphs reveals that
for the two largest tumor volumes (2.6 and 3 cm3), the diffusion coefficients measured
with a constant and half-constant gradient diverge from the diffusion gradients measured
with a narrow gradient at a diffusion time of approximately 20 ms. For the smallest tumor
volume, the divergence of diffusion coefficients from the narrow gradient experiment
occurs around 60 ms. At larger diffusion times, the diffusion coefficients measured with a
constant and half-constant gradient start to increase in value, while the diffusion
coefficient for the narrow diffusion gradient levels out at a constant value.
The lower graphs of Figs. 5.3.1 through 5.3.3 display the diffusion coefficients measured
with a narrow diffusion gradient over a larger range of diffusion times varying from 16 to
613 ms. For all three tumor volumes, the diffusion coefficient curves level out at constant
value which represents the effective diffusion coefficient, effD , of the tumor. The value
of Deff displays some proportionality to the tumor volume as Deff is highest for the largest
tumor volume and lowest for the smallest tumor volume.
Figure 5.3.4 illustrates the effects of the finite pulse width and added T2 on the diffusion
coefficient. The upper graph shows the diffusion coefficients measured with a constant
() and a narrow () diffusion gradient in a spin-echo experiment as well as the diffusion
coefficients measured with the modified stimulated-echo sequence (). Data acquired
with the modified  stimulated-echo sequence  allow relatively short diffusion gradient
pulses, thus  minimizing the finite-pulse width effects and T2-decay  during  the
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Figure 5.3.1: Measured diffusion coefficients for a RIF-1 tumor with a volume of 1.6
cm3. The upper graph shows the diffusion coefficients measured with  a constant (),
half-constant ( ) and narrow () diffusion gradient over diffusion times ranging from
16 to 133 ms. The lower graph displays the diffusion coefficients measured with a
narrow-diffusion gradient (Sequence 4 in Fig. 5.2.2.1) for an extended diffusion time
range from 16 to 613 ms.
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Figure 5.3.2: Measured diffusion coefficients for a RIF-1 tumor with a volume of 2.6
cm3. The upper graph shows the diffusion coefficients measured with  a constant (),
half-constant ( ) and narrow () diffusion gradient over diffusion times ranging from
16 to 133 ms. The lower graph displays the diffusion coefficients measured with a
narrow-diffusion gradient (Sequence 4 in Fig. 5.2.2.1) for an extended diffusion time
range from 16 to 613 ms.
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Figure 5.3.3: Measured diffusion coefficients for a RIF-1 tumor with a volume of 3.0
cm3. The upper graph shows the diffusion coefficients measured with  a constant (),
half-constant ( ) and narrow () diffusion gradient over diffusion times ranging from
16 to 133 ms. The lower graph displays the diffusion coefficients measured with a
narrow-diffusion gradient (Sequence 4 in Fig. 5.2.2.1) for an extended diffusion time
range from 16 to 613 ms.
 164
 
 
Figure 5.3.4: Measured diffusion coefficients for a RIF-1 tumor with a volume of 0.7
cm3. The upper graph shows the diffusion coefficients measured with  a constant ()
and narrow () gradient spin-echo sequence as well as the diffusion coefficient
measured with the modified stimulated-echo sequence ( ) over a diffusion time-range
from 16 to 133 ms. The lower graph displays the diffusion coefficients measured with
the modified stimulated-echo sequence (Sequence 4 in Fig. 5.2.2.1) for an extended
time range.
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experiment. The comparison of diffusion coefficients, measured with the narrow
diffusion gradient spin-echo and the modified stimulated-echo sequence, demonstrates
the effects of increasing T2 and finite pulse width on the diffusion coefficient. The values
of the diffusion coefficients are  in agreement only for short diffusion  times, but diverge
and begin to increase at approximately 20 ms. Diffusion coefficients measured with a
constant gradient display a steep increase in ADC with increasing diffusion time. The
ADC measured with the narrow diffusion-gradient-spin-echo stays constant up to a
diffusion time of 50 ms. Thereafter, the ADC increases with increasing diffusion times,
but at a slower rate than the ADC measured by the constant-gradient experiment.
5.4 Discussion and Conclusion
The observed deviation of the diffusion coefficient in the constant and half-constant
diffusion-gradient experiment is due to finite pulse width as well as relaxation effects.
With increasing diffusion gradient duration, δ , TE also has to increase for these
sequences and thus the signal from spins exhibiting short T2 relaxation times are
attenuated. T2 relaxation times for RIF-1 tumors are approximately 60 ms while the echo-
times used in the constant, half-constant and narrow diffusion-gradient spin-echo
experiment are up to 120 ms long. For these long echo times, the signal arises
preferentially from spins with long T2 relaxation times as spins with shorter relaxation
times experience a significant attenuation before signal acquisition. Since T2 is inversely
proportional to the degree of restrictions in porous media, the signal is expected to arise
from spins with the highest diffusion coefficients. The rise of the diffusion coefficient
166
with increasing diffusion gradient duration and echo time can be clearly observed in the
plots of Figs. 5.3.4.1 through 5.3.4.3.
Depending on the diffusion time, the finite pulse width effects may partially temper or
enhance the increase of the diffusion coefficient at large values of δ  and TE. It has been
shown (Mitra and Halperin, 1995a) that diffusion of water molecules during the
diffusion-sensitizing gradient can have two different effects. At short diffusion times with
short and finite diffusion gradient duration, the effects of restrictions are enhanced and
thus decrease the diffusion coefficient. For long diffusion times and long diffusion
gradient pulse duration, effects due to restrictions are reduced and the ADC increases as
shown in Figs 5.3.1 to 5.3.4. It can be inferred from the data shown in Fig. 5.3.4 that an
increase in both the diffusion gradient duration and the echo time leads to an increase of
the diffusion coefficient, ( )tD , with increasing diffusion time.
The diffusion-time dependent measurement of ( )tD  can be further used to extract
important structural information from the sample. It has been shown that the time-
dependent diffusion coefficient, ( )tD , deviates from the bulk fluid value, 0D , by a term
proportional to the surface-area to volume ratio, VS , (Mitra et al., 1992) as given by
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for a narrow-diffusion-gradient experiment and has to be modified for a constant-
diffusion-gradient experiment (Swiet and Sen, 1994) to:
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Modification of the numerical prefactor to the surface-area to volume ratio, VS , is
necessary since the entire path of the diffusing molecules must be taken into
consideration in addition to the initial and final positions of the molecule. This
demonstrates clearly the dependence of the diffusion coefficient, ( )tD , on the magnitude
of the diffusion gradient duration.
The above data demonstrate that both the gradient duration, δ , and the echo time, TE,
can have a significant impact on the results of diffusion measurements in biological
systems. This is particularly important for diffusion coefficient measurements performed
on clinical instruments where limited maximum gradient strength is often compensated
for by increasing the diffusion gradient duration. Further complications arise if the
measured diffusion coefficient needs to be compared to results obtained at different
diffusion times, t, diffusion gradient durations, δ , and echo times, TE.
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Chapter 6 
 
Murine Tumor Oxygen Mapping 
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6.0  Murine Tumor Oxygen Mapping 
The goal of this experiment was to develop a non-invasive method for the assessment of 
the tissue oxygen content during therapeutic intervention in a murine tumor. Hypoxia has 
long been associated with therapeutic failure, but there is still no clinically available non-
invasive method, with good spatial resolution, to monitor tissue oxygenation. My 
predecessors, Drs. Paul Hees, Bernard Dardzinski and Sam Han have pioneered the 
development of methods to measure tissue oxygen tension by 19F NMR. Their method 
was refined to provide a spatial resolution that would be acceptable for clinical use. In 
this experiment my responsibilities included inoculation of RIF-1 tumors, refinement of 
the 19F pO2 measurement, experimental design, data acquisition and processing, as well 
as data analysis. 
 
 
6.1  Introduction 
Cell hypoxia has long been linked with treatment resistivity and reoccurrence in human 
cancers (Gray et al., 1953). Tumor hypoxia is caused by the rapid growth rate of the 
neoplasm accompanied by defective and/or abnormal angiogenesis. The vasculature of 
tumors consists of blood vessels recruited from the host vasculature and from the vessels 
growing in response to the rapid tumor cells proliferation (Jain, 1988). The distribution of 
nutrients and oxygen through the vasculature is governed by the flow rate (Less et al., 
1991) and the vascular morphology (geometric arrangement, diameter, length, and 
number) (Less et al., 1991). Although the underlying mechanism of angiogenesis is 
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similar in the host and tumor (Patan et al., 1996), they are completely different with 
respect to organization.  The vascular architecture of tumors differs significantly from the 
host organ and the flow rate of red blood cells is no longer dependent on the vessel 
diameter but is orders of magnitude lower (Jain, 1996). In normal healthy tissue, cell 
proliferation is coupled with angiogenic processes to assure an adequate supply of 
oxygen and nutrients to all cells as well as removal of cellular waste. The rapid cell 
proliferation in tumors outgrowth the development of the vasculature and is often 
accompanied by defective angiogenesis. Cells in poorly vascularized and/or inadequately 
supplied regions of the tumor become oxygen deprived and subsequently hypoxic. 
 
Hypoxia can be categorized as diffusion-limited (chronic) and perfusion-limited (acute) 
hypoxia. Chronic hypoxia results from the limited distance oxygen can diffuse in tissue 
(Thomlinson and Gray, 1955; Vaupel, 1977; Olive et al., 1992; Torres-Filho et al., 1994). 
Acute hypoxia is the result of impaired blood flow and occurs in the vicinity of the 
vasculature (Brown, 1979; Chaplin et al., 1987; Jain, 1988). The occurrence of hypoxic 
regions within solid tumors has been confirmed by other researchers (Guichard et al., 
1980; Moulder and Rockwell, 1984; Chapman, 1984) and has long been recognized as a 
determining factor in cancer therapy outcome (Thomlinson and Gray, 1955) and 
associated with therapeutic failure (Horsman et al., 1988). 
 
Given the relationship between tumor oxygenation and treatment response, many 
invasive techniques have been proposed to detect, predict (Chapman, 1984) and/or 
improve tissue oxygenation status (Rockwell, 1985). To date there is still no non-invasive 
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clinically accepted method available, which provides good spatial resolution, to monitor 
tissue oxygenation during therapeutic intervention. Oxygen electrodes inserted into the 
tissue are now small and reliable enough to gain reproducible results but lack the spatial 
resolution to give a reasonable estimate of the hypoxic cell status and, in some instances, 
disturb microcirculation patterns. Other methods such as conventional nuclear medicine 
(Garrecht and Chapman, 1983), photometric (Grunewald and Luebbers, 1976), 
fluorescent techniques (Olive and Durand, 1983), positron emission tomography 
(Chapman, 1977) and nuclear magnetic resonance spectroscopy (Ng et al., 1982; Kim 
and Ackerman, 1988) are either invasive or lack the necessary spatial resolution 
necessary to monitor dynamic changes. 
 
MRI of administered PFC emulsions can provide anatomical and physiological 
information and has been used for 19F NMR of blood vessels (Joseph, 1985a; Joseph et 
al., 1985b; Eidelberg et al., 1988a; Eidelberg et al., 1988b), and tumors (Sotak et al., 
1993b; Longmaid et al., 1985; Ratner et al., 1988; Dardzinski et al., 1993b; Dardzinski et 
al., 1993c). The biodistribution of PFC emulsions has been studied by (McFarland et al., 
1985; Ratner et al., 1987; Sotak et al., 1993a; Sotak et al., 1993b; Barker et al., 1993; 
Dardzinski et al., 1993a). Their radiosensitizing properties (Song, et al., 1985; Rockwell 
et al., 1986) have long been exploited in the treatment of tumors by radiotherapy.  
 
Ever since the discovery that the spin-lattice relaxation times of perfluorochemicals are 
highly influenced by the dissolved oxygen concentration, many methods using these 
compounds have been proposed for the detection of tissue oxygenation and measurement 
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of partial oxygen pressure (pO2) within tissue. NMRS was first used establish that 
perfluorochemicals could be used to detect changes in tumor oxygen status (Mason et al., 
1991; Mason et al., 1996; Le et al., 1997). With a growing interest in the spatial 
distribution of the tissue oxygen status, MRI mapping methods were developed to 
monitor tumor oxygen status (Mason et al., 1989; Barker et al., 1993; Barker et al., 1994) 
although these methods suffered J-coupling effects commonly found in compunds with 
multiple NMR peaks. The introduction of a new perfluorochemical, perfluoro-15-crown-
5-ether, with a single resonance and an increased number of fluorine atoms (Sotak et al., 
1993c), combined with its biodistribution and sensitivity to oxygen status (Sotak et al., 
1993a) allowed a more efficient determination of tissue pO2 by MRS and echo-planar 
MRI (Dardzinski and Sotak, 1993a, 1994). 
 
Perfluorocarbons have been used to study tumor vascular patency (Ceckler et al., 1990) 
and to assess tumor oxygen status in vivo (Thomas et al., 1988; Mason et al., 1991; 
Dardzinski and Sotak, 1993b). Perfluorocarbon emulsions injected into the vasculature of 
a mouse will sequester in areas of macrophage activity, such as the reticuloendothelial 
system, abscesses, and solid neoplasms. The relaxation rate of these compounds is 
linearly related to the oxygen tension of their environment and can be used as a non-
invasive oxygen probe (Mason et al., 1991; Hees and Sotak, 1993; Dardzinski and Sotak, 
1993a). In combination with fast imaging techniques such as EPI, MRI of 
perfluorocarbons can be used to map tumor oxygenation and changes in pO2  in response 
to therapy. 
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The goal of this study was to develop a non-invasive method, based on the linearity 
relationship between the oxygen tension and the relaxation time of PFC's, to measure the 
oxygen status of tumors during therapeutic intervention. Characterization of the tumor 
oxygenation in response to chemotherapy could potentially be used to optimize the 
timing and effectiveness of therapeutic intervention, thereby improving patient care.  
 
 
6.2  Experimental Methods 
 
6.2.1  Animal Preparation 
All experiments and procedures were approved by the Animal Research Committee 
(ARC) of the University of Massachusetts Medical School. Animals were housed under 
diurnal lighting conditions and allowed free access to food and water before and after the 
experiment. Eight-week-old, female C3H mice (Taconic Farms, Germantown, NJ) were 
anesthetized by intraperitoneal injection of 60 mg/kg sodium pentobarbital (Abbott 
Laboratories, Chicago, IL). The right hind leg was shaved and remaining hair removed 
with a commercial hair remover (NAIR, Carter Wallace Inc., New York, NY).  
 
Radiation induced fibrosarcoma, RIF-1 (Twentyman et al., 1980), cells from a second 
passage were suspended in Waymouth's medium supplemented with 15% v/v FBS and 
10% v/v glycerol and stored in liquid nitrogen. Prior to inoculation, the frozen cells were 
defrosted and 0.15 ml of the suspension containing 1 x 105 cells was subcutaneously 
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injected into the right hind leg with a 30-gauge hypodermic needle. The tumor volume 
was monitored daily and determined by measuring the three major orthogonal axes with 
slide calipers. The volume was calculated to be 
 
HeightWidthLengthVolume ×××=
6
π               [5.2.1.1] 
 
assuming an ellipsoidal volume (Euhus et. al., 1986; Tomayko and Reynolds, 1989).  
 
For data acquisition, anesthesia was induced with 2% isofluorane delivered in air at 1 
l/min and maintained at 1.5% isofluorane at the same flow rate. The body temperature 
was maintained at 37° C by circulating 34° C warm air through the stereotax, controlled 
with a T-type temperature probe (Omega, Stanford, CT) and a two-point feedback 
system. 
 
 
6.2.2  Experimental Protocol 
The experimental protocol is shown in Fig. 6.2.2.1. C3H mice (n=5) with RIF-1 tumors 
of 0.7 cm3 received an intravenous tail-vein injection of 0.4 ml isotonic perfluoro-15-
crown-5-ether (40% v/v) emulsion. Thereafter, the PFC was given 48 hours to clear from 
the vasculature before imaging. Imaging was then performed for three consecutive days. 
Following the first day of imaging, the animals received an intraperitoneal injection of 
100 mg/kg 5-Fluorouracil (5-FU) (Sigma Chemicals, St. Louis, MO) dissolved in sterile 
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physiologic (0.9 %) saline (Baxter, Deerfield, IL). Two days after the first three 
consecutive days of MRI, the animal was reinjected with 0.4 ml of the isotonic perfluoro-
15-crown-5-ether (40% v/v) emulsion. At this point, the tumor volume is at a minimum, 
as determined by inspection of RIF-1 tumor growth curves in Fig. 4.1.4.1, and significant 
amounts of the PFC injection had cleared from the tumor. A 48-hour time period was 
given to allow the second PFC injection to clear from the vasculature before the tumor 
was again imaged for three consecutive days.  
 
 
6.2.3  NMR Measurements 
Imaging data were acquired using a horizontal bore GE CSI-II 2.0 T 45-cm imaging 
spectrometer (GE NMR Instruments, Fremont, CA), operating at 80.49 MHz for 19F and 
PFC
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Figure 6.2.2.1: Experimental protocol for pO2 monitoring of RIF-1 tumors in C3H
mice treated with 5-Fluorouracil (5-FU). Animals with a tumor volume of 0.7 cm3
received 0.4 ml of isotonic  perfluoro-15-crown-5-ether (40 % v/v) emulsion via tail-
vein injection. A 48 hour time period was given to allow the PFC from the first
injection to clear from the vasculature. The animal was then imaged for three
consecutive days. After the first imaging session animals received an i.p. injection
of 100 mg/kg 5-FU. Two days after the first three days of imaging the animal
received a second injection of 0.4 ml of perfluoro-15-crown-5-ether emulsion. The
PFC of the second injection was allowed to clear from the vasculature for two days
before the animal was imaged again for three consecutive days.
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85.56 MHz for 1H, equipped with ±20 G/cm self-shielded gradients and a four-turn 
solenoidal RF-coil with 18-mm inner diameter. 
 
Multiple-slice, inversion-recovery echo-planar imaging was used to acquire 1-mm-thick 
slices over the entire tumor volume. The eight coronal images for each slice were 
acquired with an inversion times (TI) of 0.01, 0.08, 0.2, 0.5, 1.0, 3.0, 5.0 and 8.0 seconds, 
respectively, a repetition time (TR) of 10 s, an echo time (TE) of 74 ms, a spectral width 
(SW) of ±30000 Hz, four signal averages (NEX), a field of view (FOV) of 30.0 × 30.0 
mm, and 64 × 64 digital resolution. 1H images of each slice were obtained using the same 
acquisition parameters except for TR = 6s, and were used as segmentation images during 
the calculation of the pO2 maps. 
 
 
6.2.4  Data Analysis 
In vitro T1 relaxation curves for calibration were acquired spectroscopically from the net 
perfluoro-15-crown-5-ether at four different temperatures, 22, 27, 32, and 37° C, and O2 
concentrations of 5, 21, 35, and 50%, to establish the relationship between the relaxation 
time and the oxygen content. Calibrated O2/N2 gas mixtures of 5, 21, 35, and 50% O2 
were separately bubbled through the PFC for 30 minutes before the T1 value was 
measured spectroscopically at each temperature. Calibration curves of the partial oxygen 
tension, pO2, in torr as a function of temperature, T, and the relaxivity, R1 (1/T1), were 
obtained by fitting the data using multiple-linear regression. 
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Oxygen tension maps were created from a series of 19F IR-EPI's, which were fitted, on a 
pixel-by-pixel basis, using a nonlinear-least-squares Levenberg-Marquardt algorithm to 
the equation  
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BeATIS                                            [6.2.4.1] 
 
where TI is the inversion time, A the signal intensity for TI = 0, B the inversion efficiency 
and T1 the relaxation time. Each pO2 map was masked using the 1H images to avoid 
fitting pixels that did not originate from within the tumor. Oxygen tension maps were 
then created from the calculated T1 maps using the calibration equation derived from the 
in vitro T1 measurement. Tumor T1 values smaller then 1 s and larger then 3 s were 
disregarded as a result of a poor fit and because they were out of the range of possible T1 
values achievable with perfluoro-15-crown-5-ether under physiological conditions. 
 
Histograms of relative frequency versus pO2 concentration, with a bin size of ten torr, 
were generated from each slice at each day. The mean pO2 of each histogram was 
calculated and bar graphs displaying the mean of each slice for each individual day were 
created. Further, the mean pO2 of the entire tumor was calculated at each day and plotted 
as a function of time. 
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6.3  Results 
Multiple regression was used to extract the relationship between the partial oxygen 
tension, pO2, the temperature, T, and the in vitro measured relaxation time, 11 1 RT = , 
from measurements at four oxygen concentrations and four different temperatures. The 
resulting calibration equation was 
 
TpOR 0098.00038.06897.0 21 −+=        [r
2 = 0.997]              [6.3.1] 
 
where the partial oxygen tension, pO2, is in torr, and the temperature, T, is in degrees 
Celsius. Rearranging  Eq. [6.3.1] for pO2 gives: 
 
424.1825799.2502.264 12 −+= TRpO                                 [6.3.2] 
 
Equation [6.3.2] was then used to convert the measured 19F relaxation rates, R1 (1/T1) into 
the partial oxygen tension at a given temperature of 37° C. 
 
Figure 6.3.1 shows a calculated pO2 map and a corresponding raw image at the inversion 
time, TI, of eight seconds. The map was filtered, as described in the methods section, and 
disregarded pixels due to a poor fit or physiologically unreasonable values were set to 
253. Pixels with low signal-to-noise resulted in poor fits and hence erroneous relaxation 
times. Pixels at the noise level in the raw image corresponded well with the pixels (set to  
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253) in the pO2 maps as indicated by the red arrow in Fig. 6.3.1. Figure 6.3.2 illustrates 
the signal intensity versus TI for a pixel in Fig. 6.3.1 that was disregarded.  
 
0 torr
253 torr
Figure 6.3.1: Calculated pO2 map of a slice through RIF-1 tumor (left) and a 19F IR-
EPI (with TI = 8 s) of the same slice (right). Pixels with poor fit, marked by the red
arrow,were set to a value of 253. The area of poor fitting can be seen in the 19F IR-EPI
as a region with low signal-to-noise and corresponds to the pixels with a value of 253 in
the pO2 map.
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Figure 6.3.2: Plot of the signal intensity versus TI for a pixel from Fig.
6.3.1 that was disregarded.
 180
The plot in Fig. 6.3.3 shows the signal intensity for a pixel of the same image but with a 
good fit. It can be seen that the signal magnitude for this pixel is larger then the signal 
magnitude of the poor-signal pixel and that the signal intensity follows Eq. [6.2.3]. 
 
 
The resulting pO2 maps of a representative tumor for each imaging day and slice are 
displayed in Fig. 6.3.4. Slice 1, representing the bottom of the tumor, is the first slice and 
is located at the height of the underlying muscle. The adjacent slices are then taken 
towards the top of the tumor, away from the muscle. The maps demonstrate clearly the 
difference in oxygen tension between slices and over the entire tumor volume. A 
reduction in tumor oxygenation can be seen as the tumor volume decreases following the 
administration of chemotherapy and then at later time, when the tumor volume again 
starts to increase.  
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Figure 6.3.3: Plot of the signal intensity versus inversion time, TI, for
a pixel from Fig. 6.3.1 which resulted in a good fit to Eq. [6.2.4.1].
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Figure 6.3.4: Oxygen tension maps of a representative RIF-1 tumor grown on the right hind leg of
a C3H mouse. The maps were acquired by multiple-slice 19F MRI, with a thickness of 1 mm, over
the time course of chemotherapeutic intervention. Slice 1, representing the bottom of the tumor, is
the first slice and is located at the height of the underlying muscle. The adjacent slices are taken
towards the top of the tumor. Following the first day of MRI (Day 3), the animal received a single
bolus injection of 100 mg/kg 5-Fluorouracil intraperitoneally. At Day 7, when the tumor volume
was at the minimum, the animal received a second injection of 0.4 ml perfluoro-15-crown-5-ether.
The pO2 maps illustrate the dynamic changes in tumor oxygenation between consecutive days and
for adjacent slices over the time course of chemotherapeutic treatment.
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Figure 6.3.5: Oxygen tension maps, with 1
mm slice thickness, over the entire volume of
a RIF-1 tumor one day after the
intraperitoneal bolus injection (Day 4) of
100mg/kg 5-Fluorouracil. The histograms
below are generated from the pO2 maps
above and normalized by the total non-zero
pixel count of the maps obtained by 19F EPI-
MRI.  Slice 1 is the bottom of (muscle below)
the tumor and the consecutive slices are
progressing towards the top of the tumor.
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To further visualize the differences in pO2 within an individual slice, a histogram of each 
slice was generated from the respective pO2 maps. In Fig. 6.3.5, the pO2 maps and the 
corresponding histograms are displayed for Day 4. Both the maps and the histograms 
show that the pO2 concentration in the tumor varies significantly with spatial location. 
 
During the time course of the chemotherapeutic intervention, clear changes in the 
oxygenation  status of  the tumor are observed. These changes are displayed in  Fig. 
6.3.6, where the mean pO2 over the course of the treatment is plotted for each slice and 
day. Slices at the bottom (e.g. Slice 1) and top of the tumor consistently display a higher 
mean pO2 than slices within the tumor. 
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Figure 6.3.6: Mean pO2 of each slice and each imaging day calculated form the
histograms of the maps shown in Fig. 6.3.4.
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Comparison of the mean pO2 of the entire tumor calculated from all slices of that day 
allowed visualization of the effect of treatment on the pO2 over the time course of 
therapeutic intervention. The mean pO2 at Day 3 was measured before the injection of the 
chemotherapeutic agent. Over the subsequent days (Day 4 and Day 5), the mean pO2 of 
the tumor decreases. As the tumor volume starts to increase again (Day 9 and Day 10) 
following therapy, the pO2 increases slightly. As the tumor volume gets larger (Day 11), 
increases in hypoxic tissue further reduce the tumor oxygen tension. This general 
tendency was observed in all tumors studied and a plot for a representative animal is 
shown in Fig. 6.3.7. 
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Figure 6.3.7: Plot of the mean pO2 of the
entire tumor versus time (Days) from a
representative animal, calculated from all
slices of the respective day.  The dashed line
marks the time when the PFC was reinjected
and allowed to clear from the vasculature.
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6.4  Discussion & Conclusion 
Examination of the pO2 maps demonstrates the changes of oxygen tension within the 
tumor and the necessity for good spatial resolution for the assessment of the tissue 
oxygen status. Even between adjacent slices there are large differences in oxygen tension 
(Fig. 6.3.5). Examination of Fig. 6.3.5 clearly illustrates the changes in pO2 between 
adjacent 1-mm-thick slices. The plot of the mean pO2 for each slice at Day 4 (Fig. 6.3.6) 
illustrates these changes. Slices at the bottom and top of the tumor have consistently 
higher pO2 values than the tumor core, which can be explained by the vascular growth 
pattern. Tumor vasculature in solid tumors has its highest density at the periphery and a 
decrease in density towards the core of the tumor. These regions of high pO2 can also be 
seen in Fig. 6.3.4. Areas well supplied with oxygen are mainly found at the periphery of 
the tumor. The bottom of the tumor is generally not well supplied with oxygen. In the 
case of RIF-1 tumors grown on the hind leg of a mouse, this area gains its oxygen supply 
from the well oxygenated muscle tissue adjacent to the tumor. 
 
Looking at the entire tumor volume during chemotherapy allows a complete assessment 
of changes in tissue oxygenation in response to chemotherapy. As the tumor volume 
decreases as a result of chemotherapy, so does the tissue pO2. All tumors showed the 
expected decrease in mean pO2 after the administration of the chemotherapeutic drug. 
This decrease is due to the toxic affect of the agent that causes tumor cell death. Dying 
and dead tumors cells, that have not been removed, have an extreme low oxygen tension 
and are still visible in the maps. The contribution of these cells results in an decrease in 
tissue oxygen tension that is observable in Figs. 6.3.4, 6.3.6 and 6.3.7. Dead cell material 
 186
is then removed by auto- and/or heterolysis resulting in a decrease in tumor volume. The 
decrease in pO2 continues until tumor regrowth regains a dominant role following 
treatment. At this time, the relatively small tumor is well supplied with oxygen since 
most of the cells are within the vicinity of the vasculature. This close proximity to the 
vasculature in turn results in an increased oxygen supply and tissue oxygen status. 
Imaging on Day 9 captures the end of the regrowth phase, where the tumor is still 
relatively well supplied with oxygen. The resulting high mean pO2 for this day can be 
seen in both the pO2 maps as well as in the plot of the mean pO2 versus time (Fig. 6.3.7).  
 
Data from the regrowth phase were not available due to the clearance of the sequestered 
PFC from the tumor. Reduction of the tumor volume by auto- and/or heterolysis in 
response to chemotherapeutic intervention causes not only the removal of dead cell 
material but also the partial removal of the PFC emulsion particles. In order to gain 
sufficiently high S/N for the 19F EPI, a second injection of the perfluoro-15-crown-5-
ether was necessary. The preferred time point of this injection was chosen as the time at 
which the tumor had reached its smallest volume. Reinjection at this time point was 
thought to minimize the removal of the PFC from the tumor by the chemotherapeutic 
process. Following the second injection, there was a 48-hour period during which the 
PFC was allowed to clear from the vasculature. Imaging of the tumor during this period is 
thought to result in biased of the measured pO2 by the vascular oxygen concentration. 
 
On Days 10 and 11, a decrease in pO2 can be observed as the rapid cell proliferation 
causes the tumor to again outgrow its vasculature supply. The rapidly-growing tumor is 
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not supported by a corresponding growth of the vasculature, leaving many cells within 
the tumor without adequate oxygen. While all the tumors studied displayed similar 
behavior and oxygenation pattern in response to chemotherapy, it was not possible to 
qualitatively pool the results from all tumors due to inter-tumor variability. Since each 
tumor displays its own growth pattern, which is dependent on the nutritional supply to the 
neoplasm and the host vasculature, each tumor can only be compared to the oxygen status 
before the initiation of therapy. Another factor is inter-animal differences in the rate at 
which the chemotherapeutic agent (5-FU) is metabolized for activation. Varying 
metabolic rates between animals leads to different levels of activated 5-FU and hence to 
differences in the growth pattern during chemotherapy. Consequently, the best basis for 
comparison is the pO2 distribution and the mean pO2 before treatment. Comparison of the 
pre-treatment pO2 maps (Day 3) with the pO2 maps after treatment clearly shows the 
induced changes in tissue oxygen status and the decrease in pO2. A subsequent increase 
in pO2, due to the rapid cell proliferation following treatment, eventually results in a 
significant amount of hypoxia. 
 
This study demonstrated that 19F MRI can assess tumor oxygen status non-invasively 
with a sufficiently spatial resolution to detect dynamic changes in tissue oxygen status in 
response to chemotherapy. Examination of the pO2 maps and histograms demonstrate the 
need for the spatial resolution provided by 19F EPI to monitor oxygen tension in tumors. 
The large variability of pO2 between the slices through the tumor, as well as the changes 
occurring over the time course of treatment, are difficult to capture using modalities with 
coarser spatial resolution (e.g., oxygen electrodes). Other methods, such as nuclear 
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medicine and positron emission tomography, which might be able to reproduce the same 
resolution, are invasive and cannot be used to monitor the time course over an extended 
time period. Multiple slice 19F IR-EPI should be a powerful tool for the non-invasive 
assessment of tumor oxygen status and for the guidance of chemo- or radiation therapy. 
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Chapter 7 
 
Summary 
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Summary 
The first study involved the transfer of the porous media theory to biological systems. 
Structural properties provide the connecting bridge between the two systems. The porous 
media theory has its origin in the investigation of pore space in rocks and sediments. In 
such systems there are interconnected or enclosed pore spaces surrounded by solid 
matter. Measurements of the diffusion coefficient allow the geometry of this space to be 
probed and the extraction of the surface-area to volume ratio as well as the tortuosity. 
While the surface-area to volume ratio provides information of the structural geometry, 
the tortuosity provides information regarding the connectivity of the pore space. In 
biological tissue there are similar structures. Although the restricting barriers are not 
impenetrable as in the case of porous media, water molecules in biological tissue still 
experience similar restrictions from the cell membranes and organelles. Nevertheless, the 
tortuosity in biological systems must be redefined and combined with the connectivity of 
the cell space and the permeability of the cell membranes since diffusing water molecules 
can cross cell boundaries. The application of porous media theory to biological systems 
was already shown by Dr. Latour during his stay at WPI. New in the present research is 
the use of the return-to-the-origin (RTO) probability, which is based on the porous media 
theory.  
 
Application of the RTO probability to measure structural changes as they occur in 
response to tissue necrosis was the first project. Chapter 3 shows that the RTO-
enhancement, R, decreases with increasing tumor size. Therefore, R, should be inversely 
correlated to an increasing amount of necrosis, since tumors become increasingly necrotic 
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as they grow larger. The findings of the first study were presented at the 5th Scientific 
Meeting of the International Society of Magnetic Resonance in Medicine in Vancouver. 
The next phase of the project was to extend the spectroscopy experiments to imaging. 
Measuring diffusion with high gradients resulted in two major problems: The increase in 
echo time necessary to accommodate the image acquisition and the reduced signal due to 
smaller volume. The development of the RTO imaging method was a compromise 
between the need for high k values and a good signal-to-noise ratio. The first attempts 
were very encouraging and presented at the IEEE 24th Northeastern Biomedical 
Engineering Conference in Hershey, Pennsylvania. Comparison with the histological 
sections in a follow-up study showed that in spite of the good preliminary results, the 
ADC and RTO-enhancement maps showed only general agreement in their major 
features. This is most likely a result of the large slice thickness as compared to previous 
studies. A thinner slice thickness would result in better agreement but needs to be 
demonstrated and addressed in a future study. The mean of both the ADC and the RTO-
enhancement maps agreed well with the necrotic tissue fraction determined by histology. 
 
The chemotherapy study involved the characterization of RIF-1 tumors in response to 
administration of 5-Fluorouracil. Tumor growth curves were acquired for characterization 
of the response to different doses of the drug. The purpose of the study was to determine 
if the ADC and the RTO probability were sensitive enough to detect early changes in 
tumor tissue structure in response to therapeutic intervention. This could provide a useful 
tool in the guidance of therapy and avoid prolonged exposure to chemotherapeutic agents 
if the neoplasm is not responding well to treatment. 
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The study of the influence of finite pulse width on the measured diffusion coefficient 
tried to answer some of the problems arising when limited gradient strength is 
compensated for by increasing the gradient duration. As diffusion measurements on 
clinical MRI scanner become more prevalent, many of the instruments will not have the 
required gradient strength for diffusion measurements using short pulse widths. Instead, 
the signal attenuation achieved by increasing the gradient duration is closer to a constant 
gradient experiment diffusion experiment, which makes the results of such experiments 
more difficult to interpret. Even though the differences in the measured diffusion 
coefficient, ( )tD , could be demonstrated in this study, future studies will have to be 
conducted to find quantitative and mathematical expressions to account for deviations 
from classical NMR diffusion theory. 
 
The last experiment in this series was the mapping of tissue oxygen tension in response to 
chemotherapy. Previous studies required a large slice thickness to compensate for the 
small fluorine signal arising from the injected PFC. Optimization of the complete 
process, from the PFC injection to improvements in the data acquisition methodology, 
allowed us to reduce the slice thickness to 1 mm. In the original incarnation of this study, 
a single slice with a thickness of 3 mm was used. After a conversation with Dr. 
Fitzgerald, who pointed out the significance to assess the oxygen status at a higher 
resolution, and the acceptable signal levels obtained at 1 mm slice thickness, the protocol 
was reevaluated. Oxygen maps acquired in the study illustrate the changes in tissue 
oxygen tension in response to therapeutic intervention. The results should demonstrate 
that 19F MRI of PFC's in tumors is a powerful tool for non-invasive monitoring of cancer 
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therapy. Future studies need to further refine the use of 19F MRI and its application in the 
support of cancer therapy. 
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